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ABSTRACT 
Over the years purinergic receptors have emerged as important players in the onset of 
inflammation and modulation of immune responses. One of these receptors; the P2X7R is 
an attractive drug target due to its involvement in triggering the processing and secretion of 
the proinflammatory cytokine IL-1β. The P2X7R may play a potential role in conditions 
such as rheumatoid arthritis, atherosclerosis, Alzheimer’s disease and neuropathic pain.  
 
In this study I initially established that activation of this receptor is highly dependent on 
the species, agonist and extracellular milieu. This demonstrated not only that caution 
should be exercised in designing assays to study the P2X7R but more importantly that 
changes to the extracellular environment during inflammation could easily modulate 
activation of the receptor.  
 
It was also observed that activation of the receptor could induce a range of morphological 
changes in the absence of cell death. These processes could potentially play a role not only 
in signal transduction and dissemination of pro-inflammatory responses but also in 
propagating and amplifying procoagulant signals.  
 
Finally I determined that extracellular ATP could evoke significant changes in the redox 
status of the cell; not only activating generators of reactive oxygen species but modulating 
the activity of cellular reductants. Furthermore these redox pathways were observed to play 
a highly significant role in the activation of caspase-1, processing and secretion of IL-1β 
and ultimately cell death.  
 
Here I have demonstrated that extracellular ATP and the P2X7R play an important role in 
immunomodulation, inflammation and coagulation. Therefore I conclude that purinergic 
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Toll-IL-1R domain-containing
 
adaptor protein TIRAP 
Toll-like receptors TLR 
Tumour necrosis factor TNF 
2′,3′-O-(2,4,6-Trinitrophenyl) adenosine 5′-triphosphate TNP-ATP 
Toll-IL-1R domain-containing
 
adaptor inducing IFNβ related adaptor molecule TRAM 
Toll-IL-1R domain-containing
 
adaptor inducing IFNβ TRIF 
Tris(hydroxymethyl)aminomethane hydrochloride Tris-HCl 
Thioredoxin Trx 
Thioredoxin reductase TrxR 
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AMINO ACID CODE 
 
Alanine A Ala 
Arginine R Arg 
Asparagine N Asn 
Aspartic Acid D Asp 
Cysteine C Cys 
Glutamic Acid E Glu 
Glutamine Q Gln 
Glycine G Gly 
Histidine H His 
Isoleucine I Ile 
Leucine L Leu 
Lysine K Lys 
Methionine M Met 
Phenylalanine F Phe 
Proline P Pro 
Serine S Ser 
Threonine T Thr 
Tryptophan W Trp 
Tyrosine Y Tyr 
Valine V Val 
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In recent years the role of ATP and the receptors it acts at have been increasingly linked to 
the regulation of inflammatory processes.  These processes range from the killing of 
intracellular pathogens (Fairbairn et al., 2001), cell migration (Ohsawa et al., 2007) and the 
processing and release of cytokines (Pelegrin et al., 2008). In particular the P2X7 receptor 
which is primarily expressed on cells of  haemopoetic origin, is thought to play a key role 
in inflammatory processes due to its ability to activate the interlukin-1β (IL-1β) converting 
enzyme caspase-1 (Solle et al., 2001) and induce cell death (Surprenant et al., 1996). ATP 
is usually retained within the cell cytoplasm therefore its release in to the extracellular 
mileu could potentially act as a danger signal activating the innate immune system. In this 
study I hypothesise that purinergic receptors are involved in modulating the innate immune 
response and are therefore involved in propagating pro-inflammatory and pro-coagulant 
processes.  
 
1.1 PURINERGIC SIGNALING  
The naturally occurring nucleotide adenosine 5’-triphosphate (ATP) is present in every 
living cell. It is an important multifunctional molecule; it is a cell’s molecular currency 
involved in transporting chemical energy, it is an intracellular signaling molecule which is 
critical for signal transduction processes and also an extracellular signaling molecule 
involved in inducing a number of physiological and pathophysiological events.  
 
ATP consists of adenosine (adenine ring and a ribose sugar) and three phosphate groups 
(triphosphate) and through hydrolysis can form adenosine 5’-diphosphate (ADP), 
adenosine 5’-monophosphate (AMP) and adenosine (Figure 1-1). ATP was originally 
discovered by chemist Karl Lohmann in 1929 (Langen et al., 2008) and determined to be 
the universal carrier of chemical energy in the cell by Lipmann during his work in 1939-
41(Lipmann, 1941). ATP is able to function as a carrier of energy in all living organisms 
due to the release of energy achieved when one phosphate group is removed forming ADP 
(Figure 1-2). ATP itself is synthesised from ADP in a process determined in the 1960s to 
be catalysed by ATP synthase (F0F1 ATPase / Complex V). Work by Mitchell determined 
that cellular respiration led to a difference in hydrogen ion concentration inside and outside 
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the mitochondrial membrane and that the movement of hydrogen ions would drive the 










Figure 1-2. Hydrolysis of ATP leads to the formation of ADP & the Release of Energy from High-
Energy Bonds.  
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Figure 1-3. Schematic of the generation of an electrochemical gradient across the inner membrane of 
the mitochondria by complex’s I, II, III and IV in order for the generation of ATP to occur via 
complex V.  
 
In the same year as the discovery of ATP, Drury and Szent-Györgi described the potent 
actions of purine nucleotides and nucleosides (specifically adenosine and AMP) on the 
heart and blood vessels (Drury et al., 1929). In the 1970’s seminal work by Geoffrey 
Burnstock summarized the evidence that had accumulated over the years since this initial 
observation and proposed the purinergic neurotransmission hypothesis. This hypothesis 
proposed that ATP was a neurotransmitter in nonadrenergic, noncholinergic (NANC) 
nerves (Burnstock, 1972). Implicit to this concept was the existence of purinergic receptors 
which Burnstock defined in 1976 and later in 1978 suggested the potential presence of two 
purinergic receptor families, the P1-receptors where adenosine is the principle ligand and 
P2-receptors which recognise both ATP and ADP (Burnstock, 1978; Burnstock, 1976). 
However due to the establishment of ATP being an intracellular energy source this concept 
was met with considerable resistance, as it was thought that such a ubiquitous molecule 
was unlikely to be involved in selective extracellular signaling. However the identification, 
cloning and studies of transduction mechanisms of specific purinergic receptors in the 
1980’s and 1990’s has led to the concept of ATP and other purine and pyrimidine 
molecules being extracellular signaling molecules to become widely accepted.   
 
As stated the P1/Adenosine receptors (P1/AR) are preferentially activated by adenosine 
whereas the P2 receptors are preferentially activated by ATP and/or ADP (Figure 1-4). To 
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date four subtypes of P1/AR have been cloned –A1, A2A, A2B and A3 which are all seven 
transmembrane G-protein coupled receptors. The P2 receptors family is split into two 
major subfamilies termed P2Y and P2X. The P2Y receptors (P2YR) are G-protein coupled 





Figure 1-4. Schematic of P1/A, P2Y & P2X Receptors & their Activation by Adenosine, ADP & AMP. 
P1/A and P2Y receptors are GPCRs which are typified as having seven transmembrane spanning domains, 
extracellular N-terminus and intracellular C-terminus.  The P2X receptors are ligand gated ionotrophic 
receptors; each subunit consists of two transmembrane spanning domains, intracellular N and C-termini and a 
large extracellular domain.  
 
1.1.1 P2Y Receptors 
Originally P2YRs were classified based on native purinergic responses with the 
observation that they showed greater responses to 2-(Methylthio) ATP (2meSATP) than to 
ATP (Burnstock et al., 1985). The cloning of the first P2YR occurred in 1993 (Webb et al., 
1993) and there have so far been eight mammalian P2Y subunits cloned -P2Y1, P2Y2, 
P2Y4, P2Y6, P2Y11, P2Y12, P2Y13 and P2Y14.  
 
The P2Y1, P2Y12 and P2Y13 receptors are all primarily activated by ADP (Figure 1-5). The 
P2Y2R can be activated by both ATP and uridine-triphosphate (UTP). The P2Y4R is 
activated by UTP and the P2Y6R by uridine-disphosphate (UDP). P2Y11 is activated most 
potently by ATP and the P2Y14R by UTP-glucose. P2Y1, P2Y2, P2Y4, P2Y6, P2Y11 all 
couple to the G-protein Gαq which can activate phospholipase-C (PLC) causing the 
mobilization of intracellular calcium (Figure 1-6).  P2Y11 is also able to couple in to Gαs 
causing an activation of adenylyl cyclase (AC) and therefore an increase in the cellular 
S.F.Moore 
CHAPTER 1: INTRODUCTION 
22 
cyclic adenosine monophosphate (cAMP) levels. Whereas P2Y12, P2Y13 and P2Y14 can 
couple to Gαi inhibiting AC and therefore decreasing cellular levels of cAMP. 
 
 
Figure 1-5. Schematic of the Activators of P2YRs. ADP is able to activate P2Y1, 12 & 13. ATP is able to 



















Figure 1-6. Coupling of P2YRs to G-Proteins. P2Y1, 2, 4, 6 & 11 couple to Gαq which is able to activate PLC 
leading to the mobilization of calcium ions from intracellular stores. P2Y11 is also able to couple to Gαs 
which activates AC leading to the synthesis of cAMP. P2Y12, 13 & 14 couple to Gαi which inhibits AC 
therefore leading to a decrease in cellular cAMP levels.  
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1.1.2 P2X Receptors 
P2XRs were originally classified based on native purinergic responses which determined 
that they showed greater responses to α,βmethylene ATP (α,βmeATP) and β,γ-methylene 
ATP (βγmeATP) than ATP (Burnstock et al., 1985). Cloning of the P2X1 (Valera et al., 
1994) and the P2X2 receptor subunits (Brake et al., 1994) took place simultaneously in 
1994 and to date seven P2X subunits have been identified (P2X1-7). Each subunit has been 
suggested to consist of an intracellular amino and carboxy terminus and two hydrophobic, 
putative membrane spanning domains separated by a large ectodomain (Figure 1-4). Each 
P2X channel is thought to be composed of a trimer of subunits with supportive evidence 
from Nicke et al., (Nicke et al., 1998) who observed that P2X1 and P2X3  receptors migrate 
as trimers on BN-PAGE and Barrera et al., (Barrera et al., 2005) who determined using 
atomic force microscopy on purified P2X2 subunits that the average angle between 
subunits was approximately 120
o
 constituent with these subunits forming a functional 
trimer. These subunits can either all be the same (e.g. homomeric P2X7R channel) or a 
mixture of two types (e.g. P2X2/3R channel). All of the P2XRs are non-selective cation 





) ions and an efflux of potassium (K
+
) ions.  
 
The physiological agonist of all the P2XRs is ATP; however ATP derivatives can be used 
to distinguish some of the receptors from each other (Table 1-1A). For example 
homomeric P2X1R is activated by submicromolar concentrations of ATP, α,βmeATP and 
2',3’-O-(4-benzoyl-benzoyl) ATP (BzATP). In contrast the homomeric P2X7R requires 
ATP within the high micromolar to low milllimolar range for activation.  
 
The receptors can also be differentiated pharmacologically from each other by the use of 
antagonists (Table 1-1B). Suramin is widely used as a generic P2XR antagonist although 
its IC50 values at each receptor varies widely; it blocks P2X1, P2X2, P2X3 and P2X5 in the 
low micromolar range whereas the P2X4R is relatively insensitive to blockade both by 
suramin and its analogue NF279. Furthermore as yet no selective antagonists for the 
P2X4R have yet to been identified. Over the past few years several specific human P2X7R 
antagonists have been identified; primarily due to the drug industry’s interest in P2X7R 
blockers being used as a therapies in chronic inflammation and pain. The isoquinolines 1-
[N, O-Bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN-62) and 
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N-[1-[N-methyl-p-(5 isoquinolinesulfonyl)benzyl]-2-(4 phenylpiperazine)ethyl]-5-
isoquinolinesulfonamide (KN-04) were identified in 1998 (Humphreys et al., 1998) to be 
highly selective human P2X7R antagonists. Since then AstraZeneca (Stokes et al., 2006), 
GlaxoSmithKline (Broom et al., 2008) and Abbott Laboratories (McGaraughty et al., 
2007) have all developed selective P2X7R antagonists. Of note AstraZeneca currently have 
AZD9056 in phase II clinical trials for the treatment of rheumatoid arthritis (RA).  
 
The P2XRs are also differentially modulated by a range of species; for example the broad 
spectrum antiparasitic medication ivermectin potentiates P2X4 mediated currents with an 
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A 
EC50 (µM) P2X1 P2X2 P2X3 P2X4 P2X5 P2X6 P2X7 
ATP 0.07 1.2 0.5 10 10 12 100 
2meSATP 0.07 1.2 0.3 10 10 9 100 
α,βmeATP 0.3 > 300 0.8 > 300 > 300 > 100 > 300 
BzATP 0.003 0.75 0.08 7 > 500 - 20 
 
B 
IC50 (µM) P2X1 P2X2 P2X3 P2X4 P2X5 P2X6 P2X7 
Suramin 1 10 3 >500 4 >100 500 
PPADS 1 1 1 >500 3 >100 50 
TNP-ATP 0.006 1 0.001 15 - - >30 
KN-04 
KN-62 
- - - - - - 0.3 
A-438079 >100 >100 >100 >100 - >100 0.06 
NF279 9 30 50 >100 - - 20 
GSK314181A >10 >10 >10 >10 - - 0.10 
AZ11645373 >10 >10 >10 >10 >10 - 0.10 
 
Table 1-1. Agonist EC50 and Antagonist IC50 Values at Recombinant Human P2XRs. Tables adapted 
from (Jarvis et al., 2009) with original data from (Bianchi et al., 1999; Donnelly-Roberts et al., 2007b; Gever 
et al., 2006; Honore et al., 2006; Jacobson et al., 2002; Jarvis et al., 2002; McGaraughty et al., 2007; Nelson 




1.1.3 The Role of Purinergic Signaling in Immunity & Inflammation 
As already stated extracellular ATP is involved in a number of physiological and 
pathophysiological events. These events include local control of vessel tone (through 
modulation of sympathetic transmission), detection and communication of taste, pain 
sensing and many others. However the focus of my work has been on the role of purinergic 
signaling in the initiation and modulation of immunity and inflammation; with a particular 
focus on the effect of extracellular ATP on the macrophage.  
 
                                                 
1
 EC50 and IC50 values at P2X receptors in different species can vary widely. IC50 values are only indicators 
of antagonist potency as different concentrations of agonist and agonist species will affect the value.   
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Macrophages are part of the mononuclear phagocyte family. Mononuclear phagocytes are 
innate immune cells that originate in the bone marrow from a colony-forming unit 
granulocyte-macrophage precursor with the least mature cell of the mononuclear 
phagocyte system being the monoblast (Figure 1-7). Once a monocyte is generated it will 
enter the peripheral blood. From there monocytes can migrate into extravascular tissues 
and become resident macrophages, which are able to acquire morphological and functional 
properties that are characteristic of the tissue in which they reside (Figure 1-7) (Ross et al., 
2002). Monocytes are also capable of migrating into various tissues in response to damage 
or infection transforming into macrophages. These macrophages are a major source of 





Figure1-7. Mononuclear Phagocyte System.  
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Enzymes Reactive Oxygen Intermediates 
Lysozyme Superoxide 
Lysosomal Acid Hydrolases Hydrogen Peroxide 
Neutral Proteases Hydroxyl Radical 
Complement Components  Nitric Oxide 
C1, C4, C2, C3, C5, C3a, C3b, C5a, Bb Peroxynitrite 
Factor B, Factor D, Properdin Cytokines 
Coagulation Factors IL-1, IL-6, IL-10, IL-12, IL-15 
Tissue Factor TNF-α, CXC chemokines 
Prothrombin activator Enzyme/Cytokine Inhibitors 
FII, FVII, FIX, FX, FXII IL-1 inhibitors, Protease Inhibitors 
 
Table 1-2. Selection of the 100 + Substances that have been Reported to be Secreted from 
Macrophages. (Ross et al., 2002) 
 
At sites of infection/inflammation it has been observed that ATP is released leading to 
activation of P2Rs on macrophages that play a pivotal role in inflammation and 
immunomodulation. This includes the processing and release of cytokines, killing of 
intracellular pathogens by inducing apoptosis of host cells, chemoattraction and cell 
adhesion.  Monocytes/macrophages express multiple P2R subtypes, i.e., monocytes 
express P2Y1, 2, 4, 6, 11, 12, 13 and P2X1, 4, 5, 7, and macrophages the same receptor subtypes 
except for P2Y13 (Bours et al., 2006).  
 
ATP at the P2X7R as already stated has a much lower potency than compared to other 
purinergic receptors.  This might suggest that this receptor is unlikely to be activated under 
resting/physiological conditions. Pro-inflammatory conditions where cell activation, stress, 
damage and lysis and changes to the extracellular milieu occur could create a situation 
where the P2X7R could be activated. The P2X7R has already been attributed to be involved 
in inflammatory conditions/diseases with knockout mice studies demonstrating that loss of 
the P2X7R leads to: 
• Loss of ATP evoked IL-1β processing and secretion (Solle et al., 2001)  
• Attenuation of collagen induced arthritis (Labasi et al., 2002) 
• The loss of hypersensitivity in inflammatory (adjuvant-induced) and neuropathic 
(partial nerve ligation) pain models (Chessell et al., 2005). Work which has been 
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further confirmed by the observation that administration of the P2X7R antagonist 
A-740003 to rats produced antinociception in a spinal nerve ligation model and 
attenuated tactile allodynia in both chronic constriction injury of the sciatic nerve 
and vincristin-induced neuropathy (Honore et al., 2006).  
• Changes in animal models of depression and anxiety (Basso et al., 2008). 
 
1.2 INNATE IMMUNE SYSTEM 
As previously stated the focus of my research is based on the role of purinergic signaling in 
the initiation and modulation of immunity and inflammation with respect to macrophage 
responses. These phagocytic cells form part of the innate immune system which is the first 
line of defence against infectious disease. The innate immune system’s primary role is to 
defend the host from infection by allowing immune cells to recognize and respond to 
pathogens in a non-specific manner. It however does not confer long-lasting 
protection/immunity to the host.  
 
Upon activation of an immune cell following detection of a pathogen, several responses 
will occur including: 
• Production of cytokines that will trigger a range of inflammatory responses. 
• Initiation of coagulation. 
• Pathogen phagocytosis and digestion.  
• Apoptosis and clearance of infected/damage host cells. 
 
1.2.1 Detection of Pathogens 
In order for the immune system to work the host cells needs to be able to discriminate 
between self and pathogenic cells. The innate immune system does this by using a limited 
number of germline-encoded pattern recognition receptors (PRRs). These PRR’s are able 
to recognize microbial components termed pathogen-associated molecular patterns 
(PAMPs) which are essential for microbial survival and therefore difficult for the pathogen 
to alter (Akira et al., 2006). There is deemed to be four important families of pathogen 
sensor these are the Toll-like receptors (TLR), NOD-like receptors (NLR), Rig-I-like 
receptors and C-type lectin receptors. All of these receptors upon sensing a pathogen can 
induce and up-regulate a range of immune and inflammatory genes. These receptors are 
also found to be structurally conserved involving seven distinct domains: the LRR 
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(leucine-rich repeat) domain, the TIR (Toll-IL-1 receptor) domain, the NBS (nucleotide-
binding site), the CARD (caspase recruitment domain), the PYD (pyrin domain), the 
helicase domain and the CTLD (C-type lectin domain)(Pålsson-McDermott et al., 2007).   
 
The most commonly known set of pattern recognition receptors are the TLRs which  are 
able to recognize pathogens either at the cell surface or lysosome/endosome membranes 
(Kawai et al., 2006). There have so far been 10 human TLRs identified (13 in mouse) and 
between them they are able to recognize a range of ligands such as bacterial 
lipopolysaccharide (LPS) by TLR4; viral and bacterial nucleic acids by TLR3, 7, 8 and 9; 
and glycosylphosphatidylinositol (GPI)-anchored proteins in parasites. The TLR signaling 
pathway loosely consists of a MyD88-dependent pathway common to all TLRs, and a 
MyD88-independent pathway that is selective to TLR3 and TLR4 (Figure 1-8) (Chen et 
al., 2007). The MyD88-dependent pathway will result in the activation of the transcription 
factors NFκB and AP-1 and therefore an increase in the expression of inflammatory 
cytokines such as IL-1β, TNFα and IL-6 (Medzhitov et al., 1998). The MyD88-
independent pathway or Trif-dependent pathway will result in the induction of type I IFN 




Figure 1-8. Schematic of TLR4 signaling through MyD88 Dependent & Independent Pathways.  
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The second major family of pattern recognition receptor is the NLRs which unlike the 
TLRs are cytoplasmic proteins that can clear the invading pathogen by up-regulating 
expression of chemokines such as MIP-2 and IL-8 (Vavricka et al., 2004; Viala et al., 
2004) and cytokines such as IL-1β, IL-18 and IL-6 (Kufer et al., 2005; Martinon et al., 
2002). Upon activation of an NLR, two major signaling pathways have found to be 
initiated (Wilmanski et al., 2008). The first occurs when the NLR proteins Nod1 or Nod2 
are activated by active moieties in bacterial peptidolycan. These proteins signal through 
receptor-interaction protein 2 (Rip2) which activates NF-κB and mitogen-activated protein 
kinases (MAPKs). The second occurs when NLRs such as NALP3, NALP1, IPAF or NAIP 
are activated leading to an association with apoptotic-associated speck-like protein (ASC) 
that will ultimately lead to the activation of caspase-1 (Figure 1-9). Caspase-1 has dual 
roles in that it is involved in the maturation/processing of IL-1β and the induction of 




Figure 1-9. Schematic of NLR Signaling via the ASC-Dependent Pathway Resulting in Caspase-1 
Activation.  
 
1.2.2 Production, Secretion and Effect of Members of the Interleukin-1 Superfamily 
IL-1 is produced in response to many stimuli including LPS, other microbial products, 
cytokines (TNFα, IFNγ, GM-CSF, and IL-2), T-cell/antigen presenting cell interaction and 
immune complexes (Dinarello, 1996). Both IL-1α and IL-1β are translated as 31kD 
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leaderless secretory pro-peptides. IL-1α is active in this pro form; however IL-1β needs to 
undergo a proteolytic step to become active. This cleavage is mediated by active caspase-1 
within the cytosol of the cell leading to the generation of a 17kD mature form of IL-1β 
(Cerretti et al., 1992). Furthermore IL-18 which is synthesized as a 24kD pro-peptide is 
cleaved by caspase-1 to form a mature 18kD form (Ghayur et al., 1997; Gu et al., 1997) 
and IL-33 an IL-1β-like cytokine acting at the ST2 receptor has been observed to be 
processed by caspase-1 (Schmitz et al., 2005).   
 
Once IL-1 cytokines have been synthesized they then require to be released, however they 
do not follow the classical endoplasmic reticulum/Golgi secretory pathway as they lack a 
signal peptide (Dinarello, 1996). In the case of LPS induced synthesis of IL-1 propeptides, 
a second stimulus is required to evoke both the production of mature/active cytokines and 
the release of both the pro and mature peptides. The physiological second stimulus has 
been reported to be activation of the P2X7R by ATP (Ferrari et al., 2006; Pelegrin et al., 
2008). 
 
Upon release of IL-1α and IL-1β they are able to bind and activate the IL-1RI receptor. 
This receptor belongs to the same super family as the TLRs (IL-1 receptor/TLR receptor 
superfamily) and the IL-18 receptor (IL-18R); all of which have striking sequence 
similarity in their cytosolic regions (Dunne et al., 2003; Rock et al., 1998). Activation of 
this receptor can induce the expression of many genes via activation of protein kinase 
cascades leading to the modulation of transcription factors such as NF-κB, AP-1, ATF-2 
and NF-IL6 and therefore inducing the expression of immune and inflammatory genes 
(Akira et al., 1990; Chedid et al., 1991; Krasnow et al., 1991; Welsh, 1996). The original 
responses evoked by IL-1 were reported to be the elicitation of inflammatory responses, 
induction of fever and increased production of acute phase proteins (Dinarello et al., 1983). 
The inflammatory responses evoked by IL-1 include (i) promotion of leukocyte 
extravasation by inducing adhesion receptors on vascular endothelium and stimulating 
chemokine production, (ii) production of other cytokines, (iii) accumulation of arachidonic 
acid metabolites and (iv) the up-regulation of inducible nitric oxide synthase (iNOS).  
 
S.F.Moore 
CHAPTER 1: INTRODUCTION 
32 
1.2.3 Activation of Coagulation & Cross-Talk with Inflammation 
Damage to blood vessels and capillaries will induce three mechanisms that promote 
haemostasis these are (i) vasoconstriction, (ii) platelet activation and adhesion with release 
of serotonin, ADP and thromboxane A2 (TxA2) and (iii) coagulation. The coagulation 
cascade has two pathways (Figure 1-10) termed the contact activation pathway (intrinsic) 
and the tissue factor (TF) pathway (extrinsic); the primary pathway for maintenance of 
normal haemostasis.  Both pathways are a series of reactions in which inactive enzyme 
precursors (zymogens) of a serine protease and a glycoprotein co-factor are activated to 
become active components which catalyze the next reaction in the cascade. The pathways 
will ultimately lead to the activation of the final common pathway whereby the activation 
of factor X (FX), thrombin and fibrin occurs finally leading to the formation of a fibrin 
clot.  
 
The coagulation cascade and innate immunity are intimately linked, to the point that it is 
now believed that the two systems co-evolved from a common ancestral substrate early in 
eukaryotic development (Opal et al., 2003). Inflammatory signals that induce immune 
activation will also evoke procoagulant responses; something that is evident in systemic 
inflammatory states where activation of the extrinsic coagulation cascade appears to be an 
essential component in the development of multi-organ failure. 
 
Both pathways of the coagulation cascade can be activated via inflammatory/immune 
responses. The contact factors of the intrinsic coagulation cascade are able to recognise 
damaged host cell membranes, foreign substances (including LPS) and endothelial 
abnormalities; (Levi et al., 1999; Opal et al., 2003; Pixley et al., 1993). The extrinsic/TF 
dependent pathway is usually activated when vascular damage occurs leading to contact of 
blood cells with extravascular TF expressing cells. TF expression however can be induced 
on monocytes/macrophages systemically during microbial invasion by endotoxins, 
cytokines (e.g. IL-1α and IL-1β) and C-reactive protein (Levi, 2003; Levi et al., 2003; 
Osnes et al., 1996). It has been hypothesized that localized TF expression and subsequent 
induction of coagulation might occur in order to aid the containment of 
infection/inflammation.   
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Figure 1-10. Schematic of the Extrinsic & Intrinsic Coagulation Cascades Leading to Clot Formation.  
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The link between inflammation and coagulation does not only work in one direction; 
coagulation is able to induce inflammation. Activation of the coagulation cascade results in 
the formation of several proteases, some of which are able to activate their own receptors. 
Thrombin, factor Xa (FXa) and the TF-factor VIIa (TF-FVIIa) complex have all been 
demonstrated to activate pro-inflammatory processes via the protease-activated receptors 
(PARs) (Cirino et al., 2000). The PARs are GPCRs that possess a sequestered integral 
ligand that is tethered to the amino-terminus of its extracellular domain. Thrombin is able 
to cleave and activate PAR1, PAR3 and PAR4, whereas FXa and TF-FVIIa can activate 
PAR2 (Ossovskaya et al., 2004). Activation of cells by these coagulation factors has been 
observed to increase proinflammatory cytokine production (IL-1, IL-6, MCP-1) and iNOS 
(Opal, 2003). Loss of PAR1 has been observed to result in a reduction of arthritis severity, 
reduced inflammation in glomerulonephrtis and carrageenan models and impaired 
thrombin induced pulmonary vascular leakage (Cunningham et al., 2000; Vogel et al., 
2000; Yang et al., 2005). Furthermore loss of PAR2 has been observed to reduce oedema 
and infiltration of inflammatory cells in models of allergic dermatitis (Kawagoe et al., 
2002), reduce eosinophil infiltration and hypereactivity in allergic airway inflammation 
(Schmidlin et al., 2002) and protect against adjuvant induced arthritis (Ferrell et al., 2003).  
 
1.2.4 Pathogen Clearance  
Invading pathogens are required to be removed from the blood and tissues in order to halt 
inflammation and further cellular damage. Phagocytosis is the process by which leukocytes 
recognise and ingest particles and pathogens and is critical for innate immunity. 
Macrophages upon recognition of an invading pathogen will undergo cytoskeletal changes 
in order to engulf an evading microbe and trap it within a phagosome which will rapidly 
become a digestive organelle resulting in the death of the invading pathogen (Greenberg et 
al., 2002). Killing of this entrapped pathogen can occur via oxygen independent and 
dependent processes. The oxygen independent process involves fumigating the pathogen 
with toxic proteases and enzymes. The oxygen dependent method involves pathogen 
killing by reactive oxygen and nitrogen species (ROS and RNS). The major generator of 





 is then available to react with NO to form peroxynitrite 
(ONOO
-
) or to be converted to hydrogen peroxide (H2O2). H2O2 in combination with 
chloride ions is able to form the very cytotoxic product hypochlorous acid (HOCl) when in 
the presence of myeloperoxidase (MPO).  
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1.2.5 Apoptosis and Clearance of Infected/Damaged Host Cells 
During inflammation cell damage and death occurs, depending on the type of cell death 
initiated the outcome can be either non-inflammatory or pro-inflammatory. Apoptotic cell 
death is a controlled and non-inflammatory form of cell death. Dramatic biochemical and 
cell biological events occur within an apoptotic cell and ultimately results in its recognition 
and removal by phagocytes prior to it becoming necrotic and its inflammatory contents 
spilling into surrounding tissues. Apoptosis can be initiated by two main pathways the 
death receptor (extrinsic) pathway and the mitochondrial (intrinsic) pathway (Figure 1-11). 
Both pathways result in the activation of caspases that are able to cleave specific target 
proteins resulting in the morphological and biochemical changes associated with apoptosis. 
For example DNA laddering a classic marker of apoptosis occurs by cleavage of genomic 
DNA between nucleosomes by the nuclease caspase-activated DNase (CAD). CAD is 
usually present in living cells bound to its inhibitor (ICAD), caspase-3 and caspase-7 can 
cleave off ICAD, therefore resulting in the release and activation of CAD (Enari et al., 
1998; Fink et al., 2005). Furthermore caspases have been reported to be involved in the 
process of allowing the recognition and ultimately removal of this dying cell. This involves 
the translocation of the anionic phospholipid phosphatidylserine (PS) from the inner to the 
outer leaflet of the plasma membrane. PS is not expressed on resting cells and therefore 
provides a cell surface marker for discrimination of “self” vs. other by phagocytes (Naito 
et al., 1997).  
 
1.2.6 The Innate Immune System and Disease 
The innate immune system plays a vital role in the elimination of pathogens. However 
aberrant activation can result in severe consequences including the induction of chronic 
inflammatory diseases, neurodegeneration and cancer. An important part of the innate 
immune system is the production and secretion of the IL-1 cytokines and the activation of 
caspases. Both of these play important roles in the body’s response to pathogen invasion. 
IL-1β has been implicated to have a role in many diseases including RA (Dayer et al., 
2001; Eastgate et al., 1988), atherosclerosis (Kirii et al., 2003), Alzheimer’s disease 
(Deniz-Naranjo et al., 2008), multiple sclerosis (Yiangou et al., 2006) and neuropathic 
pain (Sommer et al., 2004). Caspase-1 has been implicated to play a role in Huntington’s 
chorea (Wang et al., 2005), amyotrophic lateral sclerosis (Li et al., 2000) and Parkinson’s 
disease (Kahns et al., 2003). Mutations leading to overactivation of the caspase-1 activator; 
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NALP3 have been observed to cause autoinflammatory disorders (Neven et al., 2004), 
which are associated with recurrent inflammatory episodes generally associated with fever, 




Figure 1-11. Simplified Model of Extrinsic and Intrinsic Apoptotic Cell Death. Intrinsic apoptosis 
involves the integration and propagation of death signals originating inside the cell by the mitochondria 
(Sitailo et al., 2002). Cytochrome-c will be released (red arrow) from the mitochondria resulting in the 
formation of the Apaf containing apoptosome, which will recruit and activate caspase-9 (Li et al., 1997b). 
Caspase-9 is then able to directly cleave/activate caspase-3. Extrinsic apoptosis is initiated when a death 
receptor ligand (TNF, Fas etc) binds to and activates a death receptor. This induces receptor oligomerization 
and recruitment of adaptor/scaffold proteins including pro-caspase-8 and FADD. Caspase-8 will undergo 
oligomerization and autoactivation, resulting in either direct cleavage/activation of caspase-3 or truncation of 
Bid (tBid) (Yin et al., 1999) which can translocate to the mitochondria and induce cytochrome-c/caspase-9 
induced caspase-3 activation.  
 
1.3 AIMS 
The overall idea behind my work was to examine the role and mechanisms of purinergic 
signaling in macrophages leading to the propagation, mediation and amplification of innate 
immune and inflammatory responses. Based on this idea and the previous literature a series 
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of aims where formulated and are listed below, further detail in to each of the aims and 
reasoning for them can be found at the beginning of each results chapter.  
• Pharmacology of the P2X7R on macrophages and the effect of the extracellular 
milieu on P2X7R function. 
• Role of extracellular ATP on induction of morphological changes and cell death. 
• Role of extracellular ATP in evoking pro-coagulant responses. 
• Characterisation of ATP evoked generation of ROS.  
• Investigation of the signaling pathway/s from P2X7R activation to the generation of 
pro-inflammatory cytokines.  
S.F.Moore 




MATERIALS AND METHODS 
 
2.1 MATERIALS 
2.1.1 General Reagents 
REAGENT SUPPLIER 
Acetone Sigma-Aldrich®, UK 
Acrylamide Mix (30 %, Protogel) Fisher Scientific UK 
Albumin from Bovine Serum (BSA) Sigma-Aldrich®, UK 
Ammonium Persulfate Acros Organics 
Apyrase Grade VI Sigma-Aldrich® UK 
ATP Di-Sodium Salt Grade II Sigma-Aldrich® UK 
BzATP Sigma-Aldrich® UK 
Cadmium Chloride (CdCl2) Sigma-Aldrich® UK 
Calcium Chloride Dihydrate (CaCl2) Sigma-Aldrich® UK 
Copper (II) Chloride (CuCl2) Sigma-Aldrich® UK 
Cut-Off Filters 3K Nanosep Pall (VWR UK) 
D-(+)-Glucose Sigma-Aldrich® UK 
Digitonin Sigma-Aldrich® UK 
EDTA Fisher Scientific UK 
EGTA Sigma-Aldrich® UK 
Enhanced Chemiluminescent Advance™ (ECL) GE Healthcare Life Sciences UK 
Formaldehyde (37 %) Sigma-Aldrich®, UK 
Glutaraldehyde Sigma-Aldrich®, UK 
Glycine Fisher Scientific UK 
Griess Reagent Sigma-Aldrich®, UK 
HEPES Sigma-Aldrich® UK 
Magnesium Chloride (MgCl2) Sigma-Aldrich® UK 
Mercury (II) Chloride (HgCl2) Sigma-Aldrich® UK 
Methanol (MeOH) Fisher Scientific UK 
Nitrocellulose Membrane (0.2 µm) BIO-RAD UK 
Osmium Tetroxide Sigma-Aldrich®, UK 
Phosphate Buffered Saline (PBS) Sigma-Aldrich® UK 
Pluronic Acid F-127 Invitrogen™ UK 
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Potassium Chloride (KCl) Sigma-Aldrich® UK 
Precision Plus Protein Kaleidoscope Standards BIO-RAD UK 
Probenecid Sigma-Aldrich® UK 
Protease Inhibitor Cocktail General Use (PIC) Sigma-Aldrich® UK 
Skimmed Milk Powder OXOID (Sigma-Aldrich® UK) 
Sodium Chloride (NaCl) Sigma-Aldrich® UK 
Sodium Dodecyl Sulfate (SDS) Fisher Scientific UK 
Sodium Hydroxide (NaOH) Sigma-Aldrich® UK 
Sodium Nitrite Sigma-Aldrich®, UK 
TEMED Fisher Scientific UK 
Tris-HCl Fisher Scientific UK 
Triton-X 100 Sigma-Aldrich® UK 




Alexa 488-conjugated (Fab)2 fragments of goat 
anti-rabbit IgG 
Invitrogen™, UK 
Anti-P2X7R  Alamone Labs, Jerusalem, Israel 
Caspase-1 p10 (M-20) PAb Santa-Cruz Biotechnology, UK 
Mouse IL-1β MAb Thermo Scientific, UK 
Polyclonal Rabbit Anti-Mouse IgG/HRP DakoCytomation, UK 
Polyclonal Swine Anti-Rabbit IgG/HRP DakoCytomation, UK 
Rabbit Anti- 
Mouse anti-TF Antibody 
Axis-Shield, UK 
Rabbit IgG Invitrogen™, UK 
 
2.1.3 Cell Culture 
REAGENT SUPPLIER 
Dulbecco's Modified Eagle Medium: Nutrient 
Mixture F-12 1:1 (DMEM-F12)  
Invitrogen™ UK 
Foetal Bovine Serum (FBS) Invitrogen™ UK 
FuGENE 6 Roche UK 
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LPS from Escherichia coli 055:B5 Sigma-Aldrich® UK 
Murine Macrophage Colony Stimulating Factor 
(MCSF) 
Sigma-Aldrich® UK 
Penicillin-Streptomyosin Invitrogen™ UK 
RPMI-1640 Sigma-Aldrich® UK 
Trypsin 0.05 % with EDTA Invitrogen™,UK 
 
2.1.4 Fluorescent Indicators  
REAGENT SUPPLIER 
2,7 Dichlorodihydrofluorescein diacetate  
(H2DCF-DA) 
Invitrogen™ UK 
4',6-diamidino-2-phenylindole (DAPI) Invitrogen™, UK 
Annexin-V-Alexa Fluor® 488 Invitrogen™, UK 
Ethidium Bromide (EtBr) Fisher Scientific UK 
Fluo-4 AM Invitrogen™ UK 
L-Glutamine (200mM) Invitrogen™ UK 




2,4-Dinitrochlorobenzene (DNCB) Sigma-Aldrich® UK 
3-Morpholinosydnonimine, HCl (SIN-1) Calbiochem® UK 
A438079-HCl Tocris Bioscience UK 
Allopurinol Sigma-Aldrich® UK 
Apocynin Sigma-Aldrich® UK 
Auranofin BIOMOL® International UK 
Brilliant Blue G (BBG) Sigma-Aldrich® UK 
Carbenoxolone Sigma-Aldrich® UK 
CGS 15943 Tocris Bioscience UK 
Diphenyleneiodonium (DPI) Sigma-Aldrich® UK 
KN-62 Calbiochem® UK 
Mn-cpx 3 Calbiochem® UK 
Myxothiazol Sigma-Aldrich® UK 
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Rotenone Sigma-Aldrich® UK 
Superoxide Dismutase, Bovine (SOD) Sigma-Aldrich® UK 
Suramin Sodium Salt Sigma-Aldrich® UK 
Z-YVAD-FMK Cambridge Bioscience UK 
 
2.1.6 Coagulation Factors and Reagents 
REAGENT SUPPLIER 
Annexin V from human placenta Sigma-Aldrich®, UK 
Bovine FVa Cambridge Bioscience, UK 
Bovine FX Cambridge Bioscience, UK 
Bovine FXa Cambridge Bioscience, UK 
Human FVIIa Cambridge Bioscience, UK 
Human Prothrombin Cambridge Bioscience, UK 
S2238™ Instrumentation Laboratories, UK 






 Promega, UK 
Cytotoxicity Detection Kit Roche, UK 





2.2.1 Physiological Salt Solution  






                                                 
2
 ATP was made up as a 50mM stock in the different external solutions and the pH readjusted to 7.3 using 
NaOH.  
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Used for the majority of assays unless stated.        pH 7.3 with NaOH 
 
2.2.2 Calcium-Free Salt Solution
3
 







pH 7.3 with NaOH 
 
2.2.3 Nominal Calcium/Magnesium Salt Solution
4
 





pH 7.3 with NaOH 
 
2.3 CELL CULTURE 
2.3.1 RAW264.7 Murine Macrophage Culture 
RAW264.7 cells (ATCC, Manassas, VA) were maintained in DMEM:F12 containing 10 % 
heat inactivated FBS, 2 mM L-glutamine, 100 U ml
-1
 penicillin and 100 µg ml
-1
 
streptomycin (complete culture medium) at 37 °C in a humidified atmosphere of 5 % CO2 
and 95 % air. Cells were subcultured by mechanically scrapping cells in to culture medium 
and resuspended into fresh complete medium at a subcultivation ratio of 1:3 to 1:6 with 
medium being replaced every 2 to 3 days. Cells for experimental assays were mechanically 
scraped in to culture medium and subsequently centrifuged at 240 xg (S4180 rotor, 
                                                 
3
 Potentially nM levels of Ca
2+
 present in Calcium-free Salt Solution 
4
 Potentially µM levels of Ca2+ and Mg2+ present in Nominal Ca2+/Mg2+ Salt Solution 
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Beckman GS-15R) for 4 minutes at room temperature (RT). Waste medium was aspirated 
off and cells resuspended into fresh complete medium for counting and re-seeding. 
 
2.3.2 HEK293 Cell Culture 
Human embryonic kidney (HEK) 293 cells (ECACC, UK) were maintained in complete 
culture medium at 37 °C in a humidified atmosphere of 5 % CO2 and 95 % air. Cells were 
harvested for subculture and experimental assays by rinsing cells in sterile PBS followed 
by incubation with 0.05 % Trypsin/EDTA for 5 minutes (37 
o
C). Trypsin/EDTA was 
stopped by addition of complete medium and cells were harvested from the culture vessel 
surface by pipetting up and down. Cells were subsequently centrifuged at 240 xg (S4180 
rotor, Beckman GS-15R) for 4 minutes (RT). Waste medium was aspirate off and cells re-
suspended into fresh complete medium for counting and re-seeding. Cells were seeded at 




 for maintenance and split upon reaching 70-80 % confluence.  
 
2.3.3 HEK293 Transient Transfections 
Plasmid DNA Accession Number Source 
mP2X7R-pcDNA3 (P451) AJ489297 Prof A Surprenant 
rP2X7R-pcDNA3 CAA65131 Prof A Surprenant 
 




 in to a sterile black-walled 
cell-culture treated 96 well plate and maintained in complete medium overnight. Complete 
medium was removed from cells and replaced with antibiotic free complete culture 
medium. Cells were transfected with plasmid DNA using FuGENE-6 at a 6:1 ratio 
(FuGENE-6:DNA) following the manufacturer’s protocol. Mock transfectants, omitting 
DNA were used as controls. Transfection reagent was removed 24 hours post-transfection 
and cells used in experimental assays within 24 hours after reagent removal. 
 
2.3.4 J774.2 Murine Macrophage Culture 




 in complete 
culture medium at 37 °C in a humidified atmosphere of 5 % CO2 and 95 % air. Cells were 
subcultured by mechanically scrapping cells in to culture medium and resuspended into 
fresh complete medium at a subcultivation ratio of 1:3 to 1:6 with medium being replaced 
every 2 to 3 days. Cells for experimental assays were mechanically scraped in to complete 
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culture medium and subsequently centrifuged at 240 xg (S4180 rotor, Beckman GS-15R) 
for 4 minutes (RT). Waste medium was aspirated off and cells resuspended into fresh 
complete medium for counting and re-seeding. For LPS priming
5
, cells plated overnight in 
complete culture medium were incubated for 4-6 hours at 37 
o
C with 1 µg ml-1 LPS.  
 
2.3.5 Isolation, Generation and Culture of Murine Bone-Marrow Derived Macrophages 
Mouse bone marrow cells were collected from femurs of  C57BL/6 mice (8-12 wks) by 
flushing with 2 ml of bone marrow medium consisting of RPMI-1640 containing 15 % 
(v/v)  heat inactivated FBS, 2 mM L-glutamine, 100 U ml
-1
 penicillin and 100 µg ml
-1
 
streptomycin using a 25-gauge needle. Cell suspensions were centrifuged at 240 xg (S4108 
rotor, Beckman GS-15R) for 10 minutes at RT. Cells were resuspended in bone marrow 
medium (10 ml / mouse) and passed up and down six times through a 19-gauge needle to 
disperse cell clumps. Adherent bone marrow cells were removed by incubation at 37 
o
C for 
4 – 6 hours in T25 flasks (5 ml cell suspension / flask). The non-adherent bone marrow 
cells were placed in fresh T25 flasks and M-CSF added to give a final concentration of 10 
ng ml
-1
 (Lin et al., 2001). Cells were maintained in culture at 37 °C in a humidified 
atmosphere of 5 % CO2 and 95 % air. Media and M-CSF was completely changed on day 
five and experimental assays performed on day seven. For LPS
3
 priming, cells plated 
overnight in bone marrow medium with M-CSF were incubated for 4-6 hours at 37 
o
C with 
1 µg ml-1 LPS. Bone-marrow cells from gp91phox-/- and p47phox-/- mice (C57BL/6) were 
a generous gift from Dr A Cave and Professor A Shah (Cardiovascular Division, Kings 









 in complete medium containing 10 
% DMSO (RAW264.7, J774.2) or glycerol (HEK293) and an additional 10 % FBS. 1 ml 
volumes were aliquoted into cryotubes which were subsequently placed into a ‘Mr. Frosty’ 
(filled with 250 ml propan-2-ol). Cells were incubated at -80 
o
C overnight before long-term 
storage in liquid nitrogen.  
 
                                                 
5
 For Chapters 6 and 7 where ROS generation and its role in the processing and release of IL-1β were 
examined, cells were required to be activated with LPS to induce the expression of pro-IL-1β. 
6
 Cell line integrity was maintained by freezing down low passage stocks (<2 subcultures) which were 
thawed for use once cells in current use reached passaged 10.  
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Cryotubes were removed from liquid nitrogen and thawed at 37 
o
C. Cells were removed 
from cryotubes and diluted into 5 ml of complete culture medium in a drop-wise manner. 
Cells were centrifuged at 240 xg (S4180 rotor, Beckman GS-15R) for 4 minutes (RT) to 
removed cell freezing medium and resuspended in 5ml of complete medium and seeded 
into a T25 flask. 
 
2.4 PURINERGIC RECEPTOR FUNCTION 
2.4.1 Intracellular Calcium Concentrations 
Cell seeding conditions -  





Culture Vessel: Sterile black-walled cell-culture treated 96 well 
plates 
Media: 100 µl complete culture medium 
Duration: 17 – 24 hours 
 
Cells (1.5 x 10
5
) were loaded with 5 µM Fluo-4AM (DMEM:F12) in the presence of 
probenecid (2.5 mM) to inhibit dye leakage and sequestration via organic anion 
transporters (Di Virgillio et al., 1990), apyrase (0.32 U ml
-1
) to  breakdown ATP/ADP 
released by cells in order to inhibit desensitisation of  P2 receptors and pluronic acid (0.2 
%) to enhance dye solubility and dye uptake for 30 minutes at 37 
o
C, under limited light 
conditions. Excess Fluo-4AM was aspirated from the cells and replaced with external 
solution containing probenecid (2.5 mM). Cells were left to rest for 10 minutes (37 
o
C). 
Antagonists were added 5 minutes prior to ATP application. ATP was applied using 
Fluostar optima injection system and Fluo-4 excited at 485 nm with fluorescence collected 
at 520 nm every 3-10 s using a multimode platereader (Fluostar Optima, BMG Labtech, 
UK). At the end of each test run 15 µM digitonin was applied to lyse cells and therefore 
obtain maximum Fluo-4 fluorescence readings.  
 
Each experimental sample was performed in duplicate and values were normalized to 
baseline and maximum fluorescence readings (Equation 1). Peak responses were used to 
construct individual concentration-response curves. Final concentration-response curves 
were constructed by normalizing individual curves to maximum ATP evoked responses 
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(Equation 2). Curve fitting was performed using Prism Version 4 (GraphPad Software, San 










































Where x is the logarithm of the molar concentration of the drug, α is the maxima (max - 
baseline), logA50 is the half maximal response and nH is the Hill slope.  
 
2.4.2 Pore Formation 
Cell seeding conditions -  





Culture Vessel: Sterile black-walled cell-culture treated 96 well 
plates 
Media: 100 µl complete culture medium 
Duration: 17 – 24 hours 
 
Pore formation as a result of prolonged P2X7R activation was measured by assessing the 
influx of EtBr (394 Da). EtBr upon entry in to the cell is able to bind nucleic acids and 
produce a fluorescent signal. Cells were washed in to external solution (37 
o
C) containing 
25 µM EtBr and divalent cations/inhibitors where appropriate. Cells were left to rest for 5 
minutes (37 
o
C) prior to ATP application. EtBr was excited at 544 nm with fluorescence 
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collected at 590 nm using a multimode platereader (Fluostar Optima, BMG Labtech, UK). 
At the end of each test run 0.2 % Triton-X 100 was applied in order to obtain maximum 
permeabilisation (EtBr fluorescence) readings. 
 
Each experimental sample was performed in triplicate and values were normalized to 
baseline and maximum fluorescence readings (Equation 1). Linear regression between t = 
0 and t = 15 minutes of agonist application was used to determine rates of EtBr influx 
(Prism Version 4, GraphPad Software, San Diego CA). Final concentration-response 
curves were constructed by normalizing individual curves to maximum ATP evoked 
responses (Equation 2) in the control salt solution. Curve fitting was performed using 
Prism Version 4 (GraphPad Software, San Diego CA) using a four parameter logistic 
equation (Equation 3).  
 
Where addition of divalent cations to the external solution resulted in an increase in 
ATP/BzATP pEC50 values, ATP
4-
 concentrations were calculated in order to assess effects 





were calculated from total ATP concentrations using Webmaxc Standard (Stanford, USA) 
(Patton et al., 2004). The Kd value of BzATP was assumed to be the same as ATP 





Cell seeding conditions - 





Culture Vessel: Sterile clear-walled cell-culture treated 96 well 
plates 
Media: 100 µl complete culture medium 
Duration: 17 – 24 hours 
 
Cell death determined as total and irreversible loss of cell membrane integrity was 
evaluated by measuring the release of cytosolic lactate dehydrogenase (LDH) from cells 
(1.5 x 10
5
 cells) using either the Cytotox-96™ assay (Promega, UK), Cytotox One™ assay 
(Promega, UK) or Roche Cytotoxicity Detection Kit (Roche, UK) following the 
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divalent cation/inhibitors where appropriate. ATP was applied and cells incubated for 
various times (37 
o
C). Supernatant was removed and incubated with LDH substrate and 
read using a multimode platereader (Fluostar Optima, BMG Labtech, UK) (Cytotox-96™ 
and Roche Cytotoxicity at 490nm absorbance, Cytotox One™ at Ex/Em of 
560nm/590nm). Total cellular LDH was determined by the addition of Triton-X 100 (0.2 
%) to untreated cells. Each experimental sample was performed in triplicate and values 
were normalized to zero LDH release (cell-free external solution) and expressed as a 
percentage of total cellular LDH.  
 
2.5 CELL MORPHOLOGY 
2.5.1 Scanning Electron Microscopy
7
 
Cell seeding conditions -  
Cell No: 30,000 cells 
Culture Vessel: VWR® Micro 13 mm Round No.1 Cover Glass 
Media: Standard culture medium 
Duration: 17 – 24 hours 
 




) in standard culture medium were pipetted (100 µl) on to 
VWR® Micro 13 mm Round No.1 Cover Glass sat in sterile cell walled cell culture treated 
24-well plates. Cells were left to adhere for 1 hour (37 
o
C) before flooding the well with 
standard culture medium and leaving in the incubator overnight. Standard culture medium 
was aspirated from cells and cells washed with external solution. Cells were then incubated 
(37 
o
C) in external solution in the absence or presence of ATP (1 mM, 10 minutes) before 
fixing with 1 % glutaraldehyde for 30 minutes at RT. Cover glass was washed (x3) with 
PBS and post-fixed in 1 % osmium tetroxide in PBS. Cells were then sequentially 
dehydrated in increasing concentrations of acetone (50–100 % in dH20) and critical point 
dried for 15 minutes. Cover glasses were mounted on SEM holders and sputter-coated with 
gold before being viewed using a JEOL JSM-6480-LV electron microscope. 
 
2.5.2 Live Cell Tracking of ATP Induced Morphological Changes 
Cell seeding conditions –  
Cell No: 30,000 cells 
                                                 
7
 Samples preparation and image capture performed in University of Bath CEOS with help of Dr U.J. Potter 
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Culture Vessel: VWR® Micro 13 mm Round No.1 Cover Glass 
Media: Standard culture medium 
Duration: 17 – 24 hours 
 
RAW264.7 cells plated on VWR® Micro 13 mm Round No.1 Cover Glass
8
 were 
visualised using a laser scanning confocal microscope (FV300-SU, Olympus, Japan) with 
an oil immersion x 60 objective and images recorded with Fluoview software (Olympus, 
USA).  External solutions were continuously applied to cells via a gravity driven 
superfusion system. Images were recorded for 100 seconds before application of ATP (600 
seconds). To assess reversal of morphological changes recordings were taken for a further 
1800 seconds after ATP application had ceased. All experiments were carried out using 




Annexin-V-Alexa Fluor® 488 (AnV-488 50 µl ml-1) was used to assess ATP-induced 
phosphatidylserine translocation in RAW 264.7 cells. Cells were visualised using a laser 
scanning confocal microscope (FV300-SU, Olympus, Japan, excitation 488 nm and 
emission 505 nm) enabling simultaneous fluorescence and brightfield imaging, with a 
water immersion x 40 objective and images recorded with Fluoview software (Olympus, 
USA). Recordings of cells bathed in warmed physiological salt solution (37 
o
C) in the 
presence of AnV-488 (50 µl ml-1) were taken for 100 seconds before a 600 seconds 
application of ATP.  
 
Time-lapse images collected at 20-25 second intervals were sequenced together at three 
images per second using NIH Image J Software (W. Rasband, National Institutes
 
of Health, 
Bethesda, MD).  To assess membrane blebbing the number of cells blebbing were counted 
(≥1 bleb/cell) and expressed as a percentage of the total number of cells within the image. 
To evaluate filopodia retraction, filopodia were measured and values expressed as a 
percentage change in filopodia length from control (t = 0 seconds). 
 
2.5.3 Staining and Visualization of F-Actin with Phalloidin 
Cell seeding conditions -  
Cell No: 30, 000 cells 
                                                 
8
 Cell seeding conditions as Scanning Electron Microscopy 
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Culture Vessel: 4 well, NUNC™ Lab-Tek™ Chamber Slide™ 
System 
Media: 600 µl standard culture medium 
Duration: 17 – 24 hours 
 
Standard culture medium was aspirated off cells which were subsequently washed in 
external solution. RAW264.7 cells were stimulated with ATP (1 mM, 10 minutes, 37 
o
C) 
and fixed by the direct addition of 3.7 % formaldehyde in PBS (10 minutes, RT). Cells 
were washed (x 2) in PBS and incubated for 30 minutes (RT, reduced light conditions) 
with the high affinity F-actin probe; phalloidin-Alexa Fluor® 546 (Phalloidin-546, 20 µl 
ml
-1
, RT) in PBS containing 0.1 % Triton-X 100. Cells were washed (x2) with PBS and 
with (x1) dH2O to prevent salt crystals. The media chamber and gasket were removed from 
the slide and cover glass mounted and sealed onto the cover slide using anti-fade and nail 
varnish. Cells were visualised using a laser scanning confocal microscope (FV300-SU, 
Olympus, Japan, excitation 546 nm and emission 573 nm) enabling simultaneous 
fluorescence and brightfield imaging, with a water immersion x 40 objective and images 
recorded with Fluoview software (Olympus, USA).  
 
2.5.4 Total Cellular F-Actin Measurements 
Cell seeding conditions -  





Culture Vessel: Sterile black-walled cell-culture treated 96 well 
plates 
Media: 100 µl standard culture medium 
Duration: 17 – 24 hours 
 
Standard culture medium was aspirated off cells which were subsequently washed in 
physiological salt solution. RAW264.7 cells were stimulated in physiological salt solution 
in the absence or presence of ATP (1 mM, 10 minutes, 37 
o
C) and fixed by the direct 
addition of 3.7 % formaldehyde in PBS (30 minutes, RT). Cells were washed (x 3) in PBS 
and incubated for 30 minutes (RT, reduced light conditions) with the high affinity F-actin 
probe; phalloidin-Alexa Fluor® 546 (Phalloidin-546, 20 µl ml-1, RT) in PBS containing 
0.1 % Triton-X 100. For the final 5 minutes of the incubation the nucleic acid stain DAPI 
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(100 nM) was applied to the cells. Subsequently cells were washed (x2) in PBS. 
Fluorescence readings were recorded using a multimode plate-reader (Fluostar Optima, 
BMG Labtech, UK). Phalloidin was excited at 544 nm and fluorescence collected at 590 
nm. DAPI was excited at 355 nm and fluorescence collected at 460 nm. Each experimental 
sample was performed in triplicate and values were expressed as a ratio of phalloidin 
fluorescence over DAPI fluorescence.  
 
2.6 COAGULATION  
2.6.1 Tissue Factor Activity 
Cell seeding conditions: -  





Culture Vessel: Sterile clear-walled cell-culture treated 96 well 
plates 
Media: 100 µl standard culture medium 
Duration: 17 – 24 hours 
 
TF activity was assessed by measuring the presence of active factor X (FXa) using the 
chromogenic substrate S-2765™. S-2765™ undergoes Reaction 1 when FXa is present. 
The method for the determination of FX activity is based on the difference in absorbance 
between the pNA formed and the original substrate. The rate of pNA formation is 
proportional to the activity of FX.  
 
Reaction 1:            N-α-Z-D-Arg-Gly-Arg-pNA  N-α-Z-D-Arg-Gly-Arg·OH + pNA 
 
RAW264.7 cells were bathed in physiological salt solution in the absence or presence of 
extracellular ATP (37 
o
C). Cells were washed into physiological salt solution and 
incubated with bovine factor X (FX, 150 nM) and human factor VIIa (FVIIa, 5 nM) for 15 
minutes at 37 
o
C before addition of S-2765™ (0.5 mM). Absorbance was measured 
continuously at 405 nm using a multimode plate-reader (Fluostar Optima, BMG Labtech, 
UK). Each experimental sample was performed in triplicate and values were normalized to 
a cell-free control. Linear regression was used to determine the rate of conversion of pNA 
formation (Prism Version 4, GraphPad Software, San Diego CA).  
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2.6.2 Tissue Factor Expression 
Cell seeding conditions -  
Density: 3 x 10
6
 cells  
Culture Vessel: Sterile cell-culture treated T25 flask 
Media: 5 ml standard culture medium 





BSA 1 % (w/v) 





FBS 5 % (v/v) 
 
RAW264.7 cells were washed with physiological salt solution and bathed in physiological 
salt solution in the absence or presence of ATP (3 mM, 5 minutes, 37 
o
C). Cells were 
harvested by mechanical scrapping and centrifuged at 240 xg (4 
o
C, S4180 rotor, Beckman 




in blocking buffer and incubated for 
1 hour at 4 
o
C. Blocking buffer was removed by spinning down cells at 5000 rpm for 30 
seconds (ProFuge
TM
, Microcentrifuge 2400). Cells were incubated in FACS buffer in the 
absence or presence of either rabbit anti-mouse TF IgG (25 µg ml-1) or non-relevant rabbit 
IgG (25 µg ml-1) for 1 hour at 4 oC. Primary antibody was removed by spinning down cells 
at 5000 rpm for 30 seconds (ProFuge
TM
, Microcentrifuge 2400) and washing with FACS 
buffer (x2). Cells were incubated in FACS buffer containing Alexa 488-conjugated (Fab)2 
fragments of goat anti-rabbit IgG (10 µg ml-1) for 1 hour at 4 oC. Cells were then washed 
(x3) in FACS buffer and re-suspended in 1 ml of FACS buffer before being analysed using 
a FACSCanto
TM
 flow cytometer (Becton Dickinson).  Data were analysed using WINMDI
 
2.8 software (Microsoft). At least 10,000 viable cells per
 
condition were analysed for the 
determination of percentage
 
of positive cells. 
S.F.Moore 
CHAPTER 2: MATERIALS AND METHODS 
 
53 
2.6.3 Microvesicle Generation and Collection 
Cell seeding conditions -  
Density: 3 x 10
6
 cells  
Culture Vessel: Sterile cell-culture treated T25 flask 
Media: 5 ml standard culture medium 
Duration: 17 – 24 hours 
RAW264.7 cells were washed with external solution and incubated in external solution in 
the absence or presence of ATP (10 minutes, 37 
o
C). Supernatants was collected and 
clarified by centrifugation at 240 xg (S4180 rotor, Beckman GS-15R) for 4 minutes at 4 
o
C. Microvesicles were collected by ultracentrifugation of the clarified supernatants (100, 
000 xg, Type 70.1 Ti rotor, Beckman L8-70M) for 90 minutes at 4 
o
C. The microvesicle 
fraction (pellet) was collected and re-suspended in 150 µl physiological salt solution.  
 
2.6.4 Whole Cell Stimulation for Prothrombinase Complex Assay 
Cell seeding conditions -  





Culture Vessel: Sterile clear-walled cell-culture treated 96 well 
plates 
Media: 100 µl standard culture medium 
Duration: 17 – 24 hours 
 
RAW264.7 cells were bathed in physiological salt solution in the absence or presence ATP 
(10 minutes, 37 
o
C). Cells were washed into physiological salt solution containing grade 




2.6.5 Prothrombinase Complex Activity 
Prothrombinase complex activity was assessed by measuring the generation of thrombin 
using the chromogenic substrate S-2238™. S-2238™ undergoes Reaction 2 when 
thrombin is present. The method for determination of thrombin activity is based on the 
difference in absorbance between the pNA formed and the original substrate. The rate of 
pNA formation is proportional to enzyme activity. 
 
Reaction 2:            H-D-Phe-Pip-Arg-pNA  H-D-Phe-Pip-Arg-OH + pNA  
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RAW264.7 cells or RAW264.7 derived microvesicles in physiological salt solution were 
incubated with bovine FXa (6 nM), bovine factor Va (FVa, 3 nM), and S-2238™ (0.5 
mM). The generation of thrombin was initiated by the addition of human prothrombin (15 
nM). Absorbance was measured continuously at 405 nm using a multimode plate-reader 
(Fluostar Optima, BMG Labtech, UK).  Each experimental sample was performed in 
triplicate and values were normalized to a cell-free control. Linear regression was used to 
determine the rate of conversion of pNA formation (Prism Version 4, GraphPad Software, 
San Diego CA). Data was expressed as the fold-change in the rate of thrombin generation 
from control.  
 
2.7 OXIDATIVE STRESS  
2.7.1 Detection of Reactive Oxygen Species 
Cell seeding conditions - 





Culture Vessel: Sterile black-walled cell-culture treated 96 well 
plates 
Media: 100 µl complete culture medium 
Duration: 17 – 24 hours 
 
The accumulation of intracellular reactive oxygen and nitrogen species (ROS) was 
estimated by using 2', 7’-dichlorodihydrofluorescein diacetate (H2DCF-DA). H2DCFDA 
readily diffuses into cells where intracellular esterases cleave the acetate group of H2DCF-
DA from the molecule to yield H2DCF, which is trapped within the cells. Intracellular ROS 
oxidises H2DCF to form the highly fluorescent compound DCF. Culture medium was 
removed from LPS primed cells and cells incubated with 10 µM H2DCF-DA in 
DMEM:F12 (1:1) with 2.5 mM probenecid
9
 for 40 minutes at RT, under limited light 
conditions. Excess H2DCF-DA was aspirated from the cells and replaced with 
physiological salt solution containing probenecid (2.5 mM) and antagonist where 
appropriate. Cells were left to rest for 5 minutes (37 
o
C) prior to agonist application. DCF 
fluorescence was excited at 485nm and emission collected at 520 nm using a multimode 
plate reader (Fluostar Optima, BMG Labtech, UK). 
 
                                                 
9
 Used for inhibiting dye secretion and sequestration via organic anion transporters. 
S.F.Moore 
CHAPTER 2: MATERIALS AND METHODS 
 
55 
Each experimental sample was performed in triplicate and values were normalized to 
baseline. Linear regression between t = 0 and t ≈ 5 minutes of agonist application was used 
to determine rates of DCF generation (rate of ROS generation) (Prism Version 4, 
GraphPad Software, San Diego CA). Final concentration-response curves were constructed 
by normalizing individual curves to maximum ATP evoked responses (Equation 2) in the 
control conditions. Curve fitting was performed using Prism Version 4 (GraphPad 
Software, San Diego CA) using a four parameter logistic equation (Equation 3). 
 
2.7.2 Saville-Greiss Assay 
Cell seeding conditions -  





Culture Vessel: Sterile cell-culture treated 24 well plates 
Media: 1 ml standard culture medium  
Duration: 17 – 24 hours 
 
The Saville-Greiss assay is used to measure the non-volatile metabolite nitrite (NO2) as an 
indicator of NO formation. This assay was used in this study as a positive control for the 
effect of the NOS inhibitor L-NAME on ROS generation.  J774.2 cells were primed for 
with 1 µg ml-1 LPS (6 hours) in the absence or presence of L-NAME. Cells were washed in 
physiological salt solution and ATP was applied to cells for the final 30 minutes (37 
o
C). 
Cells were lysed in ice-cold lysis buffer containing 1 % nonidet P-40 and PIC. Griess 
reagent was incubated with the samples (1:1) and nitrite concentrations were determined 
from sodium nitrite standard curves quantified on a multimode plate reader (Fluostar 
Optima, BMG Labtech, UK) at 544 nm.  
 
2.8 PROTEIN EXPRESSION ANALYSIS 
2.8.1 Sample Generation for Receptor Expression 
Cell seeding conditions -  





Culture Vessel: Sterile cell-culture treated 24 well plates 
Media: 1 ml standard culture medium  
Duration: 17 – 24 hours 
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Media was aspirated from cells and cells washed with physiological salt solution (1 ml) 
before lysis using 1 % Triton-X 100 in PIC (75 µl, 4 oC). Samples were cleared by 
centrifugation at 1500 xg (F3601 rotor, Beckman GS-15R) for 10 minutes at 4 
o
C. Samples 




2.8.2 Sample Generation for IL-1β and Caspase-1 
Cell seeding conditions -  





Culture Vessel: Sterile cell-culture treated 24 well plates 
Media: 1 ml standard culture medium  
Duration: 17 – 24 hours 
 
Media was aspirated from LPS primed cells and cells washed with physiological salt 
solution (1 ml) before incubation in physiological salt solution (250 µl) in the absence or 
presence of ATP (37 
o
C). For analysis of the release of IL-1β, secreted protein fractions 
were collected and placed on ice before washing cells in physiological salt solution (1 ml, 
4 
o
C) and cells lysed using 1 % Triton-X 100 in PIC (75 µl, 4 oC)10. For analysis of 
caspase-1 activation cells were lysed by adding 10 % Triton-X 100 in 10x PIC (25 µl, 4 
o
C) directly to the cells and supernatant. Samples were cleared by centrifugation at 1500 xg 
(F3601 rotor, Beckman GS-15R) for 10 minutes at 4 
o
C. Secreted protein fractions were 
concentrated (x6) using 3K Nanosep cut-off filters according to the manufacturers’ 
protocol. Samples were diluted with 2x sample buffer and boiled for 5 minutes before 





12 % Resolving Gel (5 ml – 1 Gel) 
Solution Components Volume (ml) 
H2O 1.6 
30 % Acrylamide Mix 2.0 
1.5 M Tris (pH 8.8) 1.3 
10 % SDS (w/v) 0.05 
                                                 
10
 Triton-X 100 and PIC were at a final concentration of 1% and 1x respectively after addition to the well.  
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10 % Ammonium Persulfate (w/v) 0.05 
TEMED 0.002 
 
5 % Stacking Gel (1 ml – 1 Gel) 
Solution Components Volume (ml) 
H2O 0.68 
30 % Acrylamide Mix 0.17 
1 M Tris (pH 6.8) 0.13 
10 % SDS (w/v) 0.01 




Solution Components Concentration 
Glycine 192 mM 
SDS 0.1 % (w/v) 
Tri-HCl 25 mM 
 
Solubilised proteins were loaded on to an SDS-PAGE gel composed of a 5 % stacking and 
12 % resolving gel.  Samples were electrophoresed at 200 V in running buffer for 
approximately 40 minutes using the Bio-Rad Mini Protean II system (Bio-Rad, UK). A 




Solution Components Concentration 
Glycine 192 mM 
SDS 0.1 % (w/v) 
Tri-HCl 25 mM 








Solution Components Concentration 
PBS  
Tween 0.5 % (v/v) 
 
Blocking Buffer 
Solution Components Concentration 
PBS  
Tween 0.5 % (v/v) 
Skimmed Milk 5 % (w/v) 
 
Proteins were transferred by electroblotting in transfer buffer for 2 hours at 150 mA onto 
nitrocellulose membrane (0.2 µm) using the Bio-Rad Mini Trans-Blot cell (Bio-Rad, UK). 
Membranes were incubated for 60 minutes at RT in blocking buffer under constant 
agitation. The membrane was then incubated overnight at 4 
o
C under constant agitation in 
blocking buffer containing primary antibody
11
. The membrane was washed (x3, 5 minutes) 
in wash buffer and incubated in secondary antibody
12
 for 60 minutes at RT under constant 
agitation. The membrane was washed (x6, 5 minutes) in wash buffer and protein visualised 
using the Amersham™ ECL Advance™ western blotting detection agent.  
 
2.9 STATISTICAL ANALYSES 
Average results are expressed as the mean ± s.e.m from the number of assays indicated. 
Statistical analysis on experiment and control groups were performed using either 
Student’s t-test or one-way analyses of variance (ANOVA) with Dunnett’s post-hoc 
analysis where appropriate using the statistical software package Prism version 4 
(GraphPad Software, San Diego CA). Significance was reached when p<0.05. 
                                                 
11
 Primary Ab dilutions: Mouse IL-1β MAb 1:5000 / Caspase-1 p10 (M-20) 1:500 / P2X7R 1:2500 
 
12
 Secondary Ab dilutions at 1:5000: IL-1β - Polyclonal Rabbit Anti-Mouse IgG/HRP, Caspase-1/P2X7R – 
Polyclonal Swine Anti-Rabbit IgG/HRP 
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GENERAL PHARMACOLOGY & 
THE EFFECT OF DIVALENT CATIONS AT THE MURINE P2X7 RECEPTOR 
Portions of this chapter have been published in Cellular Signaling (2008), 19(4) 
Portions of this chapter are in press with Biochemical Pharmacology 
 
3.1 INTRODUCTION 
In this portion of the study the general pharmacology of an endogenously expressed 
murine macrophage P2X7R was investigated. Furthermore the ability of divalent metal 
cations to modulate P2X7R function was also assessed. Examining the properties of the 
mouse P2X7R and determining differences between species could be of importance for two 
major reasons:  
 
1. Increasing use of P2X7R KO mice and the use of animal models of disease 
drives the need to acquire knowledge of the mouse P2X7R. 
2. Prior to conducting this study much of the pharmacological characterisation 
of the P2X7R had been carried out using the rat orthologue, which may not 
be comparable to the mouse or human orthologue.  
 
Activation of the P2X7R by ATP will lead to the opening, within milliseconds of a non-




 into the cell 
(Figure 3-1). Prolonging this activation leads to the opening of a large pore within seconds 
to minutes, allowing the entry of dyes <900Da into the cell.  The dye permeation pathway 
is not fully understood, but appears to involve increases in intracellular Ca
2+
, the MAPK 
second messenger system (Faria et al., 2005) and pannexin-1 hemichannels (Pelegrin et al., 
2006). Prolonging activation of the P2X7R (≈ 30 minutes) will eventually lead to cytolytic 
cell death (Ferrari et al., 1997a; Mackenzie et al., 2005), however it is generally accepted 
that the dye permeation pathway is a separate event to cell death. These P2X7R functional 
responses led to the selection of three assays to assess the pharmacology of the mouse 
P2X7R; changes in [Ca
2+
]i, accumulation of the large molecular weight dye ethidium 
bromide (372Da) and the release of cellular lactate dehydrogenase, indicative of cell death.  
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Figure 3-1. Schematic of the Two Permeation States Induced by Activation of the P2X7R. The first 
permeation pathway is the opening on the non-selective cation ion channel. The second permeation pathway 
occurs with prolonged activation of the P2X7R and allows the uptake of large molecular weight dyes. The 
above diagram is based on the concept that the P2X7R couples to a separate pore forming protein recently 
elucidated to be pannexin-1 (Pelegrin et al., 2006). However a number of other models have been proposed 
including dilation of the channel itself (Khakh et al., 1999; Virginio et al., 1999). Potentially there are in fact 
three permeation states; opening of the non-selective cation channel, coupling to a second membrane protein 
for dye uptake and dilation of the P2X ion channel allowing the entry of larger cations such as NMDG (Jiang 
et al., 2005; Yan et al., 2008). 
 
Pharmacologically the P2X7R is the most distinct of the P2X receptors due to it being 
unusually insensitive to ATP (EC50 range of 0.1 – 1.8 mM), whilst the ATP-analogue 
BzATP is around 10-fold more potent than ATP (EC50 range of 3 - 300µM). Furthermore 
there are clear species differences in P2X7R pharmacology. For instance mouse P2X7Rs 
display markedly lower sensitivity to ATP and BzATP compared to the rat P2X7Rs (Table 
3-1A). By contrast the human P2X7R has a comparable sensitivity to BzATP but a lower 
ATP sensitivity. Mutagenesis studies have identified amino-acids (K127A and N284D) in 
the ectodomain of the P2X7R which are responsible for the differences in ATP and BzATP 
sensitivity between rat and mouse P2X7Rs (Young et al., 2007).  
 
In addition to the differences in potency of P2X7R agonists at different species of receptor, 
there are also differences in antagonist potency. Although IC50 values of P2X7R 
antagonists cannot always be accurately compared due to differences between studies on 
agonist concentration, agonist used (ATP versus BzATP), buffer composition, cell 
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background and assay used; it is generally accepted that the isoquinolines KN-62 and KN-
04 potently block human P2X7Rs with higher concentrations required to block rat P2X7Rs 
(Humphreys et al., 1998), whereas the opposite is true for Brilliant Blue G (BBG) (Jiang et 
al., 2000) (Table 3-1B). The newer highly selective P2X7R antagonists are also observed to 
have major differences in potency at different species of receptor. AZ11645373 is a highly 
selective and potent human P2X7R antagonist (IC50 = 10 – 100 nM) and is observed to be 
500-fold less potent at blocking the rat P2X7R (Stokes et al., 2006). GSK314181A has an 
IC50 range of between 18 – 85 nM at the human receptor whereas at the rat receptor it has 
an IC50 range of 29 – 980 nM (Broom et al., 2008). The Abbott Laboratories antagonists 
A-438079 and A-740003 however are reported to be highly selective and potent blockers 
at both the human and rat P2X7Rs (Donnelly-Roberts et al., 2007a). 
 
EC50 (µM) MOUSE RAT HUMAN 
ATP 900 120 1800 
BzATP 300 3 210 
 
Table 3-1A. Summary of EC50 of ATP and BzATP at the Mouse, Rat and Human P2X7Rs. Values are 
based on the findings from (Moore et al., 2007; Stokes et al., 2006; Surprenant et al., 1996; Young et al., 
2007) 
 
IC50 (nM) RAT HUMAN 
KN-62/KN-04 > 3000 30 - 100 
BBG 10 200 
 
Table 3-1B. Summary of IC50 of KN-62/KN-04 and BBG at the Rat and Human P2X7Rs. Values are 
based on the findings from (Humphreys et al., 1998; Jiang et al., 2000).  
 
P2X7Rs along with other P2XRs, are modulated by the presence of extracellular divalent 
cations, this phenomenon is also observed with other ligand-gated ion channels such as the 
glutamate receptors, GABAA receptors and nicotinic receptors (Huidobro-Toro et al., 
2008). The effects of different divalent cations are specific to each P2XR subtype (Table 3-
2). For example extracellular Zn
2+
 is observed to have no effect at the P2X1 and P2X3 
receptors (Nakazawa et al., 1997), potentiates responses at the P2X2 (< 100 µM) and P2X4 
(< 300 µM) receptors (Coddou et al., 2003; Lorca et al., 2005) and inhibits the P2X7R 
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(Virginio et al., 1997). Whereas extracellular Cu
2+
 inhibits at P2X4 and P2X7 and 
potentiates at P2X2. The mechanism for the action of the effects of these different divalent 
cations is proposed for each receptor to be a binding of the cation to specific metal binding 
sites within the receptors (Huidobro-Toro et al., 2008).  
 
 P2X1 P2X2 P2X3 P2X4 P2X5 P2X6 P2X7 
Ca
2+ 
No effect  No effect -  -  
Mg
2+
 No effect -   - -  
Cu
2+ 
-  -  - -  
Zn
2+
 No effect  No effect   -  
Cd
2+
 No effect  (weak) No effect  - -  
Hg
2+
 -  -  - - - 
 
Table 3-2. Effects of Increasing the Concentration of Extracellular Divalent Cations on P2XRs. Data 
based on (Evans et al., 1996; Giniatullin et al., 2003; Lorca et al., 2005; Nakazawa et al., 1997; Negulyaev et 
al., 2000; Seyffert et al., 2004; Virginio et al., 1997; Virginio et al., 1998; Wildman et al., 2002; Wildman et 
al., 1999a; Wildman et al., 1999b; Xiong et al., 1999). The majority of the data is for the rat orthologue of 
the receptor. Overall affects observed were not always the same between studies which maybe due to species 
of receptor used, pre-incubation time with divalent cation, cell background, concentration of agonist and 
functional response measured.  denotes potentiation,  denotes inhibition.  
 
The majority of the studies performed to investigate the effects of divalent cations at P2X 
receptors have been performed using the rat orthologues of the receptor expressed in 
HEK293 cells or Xenopus oocytes. Considering the clear species differences between the 
P2X7 receptors observed with agonists and antagonists, it could be hypothesized that 
species differences in the binding and modulation of the receptor by divalent cations may 
also occur.  
 
Another reason why it maybe of interest to study the effects of divalent cations at the 




  (Virginio et al., 
1997) would suggest that activation of the P2X7R is suppressed under physiological 
conditions, thus preventing/reducing any unwanted effects of receptor over-activation 
(potentially leading to cytolysis) whilst maintaining low level activation required for 
physiological responses (cell proliferation) (Jiang, 2008). Although ion concentrations in 
the blood are highly regulated; most cell types are not in direct contact with blood and 
S.F.Moore 
CHAPTER 3: GENERAL PHARMACOLOGY & THE EFFECT OF DIVALENT CATIONS AT THE MURINE P2X7R 
63 
 
therefore there is potential for tissue specific and localised differences in ion 
concentrations (Bosher et al., 1978, Silver et al., 1988). Furthermore there is thought to be 
a relationship between intracellular Ca
2+
 signalling events and changes to extracellular 
Ca
2+ 
concentration with the outward and inward exchange of Ca
2+
 potentially causing local 
elevations or depletions in the extracellular Ca
2+
 concentration (Hofer et al., 2003). 





 could possibly be reduced leading to an enhancement of P2X7R activation and 
therefore initiating some of the functional P2X7R responses associated with an immune 
response including the processing and secretion of IL-1β.  
 




 are of particular interest; both of these divalent ions are 
essential trace metal nutrients where imbalances have been observed to provoke a range of 
different effects. Both cations are required for the action of various enzymes, including 
superoxide dismutase, tyrosine and tryptophan hydroxylases. Zn
2+
 plays an important 
signaling role in the immune system, whereby treatment with oral Zn
2+
 has profound 
effects on immune response and acts as an anti-inflammatory therapeutic (Dardenne, 2002; 
Fraker et al., 2000). Cu
2+
 deficiencies have been related to neurological disturbances, 
anaemia and hair changes (Cerpa et al., 2005).  
 
Therefore a study on the regulation of the mouse P2X7R by divalent cations could 
potentially: 
• Reveal species differences in metal binding sites and increase our 
knowledge about P2XR regulation by divalent cations. 
• Increase our understanding on how P2X7R function maybe regulated under 
physiological and pathophysiological conditions. 
 
 
When examining if the P2X7R is modulated by divalent cations it is important to account 
for free ATP
4-
 concentrations, this form of ATP has been reported to be the active ligand at 
this receptor (Cockcroft et al., 1979; Cockcroft et al., 1980; Dahlquist et al., 1974). ATP 
has multiple ionisable groups with different acid dissociation constants. In a neutral 
solution ATP is ionized and exists mostly as ATP
4-
 with a small proportion of ATP
3-
. As 
ATP has several negatively charged groups in neutral solution it is able to chelate metals 
with very high affinity. Example binding constants for various metal ions (per mole) are 
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, 3722 and  K
+
, 8. Due to the strength of these interactions, ATP 
exists in the cell mostly in a complex with Mg
2+
. Therefore increasing the concentration of 





The key findings of this study were:  
1. ATP elicits increases in [Ca
2+
]i (seconds), uptake of EtBr (minutes) and cell death 







 primarily inhibit EtBr uptake in RAW264.7 cells by reducing 





 potentiates EtBr uptake in RAW264.7 cells 
4. Cu
2+




 has differential effects at the P2X7R depending on species, cell background 
and agonist used.  
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3.2.1 ATP Evokes an Increase in Intracellular Calcium in RAW264.7 Murine Macrophages 
Application of extracellular ATP on to RAW264.7 cells loaded with Fluo-4 AM in the 
presence of 2 mM Ca
2+
 was observed to trigger an increase in Fluo-4 fluorescence (Figure 
3-2A, Figure 3-2B) indicative of an increase in [Ca
2+
]i. Concentrations of ATP < 1mM 
induced a rapid transient increase whereas concentrations ≥ 1 mM gave a sustained 
response (> 1 minute). Plotting peak responses established that ATP evoked a 
concentration-dependent response (Figure 3-2C) with an EC50 value of 380 µM (n = 8 ± 
s.e.m, pEC50 = 3.42 ± 0.05, nH = 0.94 ± 0.08). In the absence of external Ca
2+
 (calcium-free 
external salt solution containing 1mM EGTA); responses evoked by 1 mM ATP were 
reduced, with the peak [Ca
2+
]i rise decreased by 82.83 ± 4.32 % and the sustained 
component by 92.80 ± 2.6 % (n = 6 ± s.e.m, p< 0.001) (Figure 3-2D).  
  
Pre-addition of the generic P2X receptor antagonist suramin (10 and 100 µM) failed to 
significantly inhibit ATP (0.03, 0.3 and 3 mM) induced increases in [Ca
2+
]i in RAW264.7 
cells (n = 6, Figure 3-3A, Figure 3-3B). Addition of 1 mM ATP in the presence of the 
potent human P2X7R antagonist KN-62 (Figure 3-3C) was observed to reduce increases in 
[Ca
2+
]i. Comparing peak and sustained responses in the presence and absence of KN-62 
determined that 10 µM KN-62 significantly inhibited ATP triggered rises in peak and 
sustained [Ca
2+
]i by 46.31 ± 11.78 % and 58.02 ± 3.97 % respectively (n = 6 ± s.e.m; 
p<0.05) (Figure 3-3D). Addition of 1 mM ATP in the presence of the potent rat P2X7R 
antagonist BBG (0.3 – 10 µM) yielded a dose-dependent block in ATP triggered rises in 
[Ca
2+
]i (n = 6, Figure 3-3E). 10 µM BBG was observed to inhibit the peak and sustained 
[Ca
2+
]i response induced by 1 mM ATP (Figure 3-3F) by 67.99 ± 5.03 % and 87.48 ± 4.12 













Figure 3-2. ATP Evokes Transient and Sustained Increases in [Ca
2+
]i in RAW264.7 Macrophages. A, 
Representative trace of rapid transient ATP (1 – 30 µM) induced increases in [Ca2+]i. B, Representative trace 
of transient ATP (0.1 & 0.3 mM) and sustained ATP (1 & 3 mM) induced increases in [Ca
2+
]. C, 
Concentration-response curve of the effect of ATP on [Ca
2+
]i (n = 8 ± s.e.m, pEC50 of 3.42 ± 0.05). D, 
Kinetic trace comparing the effect of ATP (1 mM)  on increases in [Ca
2+
]i in the presence (2 mM) and 
absence (1 mM EGTA) of Ca
2+
 (n  = 6 ± s.e.m).  
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Figure 3-3. ATP Induced Increases in [Ca
2+
]i are Inhibited by P2X7R Antagonists. A, Kinetic trace and 
B, histogram of the effects of suramin on ATP evoked increases in [Ca
2+
]i (n = 6 ± s.e.m). C, Kinetic trace 
and D, histogram of the effects of KN-62 on ATP evoked increases in [Ca
2+
]i (n  = 6 ± s.e.m). E, Kinetic 
trace and F, histogram of the effects of BBG on ATP evoked increases in [Ca
2+
]i (n  = 6 ± s.e.m). One-way 
ANOVA with Dunnett’s post-hoc test, *: p<0.05, **: p<0.01.  
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3.2.2 ATP Induces the Uptake of EtBr into RAW264.7 Murine Macrophages 
Application of 3 mM ATP on to RAW264.7 cells bathed in a physiological salt solution 
containing 25 µM EtBr (37 oC) was observed to induce a continuous increase in EtBr 
fluorescence above an ATP-free control (Figure 3-4A). Using a range of ATP 
concentrations and calculating rates of increase in EtBr fluorescence (0-15 minutes ATP 
application) established that a concentration ≥ 1 mM ATP was required to induce EtBr 
uptake above an ATP-free control with a peak rate of uptake achieved with 3 – 5 mM ATP. 
Plotting a concentration-response curve (Figure 3-4B) determined that ATP evoked EtBr 
uptake with an EC50 of 1.55 mM (n = 29 ± s.e.m, pEC50 = 2.81 ± 0.02, nH = 5.81 ± 0.46). 
Pre-application of KN-62 was observed to inhibit ATP (3 mM) evoked EtBr uptake 
(Figure 3-4C). This inhibition was observed to be concentration-dependent with an IC50 of 
1.32 µM (n = 9 ± s.e.m, pIC50 = 5.88 ± 0.20, nH = -0.98 ± 0.30) (Figure 3-4D). Preliminary 
experiments determined that BBG quenched and suramin increased the basal fluorescence 
of the recorded EtBr signal (data not shown) and where therefore not tested in these 
experiments. 
 
3.2.3 Prolonged ATP Stimulation Induces Cell Death 
Cell viability was determined by measuring the retention of the cytosolic enzyme LDH. An 
application of 3 mM ATP onto RAW264.7 cells bathed in physiological salt solution for > 
30 minutes (37 
o
C) was observed to induce a significant release of LDH into the external 
medium (Figure 3-5A, n = 9). Pre-addition of KN-62 was observed to block ATP (3 mM, 
60 minutes) induced LDH release with an IC50 of 407 nM (Figure 3-5B, n = 9 ± s.e.m, 
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Figure 3-4. ATP Induced EtBr Uptake is Inhibited by KN-62. A, Representative trace of ATP induced 
increase in EtBr fluorescence indicative of pore formation. B, Concentration-response curve of the effect of 
ATP on inducing pore formation (n = 29 ± s.e.m, pEC50 of 2.81 ± 0.02). C, Representative trace and D, 
concentration-inhibition curve of the effect of KN-62 on ATP evoked pore-formation (n = 9 ± s.e.m, pIC50 of 
5.88 ± 0.20).  
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Figure 3-5. ATP Induced Cell Death is Inhibited by KN-62. A, Histogram demonstrating that incubating 
cells with 3 mM ATP for 45 or 60 minutes induced a significant release of LDH (n = 9 ± s.e.m). B, 
Concentration-response curve of the effect of stimulating RAW264.7 cells with ATP in the presence of KN-
62 (n = 9 ± s.e.m, pIC50 = 6.39 ± 0.18, nH = -1.47 ± 0.73, α = -36.93 ± 4.86). One-way ANOVA with 





CHAPTER 3: GENERAL PHARMACOLOGY & THE EFFECT OF DIVALENT CATIONS AT THE MURINE P2X7R 
71 
 








In the presence of extracellular Ca
2+
 (2 mM) and Mg
2+
 (1 mM) (described as 
physiological) an application of ATP on to RAW264.7 cells was observed to trigger the 





 (described as nominal) was observed to cause an increase in the rate of dye uptake 
induced by ATP above an ATP-free control (Figure 3-6A). Constructing concentration-





decreased the EC50 to 309 µM (n = 29, p<0.001) (Figure 3-6B, Table 3-3). No significant 
change in nH or α was observed (p>0.05). Taking in to account changes in the 
concentration of ATP
4-





] (Figure 3-6C). 
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 Potentiates EtBr Uptake by Increasing Free [ATP
4-




 from the external solution on ATP (1 mM) 




 from the 
external solution on ATP induced pore formation. C, Re-plotted ATP
4-
 concentration-response curves. (n = 
29 ± s.e.m). 
 
 pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
Physiological 2.81 ± 0.02 5.81 ± 0.46 102 ± 4 
Nominal 3.51 ± 0.03*** 5.88 ± 1.14 113 ± 5 
 
Table 3-3. ATP Concentration-Response Curve Parameters for EtBr Uptake in Physiological Salt 




 Solution. n  = 29 ± s.e.m, Student’s two-tailed t-test ***:p<0.001. 
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 on EtBr Uptake  
Increasing the concentration of external Ca
2+
 in the physiological salt solution was found 
to inhibit ATP evoked EtBr uptake, as demonstrated with a rightward shift in ATP 
concentration response curve (Figure 3-7A). A significant increase in the EC50 from 1.41 
mM to 2.88 mM was obtained in the presence of 10 mM Ca
2+
 (n = 4, p<0.001) (Table 3-
4A). The hill-slope (nH) was also observed to increase with increasing concentrations of 
Ca
2+
 however this increase was not found to be statistically significant (n = 4, p>0.05). 
Taking in to account changes in the concentration of ATP
4-
 abolished the significant 
increase in EC50 obtained by increasing Ca
2+
 to 10 mM (Figure 3-7B, Table 3-4B). 
  
Increasing the concentration of external Mg
2+
 in the physiological salt solution from 1 to 3 
or 10 mM was found to inhibit ATP evoked EtBr uptake (Figure 3-8A.). A significant 
increase in the EC50 from 1.45 mM to 2.40 mM was obtained in the presence of 3 mM 
Mg
2+
 (n = 5, p<0.05) (Table 3-5A).  No significant change in nH or α was observed 
(p>0.05). Concentration-response curve fitting for ATP evoked EtBr uptake in the 
presence of 10 mM Mg
2+
 was not achieved due to responses being obtained at only two of 
the ATP concentrations tested; therefore pEC50, nH and α parameters could not be 
calculated and compared to responses in the physiological salt solution. Taking in to 
account changes in the concentration of ATP
4-
 abolished the significant increase in EC50 
obtained by increasing Mg
2+
 to 3 mM (Figure 3-8B, Table 3-5B). 
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Figure 3-7. Increasing External Ca
2+
 Inhibits EtBr Uptake by Decreasing [ATP
4-
]. ATP was injected on 
to RAW264.7 cells (1.5 x 10
5
) bathed in physiological salt solution containing either 2, 3 or 10 mM Ca
2+
 and 
25 µM EtBr (37 °C). A, Concentration-response curves demonstrating the effect of ATP on EtBr uptake in 
the presence of increasing [Ca
2+
]. B, Re-plotted ATP
4-





] mM pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
2 2.85 ± 0.07 3.86 ± 0.77 83 ± 2 
3 2.83 ± 0.11 4.13 ± 1.84 101 ± 14 





] mM pEC50 ± s.e.m 
2 4.03 ± 0.09 
3 3.87 ± 0.12 
10 4.21 ± 0.07 
 
Table 3-4. ATP Concentration-Response Curve Parameters for EtBr Uptake in the Presence of 
Increasing [Ca
2+
]e. A, ATP concentration-response curve parameters. B, ATP
4-
 pEC50 values. n = 4 ± s.e.m, 
One-Way ANOVA **:p<0.001. 
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Figure 3-8. Increasing External Mg
2+
 Inhibits EtBr Uptake by Decreasing [ATP
4-
]. ATP was injected on 
to RAW264.7 cells (1.5 x 10
5
) bathed in physiological salt solution containing either 1 (physiological), 3 or 
10 mM Mg
2+
 and 25 µM EtBr (37 °C). A, Concentration-response curves demonstrating the effect of ATP on 
EtBr uptake in the presence of increasing [Mg
2+
]. B, Re-plotted ATP
4-






] mM pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
1 2.84 ± 0.05 5.04 ± 1.35 94 ± 8 
3 2.62 ± 0.05* 5.59 ± 1.15 95 ± 14 





] mM pEC50 ± s.e.m 
1 4.01 ± 0.10 
3 4.06 ± 0.07 
10 NA 
 
Table 3-5. ATP Concentration-Response Curve Parameters for EtBr Uptake in the Presence of 
Increasing [Mg
2+
]e. A, ATP concentration-response curve parameters. B, ATP
4-
 pEC50 values. n = 5 ± s.e.m, 
One-Way ANOVA with Dunnett’s post-hoc test **:p<0.01. 
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3.2.6 Effect of Heavy Metal Cations Cadmium and Mercury of EtBr Uptake  
Addition of Hg
2+
 at concentrations ≤ 3 µM  into the external physiological salt solution 
was observed to have no significant effect on ATP evoked EtBr uptake into RAW264.7 
cells (n = 4) (Figure 3-9A, Table 3-6). An addition of 10 µM Hg2+ however was observed 
to increase the maximal rate of EtBr uptake evoked by ATP by 118 ± 54 % (n = 4). This 
was observed to occur with no significant change in nH or EC50 (n = 4, p>0.05) and in the 





 at a concentration of 1 mM was observed to rightward shift the ATP EtBr 
concentration-response curve resulting in a significant increase in the EC50 from 1.58 mM 
to 2.29 mM (n = 4, p<0.01) (Figure 3-10A, Table 3-7A). The nH was observed to decrease 
with increasing concentrations of Cd
2+
 however this decrease was not found to be 
statistically significant (n = 4, p>0.05). Taking in to account changes in the concentration 
of ATP
4-
 abolished the significant increase in EC50 obtained by evoking EtBr uptake in the 
presence of Cd
2+
 (Figure 3-10B, Table 3-7B). 
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Figure 3-9. Extracellular HgCl2 Potentiates EtBr Uptake in the Absence of Cell Death. A, 
Concentration-response curves demonstrating the effect of the presence of Hg
2+
 on ATP evoked EtBr uptake 
(n = 4 ± s.e.m). B, Histogram of the effect of Hg2+ on RAW264.7 cell death in the absence and presence of an 




] µM pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
0 2.74 ± 0.03 5.25 ± 1.12 109 ± 4 
1 2.74 ± 0.04 6.05 ± 1.98 114 ± 8 
3 2.75 ± 0.04 6.49 ± 2.29 120 ± 11 
10 2.85 ± 0.08 3.45 ± 1.34 232 ± 50* 
 
Table 3-6. ATP Concentration-Response Curve Parameters for EtBr Uptake in the Presence of Hg
2+
. n 
= 4 ± s.e.m, One-Way ANOVA with Dunnett’s post-hoc test **:p<0.05. 
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Figure 3-10. Extracellular Cd
2+
 Inhibits EtBr Uptake by Decreasing [ATP
4-
]. A, Concentration-response 
curves demonstrating the effect of ATP on EtBr uptake in the presence of Cd
2+
. B, Re-plotted ATP
4-
 





] mM pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
0 2.80 ± 0.01 5.15 ± 1.23 97 ± 4 
0.1 2.78 ± 0.02 5.38 ± 1.31 100 ± 10 
0.3 2.79 ± 0.04 6.25 ± 0.37 110 ± 10 





] mM pEC50 ± s.e.m 
0 3.88 ± 0.02 
1 4.01 ± 0.07 
 
Table 3-7. ATP Concentration-Response Curve Parameters for EtBr Uptake in the Presence of Cd
2+
. 
A, ATP concentration-response curve parameters. B, ATP
4-
 pEC50 values. n = 4 ± s.e.m, One-Way ANOVA 
or Student’s two-tailed t-test **:p<0.01. 
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3.2.7 Effect of the Trace Metal Ions Zinc and Copper on ATP Evoked EtBr Uptake 
Stimulating RAW264.7 cells with ATP in presence of ≥ 300 µM Zn2+ was observed to 
inhibit EtBr uptake. Concentration-response curves were observed to be rightward shifted 
when extracellular Zn
2+
 was present (Figure 3-11A and B), with an increase in the EC50 
from 1.51 mM to 2.57 mM (1 mM ZnCl2). Significant differences in the pEC50 values of 
ATP were calculated when in the presence of 0.3 and 1 mM Zn
2+
 (n = 9, p<0.01) (Table 3-
8A). A significant difference in the nH of the ATP concentration-response curve was 
calculated when 1 mM Zn
2+
 was present (n = 9, p<0.01). No significant change in α was 
observed with increasing concentrations of Zn
2+
 (n = 9, p>0.05), however it is debatable 
whether a true maxima for the ATP concentration-response curve in the presence of 1 mM 
ZnCl2 was reached. Taking in to account changes in the concentration of ATP
4-
 abolished 
the significant decrease in pEC50 values obtained by evoking EtBr uptake in the presence 
of  Zn
2+
 (Figure 3-11C and D, Table 3-8B). 
 
Evoking ATP induced EtBr uptake in the presence of Cu
2+
 was observed to inhibit EtBr 
uptake. Plotting concentration-response curves demonstrated that 10 and 30 µM Cu2+ 
decreased the maximum rate of EtBr uptake (Figure 3-12A). A significant reduction in α 
was determined in the presence of 30 µM Cu2+ by 67 ± 18 % (n = 4 ± s.e.m, p<0.01) 
(Table 3-9). No significant change in pEC50 or nH was observed with any of the 
concentrations of Cu
2+
 (n = 4, p>0.05). 
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Figure 3-11. Extracellular Zn
2+
 Modulates EtBr Uptake Induced by ATP. A, Concentration-response 
curves demonstrating the effect of ATP on EtBr uptake in the presence of 100 and 300 µM Zn2+. B, 
Concentration-response curves demonstrating the effect of ATP on EtBr uptake in the presence of 1 mM 
Zn
2+
. C, Re-plotted ATP
4-
 concentration response curves demonstrating the effect of 100 and 300 µM Zn2+. 
D, Re-plotted ATP
4-
 concentration response curves demonstrating the effect of 1 mM Zn
2+
.  (n = 9 ± s.e.m). 
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] mM pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
0 2.82 ± 0.04 6.10 ± 1.19 111 ± 7 
0.1 2.76 ± 0.04 4.87 ± 0.99 117 ± 9 
0.3 2.63 ± 0.04** 6.77 ± 1.71 119 ± 8 





] mM pEC50 ± s.e.m 
0 3.96 ± 0.06 
0.1 3.79 ± 0.10 
0.3 3.67 ± 0.10 
1 3.53 ± 0.32 
 
Table 3-8. ATP Concentration-Response Curve Parameters for EtBr Uptake in the Presence of Zn
2+
. 




 pEC50 values in the 
presence of Zn
2+
.  n = 9 ± s.e.m, One-Way ANOVA with Dunnett’s post-hoc test **:p<0.01.  
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Figure 3-12. Extracellular Cu
2+
 Inhibits EtBr Uptake Induced by ATP. Concentration-response curve 




] µM pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
0 2.79 ± 0.03 4.19 ± 0.92 108 ± 6 
3 2.82 ± 0.01 7.99 ± 2.68 101 ± 22 
10 2.77 ± 0.03 8.66 ± 2.12 85 ± 3 
30 2.65 ± 0.08 5.23 ± 3.14 32 ± 11** 
 
Table 3-9. ATP Concentration-Response Curve Parameters for EtBr Uptake in the Presence of Cu
2+
. n 
= 4 ± s.e.m, One-Way ANOVA with Dunnett’s post-hoc test **:p<0.01. 
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3.2.8 Effect of Zinc on Recombinant Mouse and Rat P2X7 Receptors 
The effect of Zn
2+
 on the recombinant mouse P2X7R expressed in HEK293 cells was 
studied to determine whether the lack of effect of Zn
2+
 on the mouse P2X7R endogenously 
expressed on RAW264.7 cells was due to a fault in either the expression system or assay 
used. In addition the effect of Cu
2+
 on the recombinant mouse P2X7R receptor expressed in 





 on the recombinant rat P2X7 receptor were also performed, which has previously 
been demonstrated to be inhibited by these ions (Virginio et al., 1997).  
 
An application of 5 mM ATP onto HEK293 cells transfected with the mouse P2X7 receptor 
was observed to evoke uptake of EtBr above control (Figure 3-13A). Uptake of EtBr was 
observed to be increased when 300 µM ZnCl2 was added to the physiological salt solution 
(Figure 3-13B). Constructing dose-response curves demonstrated that 300 µM Zn2+ 
decreased the EC50 of ATP from 2.64 mM to 1.68 mM (n = 5) (Figure 3-13C, Table 3-
10A), pEC50 values were found to be significantly increased (n = 5, p<0.01) with no 
significant changes in nH or α observed (n = 5). 
 
ATP was observed to elicit a dose-dependent increase in EtBr uptake in HEK293 cells 
expressing the rat P2X7R with an EC50 of 955 µM (n = 7) (Figure 3-13D), which was 
observed to be lower than the EC50 values obtained at the P2X7R in both RAW 264.7 and 
HEK293/mP2X7R cells (1.55 mM and 2.64 mM respectively). Addition of 100 µM Zn
2+
 to 
the physiological salt solution was observed to significantly inhibit EtBr uptake. This 
inhibition was due to a significant decrease in the maximal rate of EtBr uptake by 63 ± 10 
% (n = 7 ± s.e.m, p<0.01) (Table 3-10B). No significant changes in pEC50 or nH were 








Figure 3-13. EtBr Uptake Modulation by Zn
2+
 at mP2X7R and rP2X7R Expressed in HEK293 cells. A, 
Representative kinetic graph demonstrating EtBr uptake occurring only when ATP is injected onto HEK293 
cells expressing the mP2X7R. B, Representative kinetic graph demonstrating an increase in the rate of EtBr 
uptake when ATP stimulation of HEK293/mP2X7R cells occurs in the presence of 300 µM Zn
2+
. C, 
HEK293/mP2X7R concentration-response curve demonstrating a leftward shift in EtBr uptake when 300 µM 
Zn
2+
 is present (n = 5 ± s.e.m). D, HEK293/rP2X7R concentration-response curve demonstrating a decrease 
in maximal EtBr uptake when 100 µM Zn2+ is present (n = 7 ± s.e.m).   
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] µM pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
0 2.58 ± 0.05 3.97 ± 1.15 102 ± 7 






] µM pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
0 3.02 ± 0.03 3.93 ± 1.69 96 ± 1 
100 3.13 ± 0.12 4.32 ± 5.51 36 ± 9** 
 
Table 3-10. ATP Concentration-Response Curve Parameters for EtBr Uptake at the Mouse and Rat 
P2X7R in the Absence and Presence of Zn
2+
. A, ATP concentration-response curve parameters in the 
presence of Zn
2+
 for HEK293/mP2X7R. n = 5 ± s.e.m. B, ATP concentration-response curve parameters in 
the presence of Zn
2+
 for HEK293/rP2X7R. n = 7 ± s.e.m. Student’s two-tailed t-test *:p<0.05, **:p<0.01. 
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3.2.9 Effect of Copper on Recombinant Mouse and Rat P2X7 Receptors 
In a physiological salt solution ATP evoked EtBr uptake into HEK293 cells expressing 
either the mP2X7R or rP2X7R was inhibited by Cu
2+
 (Figure 3-14A and B).  A true 
maximum for the ATP concentration-response curves at the recombinant mouse P2X7R 
was not reached therefore curve fitting parameters are not given. Rate of EtBr uptake 
induced by 5 mM ATP was reduced by 35 ± 17 % (n = 5 ± s.e.m) when 30 µM Cu2+ was 
present. A true maximum for ATP concentration-response curves at the recombinant rat 
P2X7R was not reached, therefore curve fitting parameters are not given. Rate of EtBr 
uptake induced by 3 mM ATP was reduced by 37 ± 12 % (n = 4 ± s.e.m) when 30 µM 
Cu
2+









Figure 3-14. EtBr Uptake is Inhibited by Cu
2+
 at mP2X7R and rP2X7R Expressed in HEK293 cells. A, 
HEK293/mP2X7R concentration-response curve demonstrating a reduction in the maximum response when 
30 µM Cu2+ is present (n = 5 ± s.e.m). B, HEK293/rP2X7R concentration-response curve demonstrating a 
decrease in the maximum response when 30 µM Cu2+ is present (n = 4 ± s.e.m).   
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In addition to the different efficacies of antagonists between species of P2X7R, it has also 
been noted that antagonists can have differing efficacy at the same species of receptor 
when different agonists are used. Many studies of the P2X7R use the ATP analogue 
BzATP, which is regarded by some as a selective agonist of the P2X7R. This however is 
untrue. BzATP is known to activate other P2X receptors with either comparable or lower 
EC50s (Table 1-1). Therefore as part of the study into divalent cation modulation of the 
P2X7R, the effect of metal ions on BzATP evoked responses was examined.  
 
Using RAW264.7 cells an application of the non-physiological but more potent P2X7R 
agonist, BzATP was found to elicit EtBr uptake in the physiological salt solution at lower 
concentrations than ATP.  However a maximal response was not reached despite using up 





(nominal) was observed to cause an increase in the rate of dye uptake induced by BzATP 
with a maximal response reached using ≈ 300 µM BzATP and an EC50 of 89 µM 
calculated (n = 8, Figure 3-15A, Table 3-11). Comparing the responses of BzATP and ATP 




 solution revealed that BzATP evoked EtBr uptake into 
RAW264.7 cells with a significantly lower EC50 (n = 8, p<0.001) (Table 3-11.). No 
significant change in nH or α was observed (p>0.05).  Taking in to account changes in the 
concentration of BzATP
4-
 revealed that BzATP induced concentration-response curves 




 salt solution were now 












 Potentiates EtBr Uptake by Increasing Free 
[BzATP
4-
]. A, Concentration-response curves demonstrating the effect of ATP and BzATP on EtBr uptake in 




. B, Re-plotted BzATP
4-
 concentration response curves. (n = 8 ± 
s.e.m). 
 
 pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
ATP 3.56 ± 0.06 5.16 ± 1.19 119 ± 12 
BzATP 4.05 ± 0.10*** 6.31 ± 1.36 121 ± 10 
 





 Salt Solution. n = 8 ± s.e.m, Student’s two-tailed t-test where ***:p<0.001. 
S.F.Moore 
CHAPTER 3: GENERAL PHARMACOLOGY & THE EFFECT OF DIVALENT CATIONS AT THE MURINE P2X7R 
90 
 





In order to assess and compare the effect of Zn
2+
 on BzATP activation of the P2X7R, the 




 solution to construct 
full concentration-response curves. Initially I determined the effect of Zn
2+
 on modulating 




 solution.  
 
Stimulating RAW264.7 cells with ATP in the presence of 100 µM or 300 µM Zn2+ was 
observed to inhibit EtBr uptake. Construction of concentration-response curves 
demonstrated that curves were rightward shifted in the presence of Zn
2+
 (n = 6, Figure 3-
16A). The EC50 value of ATP was found to increase from 302 µM to 575µM and 603 µM 
in the presence of 100 and 300 µM Zn2+ respectively (Table 3-12A). No significant change 
in nH or α was observed (p>0.05). Taking in to account changes in the concentration of 
ATP
4-
 abolished the significant increase in EC50 obtained by evoking EtBr uptake in the 
presence of Zn
2+
 (Figure 3-16B). 
 
Stimulating the HEK293/mP2X7R with ATP in the presence of 300 µM Zn
2+
 was observed 
to potentiate EtBr uptake (n = 3). This potentiation was observed as an increase in the 
maximal response (p<0.05) without significant change in EC50 or nH (Figure 3-16C, Table 
3-12B).  
 
Stimulating the HEK293/rP2X7R with ATP in the presence of 100 µM Zn
2+
 was observed 
to inhibit EtBr uptake (n = 3, Figure 3-16D). This inhibition was observed as a significant 
increase in the EC50 from 339 µM to 871 µM (p<0.01, Table 3-12C). No significant 
change in nH or α was observed (p>0.05). Taking in to account changes in [ATP
4-]  I still 
observed a significant increase in the EC50 of ATP induced EtBr uptake in the presence of 
Zn
2+
 when compared to control responses (p<0.01, Figure 3-16E).   
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Figure 3-16. Modulation of EtBr Uptake by Zn
2+





response curve demonstrating the effect of Zn
2+
 on EtBr uptake into RAW264.7 cells (n = 6 ± s.e.m). B, Re-
plotted ATP
4-
 concentration response curves demonstrating the effect of 100 and 300 µM Zn2+. C, 
Concentration-response curve demonstrating the effect of Zn
2+
 on EtBr uptake into HEK293/mP2X7R cells 
(n = 3 ± s.e.m). D, Concentration-response curve demonstrating the effect of Zn2+ on EtBr uptake into 
HEK293/rP2X7R cells (n = 3 ± s.e.m). E, Re-plotted ATP
4-
 concentration response curves demonstrating the 
effect of 100 µM Zn2+.  
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] mM pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
0 3.52 ± 0.18 3.39 ± 0.41 114 ± 10 
0.1 3.24 ± 0.11* 4.67 ± 0.94 89 ± 11 






] mM pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
0 3.10 ± 0.11 3.31 ± 0.40 100 ± 8 






] mM pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
0 3.47 ± 0.05 1.82 ± 0.23 114 ± 6 
0.1 3.06 ± 0.01** 2.97 ± 1.2 90 ± 7 
 
 
Table 3-12. ATP Concentration-Response Curve Parameters for EtBr Uptake in the Presence of Zn
2+
 




 Salt Solution. A, RAW264.7 cells (n = 6 ± s.e.m). B, HEK293/mP2X7R cells (n = 
3 ± s.e.m). C, HEK293/rP2X7R cells (n = 3 ± s.e.m). One-Way ANOVA or two-tailed Student’s t-test 
*:p<0.05, **:p<0.01. 
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3.2.12 Effect of Zinc on BzATP Evoked EtBr Uptake 
As a maximum response to BzATP was not observed in a physiological salt solution using 
concentrations up to 1 mM, the action of extracellular Zn
2+





 salt solution. In RAW264.7 cells extracellular Zn
2+
 was observed to inhibit EtBr 
uptake with 100 µM Zn2+ shifting the EC50 to 796 µM from 91 µM (p<0.001, n = 3) 
(Figure 3-17A, Table 3-13A). No significant change in nH or α was observed (p>0.05). 
Taking into account changes in [BzATP
4-
] I still observed a significant rightward shift in 
the BzATP evoked concentration-response curve in the presence of Zn
2+
 (p<0.001, Figure 
3-13B).   
 
BzATP stimulations of HEK293/mP2X7R cells evoked EtBr uptake, however a maximal 
response was not reached using up to 1 mM BzATP (n = 3, Figure 3-17C). Application of 
300 µM Zn2+ was observed to reduce maximal EtBr uptake evoked by BzATP (n = 3). For 
HEK293/rP2X7R cells BzATP evoked EtBr uptake with an EC50 of 13.2 µM (pEC50 = -
4.88 ± 0.007, n = 3 ± s.e.m). An addition of 100 µM Zn2+ or 300 µM Zn2+ was observed to 
significantly inhibit BzATP evoked responses (n = 3) where the EC50 value increased to 
224 µM in the presence of 100 µM Zn2+ (p<0.001, Figure 3-17D, Table 3-13B). Taking 
into account changes in [BzATP
4-
] I still observed a significant rightward shift in the 
BzATP evoked concentration-response curve in the presence of Zn
2+
 (p<0.01, Figure 3-









Figure 3-17. Modulation of BzATP evoked EtBr Uptake by Zn
2+





Concentration-response curve demonstrating the effect of Zn
2+
 on EtBr uptake into RAW264.7 cells (n = 3 ± 
s.e.m). B, Re-plotted BzATP
4-
 concentration response curves demonstrating the effect of 100 and 300 µM 
Zn
2+
. C, Concentration-response curve demonstrating the effect of Zn
2+
 on EtBr uptake into 
HEK293/mP2X7R cells (n = 3 ± s.e.m). D, Concentration-response curve demonstrating the effect of Zn
2+
 on 
EtBr uptake into HEK293/rP2X7R cells (n = 3 ± s.e.m). E, Re-plotted BzATP
4-
 concentration response 
curves demonstrating the effect of 100 µM Zn2+.  
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] mM pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
0 4.04 ± 0.10 2.09 ± 0.67 117 ± 11 






] mM pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
0 4.88 ± 0.05 1.82 ± 0.23 163 ± 11 
0.1 3.65 ± 0.26** 2.97 ± 1.2 214 ± 23 
 
Table 3-13. BzATP Concentration-Response Curve Parameters for EtBr Uptake in the Presence of 
Zn
2+




 Salt Solution. A, RAW264.7 cells (n = 3 ± s.e.m). B, HEK293/rP2X7R cells 
(n = 3 ± s.e.m). One-Way ANOVA or two-tailed Student’s t-test *:p<0.05, **:p<0.01. 
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In this study I determined (i) the pharmacological properties of the murine P2X7R 














 can potentiate ATP evoked EtBr uptake, (iv) Cu
2+
 inhibits the 
activation of the P2X7R potentially through direct binding to the receptor and (v) Zn
2+
 
modulation of the P2X7R is dependent on species, cell background and agonist.  
 
3.3.1 General Pharmacology 
The RAW264.7 murine macrophage cell line has previously been determined to express 
the P2X7R (Hiken et al., 2004; Pfeiffer et al., 2004) and this was confirmed by western 
blot and immunohistochemistry (Figure A-1
13
). Extracellular ATP in the presence of 2 mM 
Ca
2+
 was observed to evoke a concentration-dependent increase in [Ca
2+
]i (Figure 3-2A). In 
order to assess the contribution of Ca
2+
 influx versus Ca
2+
 release from intracellular stores 
towards evoking this response, ATP was applied in Ca
2+
 free conditions. The results 
determined that a substantial part of the ATP evoked response is due to the uptake of Ca
2+
 
into the cells probably through the activation of multiple types of P2Rs (Figure 3-2D). 
Three points indicated that part of this response is P2X7R mediated (i) an EC50 value of 
380 µM is unlikely to be able to be accounted for by activation of P2Y or P2X1-6 receptors 
alone (ii) the responses evoked by ATP concentrations of 1 and 3 mM were sustained and 
(iii) both peak and sustained parts of the response were inhibited by BBG and KN-62 
(Figure 3-3). However the response is unlikely to be solely P2X7R mediated. Inhibition by 
BBG and KN-62 was only partial and the EC50 value of 380 µM obtained for ATP evoked 
increases in [Ca
2+
]i was lower than that observed for the membrane currents mediated by 
cloned mP2X7Rs; EC50 = 734 µM  (Chessell et al., 1998) and Ca
2+
 dependent IL-1β 
release from Bac1 macrophages; EC50 = 800 µM (Verhoef et al., 2005).  
 
ATP evoked pore formation with EC50’s ranging from 1.41 to 1.82 mM, was completely 
blocked by KN-62 (IC50 = 1.32 µM) (Figure 3-4D) suggesting P2X7 receptors alone 
stimulate EtBr uptake. Pore formation was found to occur within minutes of ATP 
application whereas prolonging ATP (3 mM) stimulation to 45 – 60 minutes was observed 
to evoke a significant release of the large cytosolic enzyme LDH, indicating a breakdown 
                                                 
13
 Figures A-1 to A7 are to be found within the I: Appendix 
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in the integrity of the cell membrane and therefore cell death. Release of LDH initiated by 
ATP could be completely blocked by pre-treating and stimulating cells in the presence of 
KN-62 (IC50 = 407 nM). This suggests and also agrees with other studies that P2X7R pore 
formation and potentially other P2X7R mediated apoptotic events can occur in the absence 
of cell death (MacKenzie et al., 2001; Mackenzie et al., 2005).  
 
In order to assess the role of divalent cations on regulating the mP2X7R I employed the use 
of RAW264.7 cells (endogenous) and HEK293 cells expressing either the recombinant 
mouse or rat P2X7R. This also gave us a more direct comparison of the sensitivity of the 
mP2X7R compared to the rP2X7R for ATP (in physiological salt solution). The 
endogenous and recombinant mP2X7R was observed to be less sensitive to ATP than the 
rat P2X7R (Table 3-14A). This pattern correlates with the literature (Young et al., 2007), 
although our EC50 values are higher than those previously reported and expression 
system/cell background seemed to play a role in regulating sensitivity of the P2X7R to 
ATP. The differences between our EC50 values and those reported may reflect the choice 
of assay used to assess P2X7R activation. I also established that the mP2X7R could be 
blocked using KN-62 with an IC50 range of 407 – 1320 nM, making the receptor more 
sensitive to blockade to KN-62 than the rat receptor but less so than the human (Table 3-
14B).  
 
EC50 (mM) MOUSE RAT HUMAN 
Our Study 1.41 – 1.82 (E) 
2.64 – 2.69 (R) 
0.95 – 1.20 N/A 
Reported 0.90 0.12 1.8 
 
Table 3-14A. Summary of EC50 of ATP at the Mouse, Rat and Human P2X7Rs. Values are based on the 
findings from (Moore et al., 2007; Stokes et al., 2006; Surprenant et al., 1996; Young et al., 2007). E = 
endogenous, R = recombinant.  
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IC50 (nM) MOUSE RAT HUMAN 
KN-62/KN-04 407 - 1320 > 3000 30 - 100 
 
Table 3-14B. Summary of IC50 of KN-62/KN-04 at the Mouse, Rat and Human P2X7Rs. Values are 
based on the findings from (Humphreys et al., 1998; Jiang et al., 2000; Moore et al., 2007).  
 
The nature of the P2X7R “pore” has been controversial. A number of models have been 
proposed including the dilation of the P2X ion channel protein and coupling to a second 
membrane protein. Dye uptake could be occurring via a conformational change of the 
receptor itself, allowing dilation and uptake of larger molecules similar to that seen with 
the P2X2 and P2X4 receptors (Khakh et al., 1999; Virginio et al., 1999); or the receptor 
opens a distinct channel protein which is permeable to these dyes, similar to the maitotoxin 
induced pore (Schilling et al., 1999). There are a number of factors favouring either 
interpretation, for the former the increase in permeability is progressive, is observed in a 
range of host cells and factors which block the initial current also block dye uptake (North, 
2002). For the latter; calmidazolium is able to block the initial current but not dye uptake 
(Virginio et al., 1997) and in some oocyte expression systems, activation of the P2X7R has 
been observed to only induce the initial current and not dye uptake (North, 2002).  
 
During this study a candidate for the P2X7R pore was suggested; this was the hemi-channel 
protein pannexin-1 (Locovei et al., 2007; Pelegrin et al., 2007; Pelegrin et al., 2006). I 
carried out initial experiments using the reported pannexin-1 current (P2X7R dye uptake) 
blockers carbenoxolone (CBX) (Bruzzone et al., 2005) and probenecid (Silverman et al., 
2008). However I failed to observe any inhibition with either of these blockers; 
furthermore in the case of CBX a dose-dependent facilitation of dye uptake occurred 
(Figure A-2). Other groups have observed different responses when treating cells with 
reported pannexin-1 blockers (CBX, Mefloquine; MFQ, peptide pannexin-1 mimetic; 
10Pnx). For example; CBX failed to inhibit EtBr uptake into ATP stimulated 2BH4 cells 
(Faria et al., 2005), MFQ, CBX and 10Pnx failed to inhibit dye-uptake into 
HEK293/P2X7R cells (Schachter et al., 2008), CBX inhibited YO-PRO uptake and Ca
2+
 
transients in astrocytes (Suadicani et al., 2006) but only inhibited YO-PRO uptake in 
HEK293/P2X7R cells (Pelegrin et al., 2006). My data does not support the involvement of 
pannexin-1 in ATP mediated uptake of large molecular weight dyes; however further 
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experiments would be required to either ultimately accept or reject a role potential for 










 Inhibits mP2X7R Activation by Reducing [ATP
4-
] 
When investigating if the mouse P2X7R could be modulated by changing divalent cation 
concentrations in the extracellular solution, I hypothesized three potential outcomes based 
on previous literature (i) inhibition due to a reduction in [ATP
4-
] (Klapperstück et al., 
2001; Michel et al., 1999), (ii) inhibition or potentiation due to a direct interaction with the 
P2X7R (Virginio et al., 1997), or (iii) no effect.  
 
I decided to use “pore formation” (EtBr uptake assay) as a measure of P2X7R activation; as 
I had already established that the effect of ATP could be completely blocked by KN-62 
and therefore was potentially mediated primarily by the P2X7R. Furthermore within the 
literature it has been established that ATP-evoked dye uptake and ATP-evoked ionic 
current properties resemble each other. For example the efficacies of ATP and BzATP are 
comparable, as is the sensitivity to block by ions and antagonists (Surprenant et al., 1996; 
Virginio et al., 1997) and species differences are observed both with dye uptake and ionic 
currents (North, 2002).  
 








 I determined that EtBr uptake was inhibited when 
these ions were present. This inhibition was observed as a rightward shift in the ATP 
concentration-response curve with a subsequent increase in the EC50. On conversion of 
[ATP]  into [ATP
4-









were observed to now overlap abolishing the apparent increase in the EC50. 
Therefore I concluded that these ions inhibit P2X7R activation by chelating and therefore 
reducing the concentration of the P2X7R ligand ATP
4-
. These results were similar to those 
obtained in studies where the effect of divalent cations on the human P2X7R (Klapperstück 
et al., 2001; Michel et al., 1999) were examined but did not correlate with studies where 
divalent cations were observed to inhibit rat P2X7R activation irrespective of there action 
on ATP
4-
 chelation (Virginio et al., 1997).   
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 Potentiates mP2X7R Activation 
Stimulating RAW264.7 cells in the presence of 10 µM Hg2+ was observed to increase the 
maximal rate of ATP evoked EtBr uptake (Figure 3-9). Hg
2+
 has been demonstrated to 
increase P2X2R activation and inhibit P2X4R activation. ATP evoked currents were 
observed to be increased 10 – 20 fold when Hg
2+
 was pre-incubated with oocytes 
expressing the rP2X2R (Lorca et al., 2005). It has been proposed that divalent ion 
potentiation of P2X2R currents was due to the ability of the metal ions to bind to 
extracellular histidines (H120, H192, H213), forming a high-affinity metal coordination 
complex. Furthermore it was hypothesised that this metal “allosteric pocket” is separate 
and independent of the ATP binding site. In the extracellular domain of the mP2X7R there 
are seven histidines, five of which are conserved in rat (H62, H85, H201, H219, H267) and 
six of which are conserved in human (H62, H85, H201, H219, H267, H268) (Figure 3-18). 
These histidines could potentially play a role in Hg
2+
 binding and modulation of the 
P2X7R.  
 
In contrast P2X4R mediated currents are inhibited by Hg
2+
 with an IC50 of 9.2 µM, and 
mutation of extracellular histidines failed to abolish this effect (Coddou et al., 2005). They 
hypothesised that Hg
2+
 could interact at a metal binding site distal to the ATP binding site 
and potentially interact with amino acids located intracellularly or in the transmembrane 













 Inhibits mP2X7R and rP2X7R Activation Directly 
In contrast to other divalent cations tested Cu
2+
 was observed to inhibit dye uptake 
independently of a reduction in [ATP
4-
] (Figure 3-12). This inhibition was observed as a 
reduction in the maxima of the ATP concentration-response curve for RAW264.7 cells, 
HEK293/mP2X7R and HEK293/rP2X7R cells. This inhibition correlates with previous 
reports where Cu
2+
 has been observed to inhibit both rat and human P2X7R mediated 
responses independently of [ATP
4-
] (Michel et al., 1999; Virginio et al., 1997). In addition, 
during the course of this study two papers were published, which elucidated the potential 
binding site of Cu
2+
 to the recombinant rat P2X7R (Acuña-Castillo et al., 2007; Liu et al., 
2008). However each of these papers proposed a different model.  
 
In the study by Liu et al., 2008 mutagenesis of H62 and D197
 
either alone or in 
combination
 
abolished inhibition by Cu
2+
 when ATP or BzATP was the activating ligand. 
Furthermore mutation of H201 or H267 paritally attenuated Cu
2+
 inhibiton of ATP but not 
BzATP evoked responses. The study by Acuña-Castilio et al., 2007 identified H267 with 
contribution from H130 and H201 to be involved in the binding of Cu
2+
 to the P2X7R. 
Both of these studies used alanine screening to identify these residues. Based on functional 
studies, it could be suggested that a common metal binding site for Cu
2+
 at the human, 
mouse and rat P2X7R exists. H62, H201 and H267 are all conserved between the mouse, 
human and rat. However D197 although conserved in human is a histidine in mouse and 
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H130 is a serine in both human and mouse (Figure 3-19). Both papers also implicate that 
the residues involved in Cu
2+
 binding respective of each study are important binding sites 
for Zn
2+





 whereas Acuña-Castilio et al., 2007 implicate H267 and H219 as important 





. H267 and H219 are conserved in the rat, mouse and human P2X7R sequences and 
therefore it would be predicted that Zn
2+
 would inhibit all three receptors in a similar way. 
However as already discussed Zn
2+





Figure 3-19. Residues Indicated to be Important in Cu
2+
 Binding to the Recombinant rP2X7R. (Acuña-




 Modulation of the P2X7R is Dependent on Species, Cell Background and 
Agonist 
In order to rule out the lack of effect of Zn
2+
 on the mouse P2X7 receptor in RAW264.7 
cells being due to the expression system used or the assay design; the effect of Zn
2+
 on the 
recombinant mouse and rat P2X7R receptor expressed in HEK293 cells was studied. In 
correlation with the literature (Virginio et al., 1997), Zn
2+
 was observed to inhibit ATP 
evoked dye uptake in HEK293/rP2X7R cells (Figure 3-13), this inhibition could not be 
accounted for by a reduction in [ATP
4-
] alone. In contrast Zn
2+
 was observed to potentiate 
ATP evoked dye uptake in HEK293/mP2X7R cells (Figure 3-13). This therefore indicated 
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depending on the cell expression system used I observed two different effects of Zn
2+
 at 
the mP2X7R (i) inhibition due to chelation of ATP
4-
 and (ii) potentiation (Table 3-15).  
 
In the study by Liu et al., 2008 different residues were observed to be involved in the 
inhibition of either ATP or BzATP evoked responses by Zn
2+
 at the rat P2X7R. It has 
already been demonstrated that rat P2X7R’s are 100 times more sensitive to BzATP than 
the mouse P2X7R and that this is attributed to two residues in the ectodomain K127 and 
N284 (also involved in ATP sensitivity) which are A127 and D284 in mouse (Young et al., 
2007) (Figure 3-20). I therefore investigated whether BzATP evoked responses at the 
mouse P2X7R were modulated by extracellular Zn
2+
. Due to BzATP being unable to evoke 
maximal dye uptake at concentrations of 1 mM at the mouse P2X7R (Figure 3-20), I had to 






I initially re-tested the effect of Zn
2+







, correlating with our previous results Zn
2+
 inhibited 
RAW264.7 cells dye uptake by reducing [ATP
4-
], potentiated HEK293/mP2X7R dye 
uptake and directly inhibited HEK293/rP2X7R dye uptake. However the form of this 
inhibition was different to that observed in the physiological salt solution, instead of seeing 
a significant reduction in the maxima I observed a rightward shift in the concentration-




 caused a direct inhibition of BzATP evoked dye uptake in HEK293 cells 
expressing the rat P2X7R. Furthermore Zn
2+
 caused inhibition of BzATP evoked dye 
uptake mediated by the endogenous and recombinant mouse P2X7R, this inhibition could 
not be accounted for by a reduction in [BzATP
4-
] alone. Based on these results I could 
hypothesize (i) that Zn
2+
 could bind to multiple sites at the P2X7R allowing selective 
inhibition of BzATP at mP2X7Rs without inhibiting ATP responses while both responses 
are inhibited at rat P2X7Rs or (ii) that the Zn
2+
 bind site is structurally altered in the 
mP2X7R allowing inhibition of BzATP but not ATP evoked responses. 
 
                                                 
14
 Effect of Cu
2+




 salt solution were also re-tested. Cu
2+
 
was observed to still inhibit at all three cell type, observed as a reduction in the maxima of the concentration-
response curve. See Figure A-3  
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Solution RAW264.7 HEK293/MP2X7 HEK293/RP2X7 
















   
Direct (EC50) 
 
Table 3-15. Effect of Extracellular Zn
2+




Figure 3-20. Residues Indicated to be Important in Zn
2+
 Binding to the Recombinant rP2X7R. (Acuña-
Castillo et al., 2007; Liu et al., 2008). Residues 127 and 284 indicated by Young et al., 2007 to be important 
in the increased sensitivity of BzATP at the rat P2X7R.  
 
3.3.6 Concluding Remarks 
Here I demonstrated the differences and similarities in the mechanisms of regulation of the 
mouse and rat P2X7Rs by metal divalent cations. These results remind us of the critical 
differences in receptor pharmacology between species of P2X receptors. Furthermore 
differences in modulation occurred depending on the cell background, assay solution and 
agonists used to evoke the response. The findings therefore suggest that caution should be 
exercised in cross-species extrapolation on studies of P2X7Rs and on the selection of the 
conditions of the assay used to examine P2X7R activation. However irrespective of 
mechanism my results suggest that divalent cations can reduce activation of the P2X7R, 
supporting the hypothesis that under physiological conditions P2X7R activation is 
suppressed by the local extracellular environment.  
S.F.Moore 




ATP INDUCES APOPTOTIC-LIKE EVENTS IN THE ABSENCE OF CELL DEATH 
Portions of this chapter have been published in Cellular Signaling, 19(4) 
 
4.1 INTRODUCTION 
In the previous section I determined that a short exposure to ATP (1 – 5 minutes) could 
evoke dye influx and extension of ATP exposure (> 30 minutes) could lead to the release 
of the large cytosolic enzyme LDH indicative of cell death. Activation of P2X7Rs 
heterologously expressed in HEK293 cells, have been observed to evoked gross changes in 
cellular morphology often associated with various forms of cell death (MacKenzie et al., 
2001; Mackenzie et al., 2005). These events include externalisation of PS, mitochondrial 
swelling, reorganisation of F-actin, large membrane blebbing (>2 µm) and microvesicle 
shedding (<1 µm). I decided to investigate whether these morphological events occurred 
when RAW264.7 macrophages were stimulated with ATP.  
 
The most obvious potential outcome of host pathogen interactions is the death of host cells; 
however the way in which cell death may occur can happen via a variety of mechanisms. 
Cell death is typically discussed as either apoptotic/programmed or necrotic/accidental. 
There are in fact many forms of cell death which can be defined by their biochemical 
features, and a better way to class forms of cell death is probably non-inflammatory and 
pro-inflammatory. Apoptosis and autophagy are non inflammatory forms of cell death, 
whereas oncosis (early phase necrosis
15
), pyroptosis and pyronecrosis are pro-
inflammatory. These different forms of cell death cause a series of distinct morphological 
changes as well as biochemical ones to the dying cell (Table 4-1). For example apoptotic 
cells are observed to shrink and round up, have condensed chromatin, bleb and finally form 
apoptotic bodies which can be cleared by phagocytosis. Whereas oncotic cells and their 
organelles swell, plasma membrane integrity is lost and the cellular contents are released.  
 
 
                                                 
15
 Necrosis is probably a final common pathway of cell death, cells undergoing oncosis will end up necrotic 
however apoptotic cells (in vitro) can end up necrotic due to the loss of coordinated metabolic activity and 
compartmentalisation of the cell.  
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 Pro-Inflammatory Morphological Features 
Apoptosis No Cell shrinkage and rounding-up, PS exposure, Membrane 
blebbing (zeiotic), Chromatin condensation, Apoptotic 
bodies 
Autophagy No Vacuolisation, Degradation of cytoplasmic contents, Slight 
chromatin condensation 
Oncosis Yes Cell swelling, Mitochondria/organelle swelling, Disruption 
of plasma membrane, Membrane blebbing 
Pyroptosis Yes Disruption of plasma membrane, Plasma membrane pore 
formation, membrane vesicles 
Pyronecrosis Yes Disruption of plasma membrane 
 
Table 4-1. Summary of Morphological Changes Associated with Different Forms of Cell Death. Data 
based on information from (Fernandes-Alnemri et al., 2007; Fink et al., 2005; Ting et al., 2008) 
 
4.1.1 Plasma Membrane Pore Formation 
I demonstrated in the previous chapter that activation of the P2X7R will lead to the uptake 
of EtBr, indicative of pore formation. Formation of a “pore” has also been reported to 
occur during pyroptosis that is a caspases-1 dependent form of apoptosis. S.Typhimurium 
infected macrophages were observed to become permeable to EtBr (394Da) whilst 
excluding a larger dye; ethidium homodimer-2 (1293Da) which was suggested to be 
consistent with the formation of discrete membrane lesions allowing passage of smaller 
molecules but exclusion of larger ones (Fink et al., 2006). This process was observed to be 
dependent on caspases-1 and actin polymerisation. Furthermore the pore was determined to 
induce dissipation of ionic gradients, influx of water, cell swelling and finally cell lysis. 
Activation of the P2X7R has also been observed to induce cell swelling and ultimately lysis 
in lymphocytes
16
 (Taylor et al., 2008), dopaminergic neurones (Jun et al., 2007), 
macrophages (Murgia et al., 1992) and HEK293 cells expressing the P2X7R (Ferrari et al., 
2007). 
 
4.1.2 Exposure of Phosphatidylserine 
Activation of the P2X7R in transfected HEK293 cells (Mackenzie et al., 2005), T-
Lymphocytes (Elliott et al., 2005), erythrocytes (Sluyter et al., 2007) and macrophages 
                                                 
16
 Cell shrinkage initially occurred in this study but was followed by cell swelling after a period of 2 minutes.  
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(Wilson et al., 2004) has been observed to induce the rapid movement of PS from the inner 
to the outer leaflet of the plasma membrane. This phenomenon is associated with apoptotic 
cell death. In viable/non-apoptotic cells, phospholipids are asymmetrically distributed 
across the plasma membrane, with the majority of anionic phospholipids (e.g. PS, 
phosphoethanolamine PE) localised on the inner leaflet (Bevers et al., 1999). The exposure 
of PS on the outer leaflet of the plasma membrane allows the recognition of apoptotic 
cells/bodies by phagocytes and ensures the safe clearance of apoptotic waste without the 
induction of inflammation.  
 
At physiological cytoplasmic Ca
2+
 concentrations asymmetry for the plasma membrane  is 
maintained by two lipid transporters a “flippase” which catalyses the rapid inward 
transport aminophospholipids (PS and PE) and a “floppase” which promotes a slower 
outward transport amino and choline (sphingomyelin and phosphatidylcholine) containing 
phospholipids (Zwaal et al., 2005). When a substantial rise in the cytoplasmic Ca
2+
 
concentration occurs the flippase is inhibited and furthermore a third lipid transporter; 
“scramblase” is activated (Williamson et al., 1995) (Figure 4-1). This scramblase is able to 
mix the lipids between the two membrane leaflets (Zwaal et al., 2005), which cannot be 
corrected and therefore leads to a loss in membrane asymmetry. Providing the flippase is 
not irreversibly inactivated by the intracellular protease calpain (activated by the rise in 
[Ca
2+
]i), efflux of  Ca
2+
 will lead to a restoration of lipid asymmetry (Comfurius et al., 
1990).  
 
Figure 4-1. Schematic of how P2X7R activation could lead to the loss of plasma membrane asymmetry. 
Red phospholipids = aminophospholipids (PS and PE). Blue phospholipids = cholinephospholipids.  
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4.1.3 Membrane Blebbing & Microvesicle Shedding 
Phospholipid asymmetry is commonly observed to be accompanied by cytoskeletal 
rearrangement, outward blebbing of the plasma membrane (> 2 µm) and the shedding of 
microvesicles (< 1 µm) in which the phospholipids are randomised over the vesicular 
membrane (Zwaal et al., 1997). P2X7R activation in transfected HEK293 cells (Mackenzie 
et al., 2005; Morelli et al., 2003), macrophages (Pfeiffer et al., 2004) and osteoblasts 
(Panupinthu et al., 2007) has been observed to evoke membrane blebbing. Furthermore 
microvesicle shedding has been observed to occur in P2X7R expressing HEK293 cells 
(MacKenzie et al., 2001), dendritic cells (Pizzirani et al., 2007), macrophages (MacKenzie 
et al., 2001) and microglia (Bianco et al., 2005) after stimulation with ATP.  
 
Both apoptotic and oncotic cell death has been observed to evoked membrane blebbing 
(Fink et al., 2005). Apoptotic blebbing is often distinguished from other types of blebbing 
by its zeiotic nature that is the process of continuous and dynamic protrusions and 
retractions. Whereas oncotic blebbing is characterised by blebs that do not retract but 
gradually enlarge to diameters of 10 – 20 µm (Mackenzie et al., 2005). Little is known 
about the mechanism behind and the reason for apoptotic membrane blebbing. It has been 
hypothesised that blebbing is dependent on caspase-mediated cleavage of a cytoskeletal 
component/regulator such as gelsolin, an actin depolymerising agent (Kothakota et al., 
1997) or ROCK I (Rho-activated serine/threonine kinase) which is involved in stabilisation 
of F-actin, phosphorylation of myosin light chains and coupling of actin-myosin filaments 
to the plasma membrane (Leverrier et al., 2001). Evidence for the involvement of ROCK I 
in P2X7R mediated blebbing is conflicting. Mackenzie et al., 2005 failed to observe 
inhibition of Ca
2+
-dependent zeiotic blebbing using the ROCK I inhibitor Y-27632 
whereas Pfieffer et al., 2004 and Morelli et al., 2001 did prevent P2X7 evoked blebbing 
using Y-27632. Blebbing could potentially play a role in the recognition and clearance of 
apoptotic cells from the immune system, furthermore inhibition of blebbing has been 
observed to inhibit the relocalisation of fragmented DNA into blebs and apoptotic bodies 
(Coleman et al., 2001).  
 
PS-rich microvesicles, also described as microparticles or ectosomes are released from a 
range of cells and support a number of biological responses. Most commonly PS-rich 
microparticles are observed to be shed from activated platelets through a process thought 
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to involve the activation of Ca
2+
-dependent calpain which facilitates the detachment of the 
vesicles from the plasma membrane via the degradation of cytoskeletal proteins (Zwaal et 
al., 2005). Recently a study by Fernandes-Alnemri et al., 2007 observed the release of 
membrane vesicles from cells undergoing pyroptosis. The release of vesicles from cells is 
thought to be of importance for coagulation, dissemination of an “eat me” signal and 
signaling between cells. Shedding of microvesicles is also thought to be of importance in 
the secretion of cytokines. As already stated microvesicle shedding occurs in cells 
expressing the P2X7R, here they are thought to mediate the secretion of the pro-
inflammatory cytokine IL-1β (Bianco et al., 2005; MacKenzie et al., 2001). P2X7R 
activation has also been reported to induce the release of exosomes. It was hypothesised 
that activation of the receptor could couple in to the formation of multivesicular bodies that 
contained exosomes with entrapped IL-1β, these multivesicular bodies could then fuse with 
the plasma membrane and release the IL-1β containing exosomes (Qu et al., 2007).  
 
4.1.4 Mitochondrial Changes 
A decrease in the mitochondrial membrane potential is considered as an initial and 
irreversible step towards apoptosis. Other changes to the mitochondria which occur during 
apoptosis include enhanced membrane permeability and the release of cytochrome-c into 
the cytosol. ATP activation of HEK293 cells expressing the hP2X7R is observed to induce 
a collapse/drop in the mitochondrial membrane potential, fragmentation of the 
mitochondrial network and mitochondrial swelling (an oncotic rather than apoptotic event) 
(Adinolfi et al., 2005; Mackenzie et al., 2005). Mackenzie et al., 2005 determined that 
these events were dependent on Ca
2+
 whereas Adinolfi et al., 2005 determined that 
mitochondrial fragmentation was blocked in Ca
2+
 free conditions; however mitochondrial 
swelling and the collapse of the mitochondrial membrane potential where not effected by 
reducing the extracellular Ca
2+
 concentration.   
 
The P2X7R has been observed to induce a variety of morphological changes associated 
with various forms of cell death. In this study I used live cell imaging to assess the kinetics 
of ATP evoked morphological changes and employed the use of scanning electron 
microscopy for further detailed investigation of cell surface changes. Furthermore I 
assessed whether ATP stimulation of RAW264.7 cells ultimately resulted in cell death or 
whether changes in morphology were reversible. The way in which a cell dies can either be 
non-inflammatory or pro-inflammatory; therefore examining such morphological changes 
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could be of importance in understanding the role ATP has during immune/inflammatory 
responses. 
 
The key findings of this study were:  
1. Stimulating RAW264.7 cells with ATP for 10 – 15 minutes and then resting the 
cells prior to a secondary ATP stimulation does not significantly affect the uptake 
of EtBr or release of LDH.  
2. Extracellular ATP evokes the externalisation of PS.  
3. Extracellular ATP does not induce bleb formation or filopodia retraction in 
RAW264.7 cells in the presence of physiological concentrations of Ca
2+
  
4. Extracellular ATP evoked formation of microvesicles is a Ca
2+
 dependent process.  
5. Extracellular ATP evoked externalisation of PS and shedding of microvesicles 
precedes the release of LDH.  
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4.2.1 Prestimulating RAW264.7 Cells with ATP Does Not Effect ATP Evoked Responses 
Extracellular ATP (3 mM) was previously determined to evoke pore formation within 1 – 5 
minutes and cell death when the application was for > 30 minutes (Moore et al., 2007). 
Prestimulating RAW264.7 cells with 3 mM ATP for 10 minutes and allowing a 60 minute 
recovery in standard culture medium, was observed to not significantly change basal 
(ATP-free) or ATP (3 mM) evoked influx of EtBr compared to controls (10 minutes buffer 
prestimulation) (Figure 4-2A, n = 3, p>0.05).  Prestimulating RAW264.7 cells with 3 mM 
ATP for 15 minutes and allowing a 60 minute recovery in standard culture medium was 
observed to not significantly change basal (ATP-free) or ATP (3 mM, 60 minutes) evoked 
LDH release compared to control (15 minutes buffer prestimulation) (Figure 4-2B, n = 3, 
p>0.05).   
 
4.2.2 High concentrations of ATP stimulate rapid PS translocation 
I used live cell imaging and AnV-488 to detect whether ATP induced the translocation of 
PS from the inner to the outer leaflet of the plasma membrane of RAW264.7 cells. Within 
5 minutes of 1 mM ATP addition, AnV-488 was observed to bind to the surface of all 
RAW 264.7 cells (Figure 4-3A, Figure 4-3B, and Movie 1). AnV-Alexa488 bound in a 
punctate non-uniform pattern at the surface of the cells and along filopodia projecting from 
the cell. Addition of 100 µM ATP did not activate PS translocation (Figure 4-3A) thus the 
receptor sensitivity for extracellular ATP correlates with activation of P2X7 receptors.  
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Figure 4-2. ATP Prestimulation Failed to Change Basal and ATP Evoked EtBr Influx or LDH Release. 
A, Histogram demonstrating that prestimulating RAW264.7 cells with ATP (3 mM) does not significantly 
change basal or ATP evoked EtBr influx (n = 3 ± s.e.m). B, Histogram demonstrating that prestimulating 
RAW264.7 cells with ATP (3 mM) does not significantly change basal or ATP evoked LDH release (n = 3 ± 
s.e.m). Student’s t-test, **: p<0.01, ***: p<0.001.  
 
S.F.Moore 




Figure 4-3. P2X7R Activation Evokes the Externalization of PS. A, Kinetic graph demonstrating that 1 
mM ATP evoked an increase in AnV-488 binding to RAW264.7 cells (n = 4 ± s.e.m). B, Images 
demonstrating the localisation of AnV-488 at the plasma membrane and along filopodia of RAW264.7 cells 
after stimulation with 1 mM ATP for 5 minutes. Above images are representative of 4 experiments, with 
control images being those collected at t = 0 seconds and ATP images being those collected at t = 400 
seconds (5 minutes ATP application).  One-way ANOVA with Dunnett’s post-hoc test, **: p<0.01. 
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4.2.3 ATP Evokes Membrane Blebbing & Filopodia Retraction in the Absence of Ca
2+
 
Live cell imaging of RAW264.7 cells bathed in a physiological salt solution revealed that a 
10 minute application of 3 mM ATP did not evoke any significant changes in cellular 
morphology (n = 9) (Figure 4-4, Figure 4-5A and B, Movie 2).  In contrast imaging of 
RAW264.7 cells bathed in a Ca
2+
-free salt solution revealed that ATP (3 mM, 10 minutes) 
evoked substantial changes in cellular morphology. Cells appeared rounded, had retracted 
filopodia and large membrane blebs protruding from the cell surface (n = 8, Figure 4-4, 
Movie 3). Filopodia retraction was observed to occur in 85 ± 4 % of cells whilst membrane 
blebbing was observed to occur in 83 ± 12 % of cells (n = 8 ± s.e.m) (Figure 4-5A and B). 
Membrane blebbing was a dynamic and zeiotic event where blebs continued to appear 
during the washout of the agonist. Membrane blebs however where observed to retract 
within 15 – 30 minutes following removal of ATP (n = 8, Figure 4-5A, Movie 2).  
 
4.2.4 ATP Mediated Cytoskeletal Reorganisation 
Stimulating RAW264.7 cells with ATP (3 mM, 10 minutes) bathed in the presence of Ca
2+
 
was observed to not significantly change total levels of F-Actin content (n  = 9, p>0.05) 
(Figure 4-5C). Using fixed RAW264.7 cells stained with Phalloidin-546; I determined that 
ATP (3 mM, 10 minutes) stimulation in the presence of Ca
2+
 induced some changes in the 
localisation of F-actin with a ring of actin being observed to be localised at the plasma 
membrane  (n  = 3) (Figure 4-6A and B). RAW264.7 cells stimulated with ATP (3 mM, 10 
minutes) in the absence of Ca
2+
 demonstrated that cells in contrast to controls were 
rounded, had retracted filopodia and membrane blebs where F-Actin was observed to be 
localised (Figure 4-6C) (n  = 3). 
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Figure 4-4. ATP Induces Filopodia Retraction and Membrane Blebbing in the Absence of External 
Ca
2+
. Cells (30, 000) were bathed in either physiological salt solution or Ca
2+
-free salt solution (warmed to 
37 
o
C). Images were collected using a laser scanning confocal microscope (FV300-SU, Olympus, Japan) for 
100 seconds before addition of 3 mM ATP (600 seconds). Above images are representative of 8 – 9 
experiments, with control images being those collected at t = 0s and ATP images being those collected at t = 
700 seconds (10 minutes ATP application).   
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Figure 4-5. ATP Induces Reversible Membrane Blebbing in the Absence of External Ca
2+
. A, 
Summarizes the observed total number of cells blebbing as a percentage of the observed total number of cells 
at t = 0 seconds, t = 700 seconds (10 minutes ATP), t = 1300s (10 minutes wash-out) and t = 2500s (30 
minutes wash-out) (n = 8/9 ± s.e.m). B, Summarizes the change in filopodia length normalized to filopodia 
length at t = 0 seconds whilst bathing cells in the absence or presence of ATP (3 mM) for 10 minutes (n = 8/9 
± s.e.m). C, Total F-Actin content was determined by staining cells stimulated in physiological salt solution 
in the absence or presence of ATP (3 mM, 10 minutes, 37 
o
C) with Phalloidin-546 and DAPI (n = 9 ± s.e.m). 
Student’s two-tailed t-test, *: p<0.05, **: p<0.01.  
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Figure 4-6. ATP Evoked Changes in Cytoskeletal Organisation.  A, Cells bathed in physiological salt 
solution for 10 minutes. B, Cells bathed in physiological salt solution for 10 minutes in the presence of 3 mM 
ATP. C, Cells bathed in Ca
2+
-free salt solution for 10 minutes in the presence of 3 mM ATP. Above images 
are representative of 3 experiments. 
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4.2.5 Scanning Electron Microscopy Reveals Formation of Microvesicles 
In agreement with live cell imaging experiments, ATP stimulated RAW264.7 cells did not 
display retraction of filopodia or large membrane bleb formation (>2 µM) in scanning 
electron micrographs (Figure 4-7A, B, C and D). However, it was now apparent that the 
macrophage surface was covered in small microvesicles (<1 µM) that were not resolved by 
light microscopy. RAW264.7 cells stimulated with ATP in the absence of Ca
2+
 were 
observed to have swelled compared to controls (Figure 4-7E and F) and in agreement with 
live cell imaging had large membrane blebs protruding from the cell surface (Figure 4-7G 
and H). Furthermore far fewer microvesicles were observed to be present on RAW264.7 
cells stimulated with ATP in the absence on Ca
2+
 compared to cells stimulated in the 
presence of Ca
2+
. Control RAW264.7 bathed in the absence of Ca
2+
 appeared to a have a 




4.2.6 Cell Viability 
Cell viability was measured as the retention of cytosolic LDH; release into the external 
medium indicates a disruption of the plasma membrane and therefore cell death. 
Application of a range of ATP concentrations (0.3 – 5 mM) for 15 minutes failed to evoke 
significant release of LDH above control (Figure 4-8A. n = 3, p>0.05). Extending the 
application of ATP to 30 and 60 minutes caused a significant release of LDH with 
concentrations ≥ 2 mM (Figure 4-8B and C, n = 3, p<0.01). ATP evoked LDH release was 
observed to peak using concentrations between 2 – 3 mM and decreased slightly using a 









Figure 4-7. ATP Evokes Microvesicle Formation under Physiological Conditions. A & B, Cells bathed in 
physiological salt solution for 10 minutes. C & D, Cells bathed in physiological salt solution for 10 minutes 
in the presence of 1 mM ATP. E & F, Cells bathed in Ca
2+
-free salt solution for 10 minutes. G & H, Cells 
bathed in Ca
2+
-free salt solution for 10 minutes in the presence of 1 mM ATP.  
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Figure 4-8. Prolonged ATP Stimulation of RAW264.7 Cells Can Evoke LDH Release. A, Histogram 
demonstrating that a 15 minute application of ATP at various concentrations does not evoke release of LDH 
above basal release (n = 3 ± s.e.m). B, Histogram demonstrating that a 30 minute application of 2 and 3 mM 
evokes the release of LDH (n = 3 ± s.e.m). C, Histogram demonstrating that a 60 minute application of ≥ 2 
mM ATP evokes the release of LDH (n = 3 ± s.e.m). One-way ANOVA with Dunnett’s post-hoc test, *: 
p<0.05, **: p<0.01. 
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In this study I determined (i) brief pre-activation of the P2X7R does not effect further ATP 
evoked responses (ii) ATP in physiological conditions rapidly evokes microvesicle 
shedding and PS exposure in the absence of cell death (iii) ATP in Ca
2+
 free conditions 
rapidly evokes substantial morphological changes such as cell rounding, filopodia 
retraction and reversible membrane blebbing.  
 
 Calcium Calcium Free 
Pore Formation  - 
PS Exposure  - 
Filopodia Retraction   
Membrane Blebbing   
Microvesicle Shedding  Reduced 
Cell Death    
 
Table 4-2. Summary of Morphological Changes Observed to be Induced by ATP in RAW264.7 Cells 




4.3.1 ATP Induced Morphological Changes in the Presence of Calcium 
High concentrations of ATP have long been known to induce cell death in a variety of 
cells, through the activation of the P2X7R. The exact form of cell death induced though is 
controversial with reports of apoptotic and oncotic events occurring due to P2X7R 
activation. Under physiological conditions I observed that ATP evoked pore formation, PS 
exposure and microvesicle shedding. Events which are associated with apoptotic and 
pyroptotic cell death. However these events consistent with the literature where observed 
to be evoked in the absence of cell death. Evidence for this includes (i) PS exposure and 
microvesicle shedding was evoked by 1 mM ATP which was observed to not induce LDH 
release with up to a 60 minute stimulation and (ii) basal and ATP evoked pore formation 
were not significantly changed by pre-stimulating cells with ATP (10 minutes).  
 
It is possible that this receptor can couple to the same biochemical signaling cascades that 
are associated with evoking apoptotic and pyroptotic events without ultimately leading to 
cell death or potentially the receptor may couple to distinct pathways. For example 
Mackenzie et al., 2005 determined that the P2X7R could couple to two distinct pathways 
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 dependent pathway causing PS exposure, zeiotic membrane blebbing and 
mitochondrial swelling
17
 and (ii) a Ca
2+
 independent ROCK I dependent pathway that was 
responsible for oncotic blebbing, cytochrome C release and ultimately cell death.  
 
Although PS exposure is considered to be a hallmark of apoptosis, it can be dissociated 
from other features of the apoptotic process as PS-dependent phagocytic recognition of 
cells has been observed to occur earlier or independently of later apoptotic events such as 
caspase activation and DNA fragmentation (Uthaisang et al., 2003; Zhuang et al., 1998). 
The study by Zhuang et al., 1998 determined that the mitochondrial inhibitors antimycin A 
and oligomycin blocked increased plasma membrane permeability (assessed using Hoechst 




fragmentation or decreases in the mitochondrial membrane potential. 
 
The translocation of PS on to the outer leaflet of the plasma membrane mediated by the 
P2X7R could potentially be involved in the clearance of apoptotic cells; the expression of 
PS on the surface of both macrophages and their apoptotic targets is required for efficient 
phagocytosis (Callahan et al., 2003). It could be hypothesised that in areas where 
inflammatory cell death is occurring, high concentrations of extracellular ATP could 
accumulate and therefore activate P2X7Rs expressed on macrophages. This process could 
potentially lead to the initiation or enhance the phagocytic clearance of cell corpses.  
 
PS exposure could potentially play a role in signal transduction. Elliott et al., 2005 





uptake in response to P2X7R activation. Their hypothesis was that PS on the intracellular 
leaflet of the plasma membrane inhibited P2X7R activity. This however does not appear to 
fit with my results as increases in [Ca
2+
]i were observed to occur prior to the 
externalisation of PS. Another potential role of P2X7R mediated PS exposure could simply 
be for the secretion of cytokines such as IL-1β via microvesicles. As already stated PS 
exposure is often seen to precede events such as membrane blebbing and shedding of 
membrane vesicles. Membrane phospholipid asymmetry has been implicated as a 
mechanism of inducing membrane curvature required for endocytotic vesicles to be 
pinched off from the plasma membrane. Could PS exposure potentially play a role in the 
                                                 
17
 Attempts to visualise mitochondrial changes in RAW264.7 cells using Mitotracker
®
 probes were made, 
however results where inconclusive due to the resolution of the images.  
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formation of and shedding microvesicles? Cells undergoing pyroptotic cell death an event 
dependent on caspase-1 activation are observed to shed membrane vesicles and release IL-
1β and IL-18. This could therefore warrant further investigations to establish whether 
P2X7R activation induces pyroptotic cell death, or couples into similar signaling pathways 
associated with pyroptosis.  
 
4.3.2 ATP Induced Morphological Changes in the Absence of Calcium 
Pfeiffer et al., 2004 had previously reported that application of high concentrations of ATP 
to RAW264.7 cells was able to induce zeiotic membrane blebbing, actin reorganisation and 
filopodia retraction within 5 minutes. This conflicted with my results where I determined 
that in physiological concentrations of extracellular Ca
2+
 an application of 3 mM ATP 
failed to induce zeiotic membrane blebbing and filopodia retraction. However cell 
rounding; filopodia retraction and large membrane blebbing were observed when ATP 
stimulations were performed in the absence of extracellular Ca
2+
. These events are 
generally viewed as apoptotic events. However consistent with the literature (Mackenzie et 
al., 2005; Morelli et al., 2003; Verhoef et al., 2003); removal of ATP and washing for 30 
minutes; reversed membrane blebbing indicating that the cells were still viable.  
 
4.3.3 Concluding Remarks 
Here I demonstrate that in the presence of Ca
2+
 the P2X7R can couple into pathways and 
induce events (e.g. PS translocation) generally associated with two forms of cell death; 
apoptosis and pyroptosis. However this does not mean that the cell has to ultimately 
undergo cell death. For example P2X7R evoked PS translocation has been reported to be 
reversible (Mackenzie et al., 2005) and in this and other studies is observed to occur within 
a timeline were cell lysis is not detected (Figure 4-9).  If activation of the P2X7R is able to 
induce these cell-death events for signal transduction and/or secretion of cytokines in the 
absence of cell lysis this would indicate a level of control. Release of microvesicles 
although a pro-inflammatory event allows the dissemination of pro-inflammatory factors, 
whereas cell lysis would evoke mass release of all cellular contents in a localised area.  
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Figure 4-9. Timeline of Extracellular ATP Induced Events. Events are those observed stimulating 
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CHAPTER 5 
MURINE MACROPHAGE P2X7 RECEPTORS SUPPORT RAPID PROTHROMBOTIC 
RESPONSES 
Portions of this chapter have been published in Cellular Signaling, 19(4) 
 
5. 1 INTRODUCTION  
In the previous chapter I demonstrated that stimulation of RAW264.7 cells with ATP in the 
presence of Ca
2+
 evoked the translocation of PS from the inner to the outer leaflet of the 
plasma membrane and the shedding of microvesicles. Exposure of PS is generally 
associated with cell death and is an important recognition signal for the clearance of 
apoptotic cells by macrophages. However, PS externalisation also plays an important role 
in the regulation of the coagulation cascade. Several enzymes of the coagulation cascade 
require assembly on a receptive membrane surface for full expression of catalytic activity. 
In the case of the prothrombinase complex; this surface is thought to be one rich in anionic 
phospholipids such as PS and phosphatidylethanolamine (PE) (Sims et al., 2001). 
Furthermore activity of TF; the initiator of the extrinsic coagulation cascade is thought to 
be regulated by the local phospholipid environment (Bach, 2006). I therefore decided to 
examine whether P2X7R activation on macrophages could be involved in potentially 
propagating and amplifying pro-coagulant effects. This could be of importance in 
inflammatory responses/diseases where a dysregulation of coagulation is also observed; 
such as severe sepsis and atherosclerosis (Opal et al., 2003b).  
 
5.1.1 Induction of Tissue Factor Pro-Coagulant Activity 
TF (thromboplastin, FIII or CD142) is a 47 kDa membrane bound glycoprotein with an 
extracellular domain, transmemembrane domain and a short intracellular domain. It is 
expressed on a variety of cells, which are not normally exposed to flowing blood unless 
physical injury or rupture of atherosclerotic plaques occurs. Upon injury and exposure of 
TF expressing cells; the extrinsic coagulation cascade is initiated. The exposed TF is able 
to complex with the plasma serine protease, activated Factor VII (FVIIa). This complex is 
then able to trigger the proteolysis of Factor X (FX) into bioactive Factor Xa (FXa), with 
the pathway ultimately leading to the formation of thrombin and deposition of fibrin 
(Figure 5-1) (Key et al., 2007).  
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In addition to its role as the main initiator of the extrinsic coagulation cascade, TF also 
participates in inflammatory processes, tumour biology and angiogenesis. For example the 
TF-FVIIa complex can initiate cellular signaling leading to the production of growth 
factors and cytokines such as IL-8 (Hjortoe et al., 2004). TF expression can be increased in 
response a variety of factors such as; endotoxins (LPS), TNFα, IL-1β and oxidized LDL 
(Liu et al., 2004; Wada et al., 1994). This correlates with the finding that within 
atherosclerotic plaques TF can be found to be localized on foam-cell macrophages 
(Landers et al., 1994).  
 
As already stated TF is expressed by cells which are not normally exposed to flowing 
blood. Therefore it is generally believed that an intact endothelium is the most important 
factor in preventing TF-initiated coagulation however recent evidence of TF being found in 
normal blood suggests this is not the complete story (Giesen et al., 1999; Key et al., 1998).  
 
Encryption of TF is now emerging as the primary mechanism of controlling the 
procoagulant activity of TF. Resting cells which express TF, were observed to express 
little TF procoagulant activity, therefore it was hypothesized that a stimulus was required 
to induce this (Bach et al., 1990). Several agents have been observed to induce the 
activation of TF; for example calcium ionophores have been observed to increase the 
activity of TF on ‘primed’ monocytes (Bach et al., 1990; Henriksson et al., 2007).  
 
As previously stated changes in intracellular calcium homeostasis can initiate the 
translocation by anionic phospholipids from the inner to the outer leaflet of the plasma 
membrane by activation of scramblase and inhibition of flippase. Therefore it comes of no 
surprise that increases in TF activity are associated with the exposure of PS on the outer 
leaflet of the plasma membrane and cell death (Greeno et al., 1996; Henriksson et al., 
2007). It is hypothesized that PS can increase the Vmax and decrease the Km of the 
conversion of FX to FXa by the TF-FVIIa complex. The increase in Vmax has been 
suggested to be due to (i) PS inducing a change in the TF quaternary structure therefore 
increasing the number of active catalytic sites and (ii) PS exposure optimizing the 
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Figure 5-1. Schematic of the extrinsic (TF) coagulation pathway. Translocation of anionic phospholipids 
(red) from the inner to the outer leaflet of the plasma membrane increase TF pro-coagulant activity leading to 
the activation of FX. FXa is then able to convert prothrombin (FII) to thrombin (FIIa), a reaction which is 
catalyzed by the assembly of FXa with its co-factor FVa on a PS-rich membrane surface (prothrombinase 
complex).  
 
5.1.2 Enhancement of Thrombin Generation 
Thrombin (FIIa) is one of the end products of both the intrinsic and extrinsic coagulation 
cascade. It not only converts soluble fibrinogen to form insoluble strands of fibrin, used to 
form a haemostatic plug/clot over a wound but is involved in the activation of other factors 
of the coagulation cascade (FXI, FV and FVIII) and therefore accelerates its own 
production.  
 
Thrombin is produced by the cleavage of prothrombin (FII). Several proteolytic enzymes 
can bring about this reaction but under physiological conditions the serine protease factor 
Xa (FXa) is the activating enzyme. FXa is able to cleave prothrombin at R271 followed by 
R320 to yield thrombin; this however is a slow process but can be catalysed by the 
prothrombinase complex. The prothrombinase complex consists of FXa, the cofactor/factor 
Va (FVa), PS and Ca
2+
 (Figure 5-1). This complex is able to increase the efficiency of 
prothrombin cleavage by FXa in two ways (Lentz, 2003; Weinreb et al., 2003).  
 
1. The presence of FVa increases the Vmax of thrombin formation by forming a 
complex with FXa allowing the cleavage of prothrombin at R320 followed by 
R271. 
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2. Exposure of PS decreases the Km of prothrombin by increasing the catalytic 
efficiency of FXa by triggering a close association of FXa with FVa. 
 
It has been indicated in several studies that monocytes are able to support pro-coagulant 
responses and the assembly of the prothrombinase complex. Furthermore it has been 
observed that stimulating monocytes or macrophages for several hours with either 
lipopolysaccharide (LPS), oxidise LDL or p-selectin leading to the exposure of PS can 
ultimately increase the generation of thrombin from prothrombin (Ananyeva et al., 2002; 
del Conde et al., 2005; Satta et al., 1994). 
 
5.1.3 Role for the P2X7R in Coagulation 
ATP activation of the P2X7R has been demonstrated to rapidly induce the exposure of PS 
on the outer leaflet of monocyte/macrophage plasma membranes (MacKenzie et al., 2001; 
Moore et al., 2007). Therefore I propose that ATP stimulated macrophages could 
potentially play a role in propagating and amplifying coagulatory responses. Furthermore 
the shed microvesicles from these ATP stimulated cells could themselves be involved in 
supporting prothrombotic activity. A major source of blood-borne TF is PS-rich 
microvesicles (Giesen et al., 1999) and a study by Satta et al., 1994 demonstrated that 
microvesicles released from monocytes after LPS stimulation (4-6hr) could increase 
prothrombinase activity.  
 
The key findings of this study were:  
1. ATP stimulation of RAW264.7 cells increases their ability to activate FX in the 
presence of FVIIa via a TF and PS dependent pathway. 
2. ATP stimulation of RAW264.7 cells increased their ability to generate thrombin in 
the presence of FXa, FVa and prothrombin.  
3. Microvesicles derived from ATP stimulated RAW264.7 cells are able to generate 
thrombin in the presence of FXa, FVa and prothrombin.  
S.F.Moore 
CHAPTER 5: MURINE MACROPHAGE P2X7RS SUPPORT RAPID PROTHROMBOTIC RESPONSES 
129 
5.2 RESULTS 
5.2.1 ATP Stimulated Cell Surfaces Catalyse the Activation of FX 
The exposure of PS on the outer leaflet of the plasma membrane is known to increase the 
pro-coagulant activity of the TF-FVIIa complex leading to the activation of FX. Here I 
tested whether ATP evoked PS translocation in RAW 264.7 macrophages is able to 
enhance the rate of FX activation as measured using the chromogenic substrate S-2765™.  
 




C) was observed to increase the rate of change in absorbance of the FXa substrate 
S2765
TM
 when in the presence of FVIIa (Figure 5-2A). Activating RAW264.7 cells with 3 
mM ATP for a range of times determined that a 5 – 10 min exposure was required to 
induce a significant increase in the activity of FX (n =3, p<0.05, Figure 5-2B). However 
the increase in FX activity was transient; where a 15 minute stimulation (3 mM ATP) was 
observed to not induce a significant increase in the activity of FX above an ATP-free 
control (n = 3, p>0.05). Using a 5 min stimulation time with a range of ATP concentrations 
revealed that concentrations ≥1 mM were required to activate FX (n = 3, Figure 5-2C). 
 
5.2.2 ATP Induced FX Activation is TF Dependent 
ATP-dependent FX activation was blocked when stimulated cells were incubated with 
FVIIa in the presence of an anti-TF IgG (p<0.05) while a non-specific IgG control had no 
effect (n = 3, Figure 5-3A). Basal levels of FX activation were unaffected by the co-
incubation with anti-TF IgG. Incubating cells with the P2X7R antagonist KN-62 (10 µM) 
for 5 min prior and during a 3 mM ATP (5 min) stimulation was observed to block ATP 
induced activation of FX (n = 3, Figure 5-3B). Incubating ATP stimulated cells with 
annexin-V, which is able to bind to exposed PS was observed to partially reduce ATP 
induced increases in FX activity (n = 3, Figure 5-3C).  
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Figure 5-2. Stimulating RAW264.7 cells with ATP Increases the Activity of FX in the Presence of 
FVIIa. A, Representative kinetic of ATP evoked increases in the absorbance of S2765
TM
 indicative of an 
increase in the presence of active FX. B, Histogram demonstrating that a 5 – 10 min exposure of RAW264.7 
cells to 3 mM ATP induces a significant increase in FX activity (n = 3 ± s.e.m). C, Histogram demonstrating 
that ATP (5 min) concentrations ≥1 mM are required to significantly increase FX activity (n = 3 ± s.e.m).  
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Figure 5-3. ATP Evoked Increases in FXa are Dependent on TF, PS Exposure and P2X7R Activation. 
A, Histogram demonstrating that incubating ATP stimulated RAW264.7 cells with FVIIa in the presence of a 
anti-TF IgG significantly decreases FX activity (n = 3 ± s.e.m). B, Histogram demonstrating that stimulating 
RAW264.7 cells with ATP in the presence of KN-62 significantly decreases FX activity (n = 3 ± s.e.m). C, 
Histogram demonstrating that incubating ATP stimulated RAW264.7 cells with FVIIa in the presence of  
An-V inhibits the ATP induced significant increase in FX activity (n = 3 ± s.e.m). Student’s t-test, *: p<0.05, 
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5.2.3 ATP Decreases TF Cell Surface Expression 
Labelling cell surfaces with anti-TF IgG and analyzing cells using FACS it was observed 
that 96 ± 2 % of unstimulated RAW264.7 cells (n = 3 ± s.e.m, Figure 5-4A) expressed cell 
surface TF. Stimulating cells with ATP (3 mM, 5 min) did not significantly alter the 
percentage of cells expressing surface TF (80 ± 11 %, n = 3 ± s.e.m, p>0.05). However the 
level of TF expression decreased with ATP stimulation (n = 3, p<0.01, Figure 5-4B).  
 
I previously demonstrated that stimulation of RAW264.7 cells with ATP induced the 
appearance of microvesicles. The loss of TF expression from the surface of RAW264.7 
cells could be hypothesised to be due to the shedding of TF expressing microvesicles. To 
determine whether microvesicles shed by RAW264.7 cells in response to ATP stimulation 
contained levels of TF sufficient to cause activation of FX in the presence of FVIIa, 
microvesicles were isolated from the supernatants of RAW264.7 cells by 
ultracentrifugation. No FX activity was recorded from either control or ATP derived 
microvesicle populations  (n = 3, p>0.05, data not shown).  
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Figure 5-4. ATP Evokes a Decrease in TF Cell Surface Expression. A, Representative FACS overlay 
demonstrating that ATP stimulation of RAW264.7 cells decreases cell surface expression of TF. B, 
Histogram demonstrating that stimulating RAW264.7 cells with ATP decreases cell surface expression of TF 
(n = 3 ± s.e.m).  .   
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5.2.4 ATP stimulated Cell Surfaces Catalyse Thrombin Generation 
The appearance of PS a component of the prothrombinase complex in the outer leaflet of 
the plasma membrane is observed to catalyse the cleavage of prothrombin to thrombin by 
factor Xa in the presence of factor Va and Ca
2+
 ions. Here I tested whether ATP evoked PS 
translocation in RAW 264.7 macrophages is able to enhance the rate of thrombin 
generation as measured using the chromogenic substrate S-2338™. Cell surfaces of 
RAW264.7 cells stimulated with ATP (10 min, 37 
o
C) in the presence of Ca
2+
 were 
observed to induce an increase in the rate of thrombin generation (Figure 5-5A, p<0.05, n 
= 9).  
 
Stimulating RAW264.7 cells with a range of ATP concentrations determined that 1 mM 
ATP evoked a peak response (1.76 ± 0.12, n = 9 ± s.e.m) in the rate of thrombin generation 
(Figure 5-5B). The peak response evoked by ATP (1 mM) was not significantly reduced by 
pre-incubating and stimulating RAW264.7 cells in the presence of KN-62 (Figure 5-5C, 
p>0.05, n = 9). However ATP in the presence of KN-62 did not induce a significant 
increase in the rate of thrombin generation compared to the KN-62 control (p>0.05, n = 9).  
 
To evaluate the contribution of translocated PS, stimulated RAW264.7 cells were pre-
incubated with the PS-capping agent An-V (500 nM, 5 min, 37 
o
C). Addition of An-V 
significantly reduced the ATP (1 mM) evoked response (Figure 5-5D, p<0.05, n = 9).  
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Figure 5-5. ATP Treated Cell Surfaces can Increase Thrombin Generation. A, Representative kinetic of 
ATP (10 min) evoked increases in the absorbance of S2238
TM
 indicative of an increase in the generation of 
thrombin. B, Histogram demonstrating that a range of ATP concentrations can induce a significant increase 
in thrombin generation (n = 9 ± s.e.m). C, Histogram demonstrating that pre-incubating and stimulating 
RAW264.7 cells in the presence of KN-62 did not significantly reduce ATP evoked increases in thrombin 
generation (n = 9 ± s.e.m). D, Histogram demonstrating that treating ATP stimulated RAW264.7 cells with 
An-V significantly reduces ATP evoked increases in thrombin generation (n = 9 ± s.e.m). One-way ANOVA 
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5.2.5 Shed Microvesicles from ATP Stimulated Cells Catalyse Thrombin Generation  
I previously demonstrated that stimulation of RAW264.7 cells with ATP induced the 
appearance of microvesicles; an observation that correlated with the finding that activation 
of the P2X7R induced the shedding of PS-rich microvesicles from LPS treated THP-1 
monocytes (MacKenzie et al., 2001). To determine whether microvesicles shed by 
RAW264.7 cells (untreated) in response to ATP stimulation  are able to enhance the rate of 
thrombin generation, microvesicles were isolated from the supernatant of RAW264.7 cells 
and the rate of thrombin generation measured using the chromogenic substrate S-2338™.  
 
Shed microvesicles were isolated from the supernatants of RAW264.7 cells and added to 
FXa and FVa and S-2238™. Upon application of prothrombin; microvesicle fractions 
collected from cells primed with 1 mM ATP (10 min) were observed to evoke an increased 
rate of thrombin generation (Figure 5-6A). This increase was calculated to be 2.2 ± 0.24 
fold (range 1.27 – 3.17) above the microvesicle fraction collected from control (ATP-free) 
cells (n = 9 ± s.e.m, p<0.01).  
 
The increased rate of thrombin formation was observed to peak with a 10 min ATP (1 mM) 
application and declined with 30 min ATP (1 mM) stimulation; this could have resulted 
from the lysis of released microvesicles (Figure 5-6B). An increased rate of microvesicle 
dependent thrombin generation was not observed when RAW264.7 cells where stimulated 
with concentrations of ATP ≤100 µM (Figure 5-6C).  
 
All subsequent measurements of prothrombinase activity in the presence of microvesicles 
were performed following 10 min ATP stimulation. 
S.F.Moore 
CHAPTER 5: MURINE MACROPHAGE P2X7RS SUPPORT RAPID PROTHROMBOTIC RESPONSES 
137 
 
Figure 5-6. Microvesicles Generated by ATP can Increase Thrombin Generation. A, Representative 
kinetic of ATP (10 min) evoked increases in the absorbance of S-2238
TM
 indicative of an increase in the 
generation of thrombin. B, Histogram demonstrating that a 10 min ATP (1 mM) stimulation can induce a 
significant increase in thrombin generation, whereas a  30 min stimulation results in a decline (n = 9 ± s.e.m). 
C, Histogram demonstrating that microvesicle fractions from cells stimulated with concentrations of ATP 
≤100 µM do not evoke a significant increase in thrombin generation  (n = 9 ± s.e.m). One-way ANOVA with 
Dunnett’s post-hoc test or Student’s t-test, **: p<0.01. 
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5.2.6 Microvesicle Induced Thrombin Generation is Dependent the P2X7R, PS and Ca
2+
 
Concentrations of ATP >100 µM are required to evoke microvesicle induced thrombin 
generation. Therefore I hypothesised that activation of the P2X7R was required for 
microvesicle shedding and subsequent increases in thrombin generation to occur. I tested 
this hypothesis by stimulating RAW264.7 cells with ATP in the presence of the P2X7R 
antagonists KN-62 (10 µM) and BBG (1 µM). Microvesicle fractions collected from cells 
stimulated in the presence of either of these inhibitors failed to evoke significant increases 
in thrombin generation in the presence of FVa, FXa and prothrombin (Figure 5-7A, KN-62 
p<0.001, Figure 5-7B, BBG p<0.0001, n = 9).  
 
To evaluate the contribution of exposed PS on the generation of thrombin, the isolated 
microvesicles were pre-incubated with 500 nM An-V to bind and cap the exposed PS on 
the surface of the microvesicles. Addition of An-V was observed to attenuate ATP (1 mM) 
evoked increases in thrombin generation (Figure 5-7C, p<0.001, n = 9).  
 
PS exposure is reported to occur when a large and rapid increase in [Ca
2+
]i occurs leading 
to the activation of scramblase and the inhibition of flippase. Furthermore I observed that 
microvesicle formation on RAW264.7 cells was reduced when the cells were stimulated 
with ATP in the absence of extracellular Ca
2+
. Therefore I assessed the contribution of 
extracellular Ca
2+
 on microvesicle formation and subsequent thrombin generation by 
stimulating RAW264.7 cells in the absence of external Ca
2+
. Microvesicle fractions 
generated from RAW264.7 cells stimulated in the absence of external Ca
2+
 were observed 
to have significantly lower basal and ATP evoked thrombin generation (Figure 5-7D, 








Figure 5-7. Microvesicle Induced Thrombin Generation is Dependent on the P2X7R, PS and Ca
2+
. A, 
Histogram demonstrating that blockade of the P2X7R with KN-62 inhibits microvesicle induced thrombin 
generation (n = 9 ± s.e.m). B, Histogram demonstrating that blockade of the P2X7R with BBG inhibits 
microvesicle induced thrombin generation (n = 9 ± s.e.m). C, Histogram demonstrating that capping exposed 
PS on ATP generated microvesicles inhibits thrombin generation (n = 9 ± s.e.m). D, Histogram 
demonstrating that stimulating RAW264.7 cells in the absence of external Ca
2+
 inhibits microvesicle induced 
thrombin generation (n = 9 ± s.e.m). Student’s t-test, **: p<0.01, ***:p<0.001.  
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5.3 DISCUSSION 
In this study I determined the ATP is potentially involved in pro-coagulant responses, due 
to its ability to evoke changes on cell membrane surfaces. The evidence for this is (i) ATP 
stimulated RAW264.7 cells can support TF dependent activation of FX, (ii) ATP 
stimulated RAW264.7 cells can catalyse thrombin generation in the presence of FVa, FXa 
and prothrombin and (iii) Microvesicle fractions from ATP stimulated RAW264.7 cells 
can catalyse thrombin generation in the presence of FVa, FXa and prothrombin.  
 
5.3.1 ATP Stimulated Cell Surfaces can Activate FX 
Extracellular ATP was determined to increase the activity of FX via a TF and a PS 
dependent pathway (Figure 5-3). This occurred in the absence of an increase in cell surface 
expression of TF leading to the hypothesis that extracellular ATP is able to increase the 
procoagulant activity of the TF already present on the RAW264.7 cells (Figure 5-4). Based 
on the following observations I propose that extracellular ATP is acting at the P2X7R to 
increase FX activity because (i) concentrations ≥ 1 mM ATP are required to elicit this 
increase, (ii) inhibition of the increase by the P2X7R antagonist KN-62 and (iii) PS 
exposure was previously found to not occur using ATP concentrations of ≤ 100 µM.  
 
Based on the findings of previous studies using calcium ionophores (Bach et al., 1990) I 
suggest that the sustained increase in [Ca
2+
]i initiated by P2X7R activation leads to the 
exposure of PS on the outer leaflet of the plasma membrane. This PS exposure is then able 
to increase the procoagulant activity of TF via an increase in the Vmax and decrease in the 
Km of TF-FVIIa conversion of FX to FXa.  
 
Examination of cell surface TF expression on RAW264.7 cells determined that ATP 
induced a loss in TF expression. I hypothesise that this loss could potentially be due to the 
shedding of microvesicles (Moore et al., 2007). A study by Baroni et al., 2007 determined 
that stimulation of the P2X7R with BzATP led to the shedding of microvesicles from 
dendritic cells. These microvesicles were determined to express TF and could support the 
activation of FX in the presence of FVIIa (Baroni et al., 2007). In the current study the 
microvesicles collected from ATP stimulated RAW264.7 cells failed to cause a significant 
increase in the activation of FX. I hypothesise that this is due to either TF not being shed 
on microvesicles due to it being localised on different areas of the plasma membrane 
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compared to where microvesicles arise (Del Conde et al., 2005b; Dietzen et al., 2004) or 
more likely that the levels of TF expressed on microvesicles were below the levels required 
for detection in the S2765
TM
 assay.  
 
5.3.2 ATP Stimulated Cell Surfaces Enhance Thrombin Generation 
Exposed PS as part of the prothrombinase complex is well documented to have an 
important role in the catalysis of thrombin generation (Weinreb et al., 2003). In agreement 
with this the cell surfaces of RAW264.7 cells exposed to 1 mM ATP demonstrated PS 
translocation that was able to induce an increase in the rate of thrombin generation (Figure 
5-5). This increased rate in thrombin generation was partially attenuated by An-V which 
specifically binds and caps exposed PS. I initially hypothesised that PS exposure and the 
subsequent increase in thrombin generation to be due to the activation of the P2X7R based 
on the finding that 1 mM ATP but not 100 µM ATP evoked the binding of AnV-488 to 
RAW264.7 cell surfaces. However an increase in the rate of thrombin generation was 
observed using 100 µM ATP to stimulate RAW264.7 cells and KN-62 failed to 
significantly change the rate of thrombin generation, although the rate of thrombin 
generation between cells treated with KN-62 in the absence of ATP versus cells treated 
with KN-62 in the presence of ATP was not significantly different (Figure 5-5).  
 
5.3.3 Microvesicle Fractions from ATP Stimulated Cells Enhance Thrombin Generation 
A study by Satta et al., 1994 has previously observed that PS-rich microvesicles released 
by priming monocytes with LPS for 4-6 hrs were able to catalyse the generation of 
thrombin through the assembly of the prothrombinase complex. In agreement with this, 
microvesicle fractions derived from RAW264.7 cells stimulated briefly with ATP (1 mM, 
10 min) increased the rate of thrombin generation more than 2-fold (Figure 5-6). I believed 
that ATP was activating the P2X7R to induce the shedding of PS-rich microvesicles which 
were able to catalyse thrombin generation; this was supported by three findings:  
 
1. Microvesicle fractions collected from RAW264.7 cells pre-incubated with either 
KN-62 or BBG had dramatically reduced ATP evoked thrombin generation. 
2. Pre-treatment of microvesicle fractions with An-V significantly attenuated 
thrombin generation.  
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3. Microvesicle fractions collected from RAW264.7 cells stimulated with ATP in the 
absence of external Ca
2+
 had reduced basal and ATP evoked thrombin generation.  
 
5.3.4 Is there a PS-Independent Component of the Prothrombinase Complex? 
Treatment of RAW264.7 cell surfaces and microvesicle fractions with An-V failed to 
completely inhibit ATP evoked thrombin generation. Two explanations could be provided 
for this observation either that the concentration of An-V was insufficient to fully cap all 
exposed PS or that a PS independent component is involved in the formation of the 
prothrombinase complex. The second explanation would correlate with the fact that cell 
surfaces treated with 100 µM ATP were able to enhance thrombin generation, although 
this concentration of ATP had failed to induce AnV-488 binding to RAW264.7 cell 
surfaces. This PS independent component maybe due to the action of other exposed 
anionic phospholipids such as PE (Smirnov et al., 1999).  
 
5.3.5 ATP, PS and Thrombin in Inflammatory Reactions & Diseases 
PS plays a crucial role in the coagulation cascade via its ability to enhance the activity of 
enzyme complexes of the coagulation cascade such as TF-FVIIa, FXa-FVa which were 
discussed in this chapter and also the FVIIIa:FIXa (tenase) complex involved in the 
activation of FX via the intrinsic coagulation cascade. I therefore hypothesise that in 
inflammatory areas such as atherosclerotic plaques, ATP released by damaged cells, 
infiltrating inflammatory cells and activated platelets could play several roles in 
procoagulant responses. 
• ADP generated from ATP would stimulate platelet P2Y1 and P2Y12 receptors 
facilitating platelet aggregation.   
• Exposure of PS on macrophages would increase TF-FVIIa activity leading to an 
increase in FXa generation. 
• Exposure of PS on macrophages would increase FVa-FXa activity leading to an 
increase in thrombin generation which would ultimately lead to the deposition of 
fibrin.  
• Release of PS containing microvesicles from macrophages could disseminate the 
procoagulant response in to areas surrounding the major inflammatory site.  
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Extracellular ATP could also potentially play a role in pro-inflammatory responses in 
atherosclerosis. Firstly ATP could be involved in the recruitment of monocytes and 
macrophages into the plaque (Wong et al., 2006). Secondly as previously stated ATP can 
induce the processing and release of IL-1 cytokines via action of the P2X7R on ‘primed’ 
monocytic cells (Ferrari et al., 1997b; MacKenzie et al., 2001). Knocking out IL-1β has 
been observed to decrease the severity of atherosclerosis in apoE deficient mice (Kirii et 
al., 2003). Thirdly the TF-FVIIa complex (Hjortoe et al., 2004), FXa (Busch et al., 2005) 
and thrombin (Szaba et al., 2002) can all stimulate the production and release of a range of 
pro-inflammatory cytokines.  
 
5.3.6 Concluding Remarks 
This study has demonstrated that stimulation of macrophages with high concentrations of 
ATP could lead to the propagation and amplification of the coagulation cascade (Figure 4-
8). Increases in TF pro-coagulant activity and prothrombinase complex formation were 
observed to occur within a faster time course in comparison to previous studies where 
monocytes were required to be stimulated for hours rather than minutes in order to lead an 
increase in their pro-coagulant properties (Bach et al., 1990; Satta et al., 1994). 
Furthermore based on LDH experiments these events occurred within a time frame where 
ATP failed to induce cell death.  The observation that activation of the P2 receptors by 
ATP can evoke pro-coagulant responses could be important in conditions were 
dysregulation of coagulation and inflammation occurs such as sepsis and atherosclerosis.  
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Figure 5-8. Summary Schematic of P2X7R Activation Coupling to Prothrombotic Responses. ATP 




]i. This leads to the translocation of PS initiating 
the de-encryption of tissue factor (yellow), formation of the prothrombinase complex and shedding of PS-
rich microvesicles. In the presence of other coagulation cascade factors this would ultimately lead to the 
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CHAPTER 6  
ATP INDUCES REACTIVE OXYGEN SPECIES GENERATION VIA NADPH OXIDASE 
 
6.1 INTRODUCTION 
In this part of the study the ability of extracellular ATP to initiated cellular oxidation in 
murine macrophages was investigated. Furthermore the source of ROS was assessed and 
the potential role they may play in initiating ATP induced cell death. Examining the role of 
ATP in evoking ROS generation could be of interest because: 
• ROS and activation of P2 receptors are both associated with pro-inflammatory 
events and cell death. 
• Increasing evidence implicates ROS as important signaling molecules under 
physiological and pathophysiological conditions, and therefore may be a 
downstream mediator of some of the events associated with P2 receptor activation.   
 
Two papers in the 1980’s observed that extracellular ATP was able to generate the 
production of O2
-
 in neutrophils (Ward et al., 1988) (Kuhns et al., 1988). Recently several 
papers have demonstrated that ATP potentially acting at the P2X7R can evoke ROS 
generation in a variety of cell types including; primary rat microglia (Parvathenani et al., 
2003; Skaper et al., 2006), RAW264.7 murine macrophages (Pfeiffer et al., 2007), human 
eosinophils (Ferrari et al., 2000) and neutrophils (Suh et al., 2001).   
 
Under physiological conditions the most important source of O2
-
 is the mitochondrial 
electron transport chain (ETC), which as part of normal metabolism can transfer electrons 
onto O2. It is estimated that 1 – 2 % of O2 reduced in the mitochondria is in the form of O2
-
 
(Turrens, 1997). This occurs at two sites, complex I (NADH dehydrogenase) and complex 
III (ubiquinone-cytochrome c reductase). Several other enzymes also contribute to O2 
generation; these include xanthine oxidase, cytochrome P450 enzymes, NOS and NADPH 
oxidase.  
 
All macrophages express NADPH Oxidase (NOX2) which is a major source of O2
-
 in 
phagocytic cells. Furthermore NOX2 has been suggested as the generator of extracellular 
ATP induced ROS generation (Hewinson et al., 2008; Noguchi et al., 2008; Parvathenani 
et al., 2003; Seil et al., 2008). In resting cells the components of NADPH oxidase are 
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located in different subcellular compartments; gp91phox and p22phox (flavocytochrome 
b558) are located at the plasma membrane whereas p47phox, p67phox and p22phox are 
located within the cytosol (Forman et al., 2001). Upon activation of the cell either by 
phagocytosis or a soluble mediator the cytosolic components along with the small GTPase 
Rac translocate to the plasma membrane and associate with the membrane bound 




Figure 6-1. Schematic of NADPH Oxidase Subunits and Assembly upon Activation.  
 
The gp91phox subunit contains a haem binding domain within its transmembrane 
segments and within its C-terminus a NADPH binding site and a flavin centre. Upon 
assembly of the complex the flavin centre transfers electrons from the physiological 
electron donor NADPH to the haem groups which mediate the final electron transfer to O2, 
resulting in the generation of O2
-
 in the extracellular of intraphagosomal space (Figure 4-2) 
(Yu et al., 1998).  
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 produced provides a source for the formation of all ROS and plays a vital role in 
the elimination of pathogens. This is highlighted by the fact that defects in the subunits of 
NADPH oxidase are the known cause of the hereditary condition; chronic granulomatous 
disease (Dinauer et al., 1987). Patients with this disease have severe recurrent bacterial 
infections. However aberrant activation of NADPH oxidase will lead to excessive ROS 
generation which could potentially damage tissues and cells nearby. Increasing evidence 
exists for the role of NOX2 in a range of inflammatory diseases such as arthritis, and 
atherosclerosis. NOX2 activity and p47phox phosphorylation have been observed to be 
increased in neutrophils from arthritic patients (El Benna et al., 2002). Furthermore an 
abundance of proteins modified by ROS have been documented to be present in the joint 
fluid of patients with rheumatoid arthritis (Chapman et al., 1989; Kaur et al., 1994). 
 
Besides the role of ROS in oxidative burst and tissue damage, NADPH oxidase products 
are implicated to potentially act as second messenger molecules (Forman et al., 2001). 
Macrophages are involved in the propagation of inflammation via the secretion of pro-
inflammatory molecules and resolution of inflammation via recognition and phagocytosis 
of cell corpses. Could ROS be involved in signaling these macrophage responses? Previous 
studies and evidence collected through the course of my investigations demonstrates the 
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importance of the P2X7R in macrophage evoked pro-inflammatory responses. If the P2X7R 
can evoke ROS generation in macrophages, could it be a potential mechanism of activating 
these inflammatory responses? Therefore the aims of this study were to determine whether 
the activation of the P2X7R in ‘primed’ murine macrophages can elicit cellular oxidation. 
Furthermore I proposed to use a combination of pharmacological agents and knock-out 
studies to determine whether NADPH Oxidase (NOX2) is the generator of these ROS. I 
proposed to finalise this part of the study by examining whether ATP induced oxidative 
stress could potentially induce cell death. In this and the proceeding chapter the study was 
conducted using the J774.2 murine macrophage cell line instead of RAW264.7 
macrophages. The reasoning for this is that I wished to examine the role of ROS in the 
maturation of IL-1β and RAW264.7 cells had been observed to not process IL-1β (Pelegrin 
et al., 2008; Verhoef et al., 2005).  
 
The key findings of this study were:  
1. Concentrations of ATP ≥ 500 µM evokes the generation of ROS in J774.2 cells and 
bone-marrow derived macrophages (BMDMø).  
2. Antagonism of the translocation of the p47phox subunit of NADPH or knocking 
out of either p47phox or gp91phox subunits inhibits ATP evoked ROS generation.  
3. ATP induced cytotoxicity in J774.2 cells but not BMDMø is regulated by cellular 
oxidation.  
4. ATP induced cytotoxicity in murine macrophages is partially regulated by capase-
1. 
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6.2 RESULTS 
6.2.1 ATP Induces the Generation of ROS in Murine Macrophages 
Addition of ATP onto LPS ‘primed’ J774.2 cells (Figure 6-3A) and BMDMø (Figure 6-
3B) loaded with H2DCF was observed to evoke rapid and sustained formation of the 
fluorescent compound DCF indicative of ROS generation. In the J774.2 cells, ATP intiated 
ROS generation with a bell-shaped concentration response curve with a peak response 
detected at 1 mM ATP (Figure 6-3C). The up-phase had an apparent EC50 value of 575 µM 
(pEC50 = 3.24 ± 0.04) and the down-phase an apparent EC50 of 2.75 mM (2.56 ± 0.05) (n = 
10 ± s.e.m). By contrast ATP evoked EtBr influx into J774.2 cells with a concentration 
response curve peaking at 3 – 5 mM with an EC50 of 1.51 mM (pEC50 =  2.82 ± 0.03) (n = 
3 ± s.e.m) (Figure 6-3E). In BMDMø, ATP evoked ROS generation was observed to 
plateau with concentrations of 2 - 5 mM (Figure 6-3D). This response was similar to that 
observed with ATP evoked EtBr influx into BMDMø (Figure 6-3F).  
 
ATP evoked ROS generation and EtBr influx in J774.2 cells was not observed to be 
significantly inhibited by the P2X7R antagonist 10 µM KN-04 (n = 3, p>0.05) (Figure 6-
4A, Figure 6-4B, Table 6-1). In contrast 10 µM KN-62 significantly reduced ATP evoked 
ROS generation; responses evoked by 1 mM ATP were reduced by 91 ± 2 % (Figure 6-4A, 
n = 3 ± s.e.m, p<0.001). EtBr influx into J774.2 cells was also inhibited by KN-62; this 
was observed as a significant reduction in the maxima (Figure 6-4B, Table 6-1, n = 3, 
p<0.05).  
 
The cell permeable glutathione precursor NAC (20 mM, 2 hours) was observed to 
significantly reduce ATP evoked ROS generation (Figure 6-5A, n = 3, p<0.01) without 
effect on EtBr influx in J774.2 (Figure 6-5B). Similar results were observed using 
BMDMø (Figure 6-5E). Furthermore DPI (100 µM, 1.5 hours), an inhibitor of flavoprotein 
oxidoreductases significantly attenuated ATP induced ROS generation in J774.2 cells 
(Figure 6-5C, n = 3, p<0.01) and BMDMø (Figure 6-5F) without effect on EtBr influx 
(Figure 6-5D).  
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Figure 6-3. ATP Evokes ROS Generation in Murine Macrophages. A, Representative trace 
demonstrating that 1 mM ATP evokes an increase in DCF fluorescence in J774.2 cells. B, Representative 
trace demonstrating that 5 mM ATP evokes an increase in DCF fluorescence in BMDMø. C, Concentration 
response curve of ATP evoked ROS generation in J774.2 cells (pEC50 = 3.24 ± 0.04 & pEC50 = 2.56 ± 0.05) 
(n = 10 ± s.e.m). D, Histogram demonstrating concentration-dependent ATP evoked ROS generation in 
BMDMø (n = 3 ± s.e.m). E, Concentration response curve of ATP evoked EtBr influx in J774.2 cells (pEC50 
= 2.82 ± 0.03) (n = 3 ± s.e.m). F, Histogram demonstrating concentration-dependent ATP evoked EtBr influx 
in BMDMø (n = 3 ± s.e.m).  
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Figure 6-4. ATP Evoked ROS in Inhibited by KN-62 but not KN-04. A, Concentration response curve of 
ATP evoked ROS generation in J774.2 cells in the presence of 10 µM KN-04 or KN-62 (n = 3 ± s.e.m). B, 
Concentration response curve of ATP evoked EtBr influx in J774.2 cells in the presence of 10 µM KN-04 or 




 pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
Control 3.12 ± 0.11 5.53 ± 1.51 113 ± 9 
KN-62 NA NA NA 




 pEC50 ± s.e.m nH ± s.e.m α ± s.e.m 
Control 2.75 ± 0.01 5.12 ± 0.61 102 ± 2 
KN-62 2.70 ± 0.02 4.97 ± 0.99 68 ± 12* 
KN-04 2.75 ± 0.01 4.79 ± 0.56 93 ± 8 
 
Table 6-1. ATP Evoked ROS Generation (A) and EtBr Influx (B) Concentration Response Parameters 
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Figure 6-5. ATP Evoked ROS Generation is inhibited by NAC and DPI. A & B, Histograms 
demonstrating inhibition of ATP evoked ROS generation (A) but not EtBr influx (B) in J774.2 cells by pre-
incubating cells with NAC (2 hours) (n = 3 ± s.e.m). C & D, Histograms demonstrating inhibition of ATP 
evoked ROS generation (C) but not EtBr influx (D) in J774.2 cells by pre-incubating cells with DPI (1.5 
hours) (n = 3 ± s.e.m). E & F, Histograms demonstrating that ATP evoked ROS generation in BMDMø is 
inhibited by NAC (E) and DPI (F) (n = 3 ± s.e.m). Student’s two-tailed t-test **:p<0.01, ***:p<0.001. 
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6.2.2 Evidence for the Role of NADPH Oxidase in ATP Evoked ROS Generation 
DPI is used as a general inhibitor of O2
-
 production and is sometimes referred to as a 
specific inhibitor of NADPH oxidase. However DPI actually inhibits this enzyme by 
inactivating it at its flavin site during electron-transfer, therefore it is actually a general 
inhibitor of flavoprotein oxidoreductases. This means it is able to inhibit several important 
flavoprotein-containing systems including xanthine oxidase, NOS, mitochondrial electron 
transport, cytochrome P450 reductase and other oxidoreducatases (Li et al., 1998; 
O'Donnell et al., 1994; Stuehr et al., 1991). In order to elucidate the generator of ATP 
evoked ROS I employed the use of several more selective inhibitors of different 
flavoprotein oxidoreductases.  
 
The xanthine oxidase inhibitor (Scott et al., 1966), allopurinol (100 µM, 30 min) failed to 
significantly attenuate ATP evoked increases in cellular oxidation in J774.2 cells (Figure 
6-6A, n = 3, p>0.05). The NOS inhibitor; L-NAME (1 mM, 1 hour) was also observed to 
not significantly reduce ATP evoked ROS generation in J774.2 cells (Figure 6-6B, n = 3, 
p>0.05). However it was observed to significantly reduce nitrate levels in both untreated 
and ATP stimulated J774.2 cell lysates as measured using the Saville-Griess method 
(Figure 6-6C,  n = 3, p<0.01).  
 
Pre-treating J774.2 cells with the mitochondrial complex I inhibitor rotenone (5 µM, 30 
min) or complex III inhibitor myxathiazole (1 µM, 5 min) had no significant effect on ATP 
induced increases in cellular oxidation (Figure 6-7A & C, n = 3, p>0.05). In contrast 
rotenone (5 µM, 30 min) significantly attenuated ROS generation in the BMDMø (Figure 
6-7B, n = 3, p<0.01).  
 
Pre-incubating and stimulating J774.2 cells in the presence of the NADPH Oxidase 
inhibitor; apocynin (100 µM) was observed to significantly reduce ATP evoked ROS 
generation (Figure 6-8A, n = 3, p<0.05). This occurred without effect on EtBr influx 
(Figure 6-8B, n = 3, p>0.05). Furthermore employing the use of gp91phox
-/-
 (n = 5) and 
p47phox
-/-
 (n = 3) BMDMø demonstrated that knocking-out NADPH oxidase inhibited 
ATP evoked ROS generation back to control levels (Figure 6-8C & E) without effect on 
EtBr influx (Figure 6-8D & F) or H2DCF loading (Figure A-4).  
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Figure 6-6. ATP Evoked ROS Generation is not mediated by Xanthine Oxidase or NO Synthase. A, 
Histogram demonstrating that the xanthine oxidase inhibitor; allopurinol (100 µM, 30 min) does not inhibit 
ATP evoked ROS generation in J774.2 cells (n = 3 ± s.e.m). B, Histogram demonstrating that the NOS 
inhibitor; L-NAME (1 mM, 1 hour) does not inhibit ATP evoked ROS generation in J774.2 cells (n = 3 ± 
s.e.m). C, Histogram demonstrating that L-NAME (1 mM, 1 hour) significantly decreases the amount of 
nitrate in J774.2 cell lysates cells (n = 3 ± s.e.m). Student’s two-tailed t-test *:p<0.05.  
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Figure 6-7. Effect of Mitochondrial ETC Inhibitors on ATP Evoked ROS Generation. A, Histogram 
demonstrating that the complex I inhibitor; rotenone (5 µM, 30 min) does not inhibit ATP evoked ROS 
generation in J774.2 cells (n = 3 ± s.e.m). B, Histogram demonstrating that the complex I inhibitor; rotenone 
(5 µM, 30 min) significantly reduces ATP evoked increases in ROS generation in BMDMø (n = 3 ± s.e.m). 
C, Histogram demonstrating that the complex III inhibitor; myxathiazole (1 µM, 5 min) does not inhibit ATP 
evoked ROS generation in J774.2 cells (n = 3 ± s.e.m). Student’s two-tailed t-test **: p<0.01.  
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Figure 6-8. Evidence for ATP Evoked Activation of NADPH Oxidase in Generating ROS. A & B, 
Histograms demonstrating that the NADPH oxidase inhibitor; apocynin (100 µM, 30 min) significantly 
reduces ATP evoked ROS generation (A) without inhibiting EtBr influx (B) into J774.2 cells (n = 3 ± s.e.m). 
C & D, Histograms demonstrating that ATP does not evoke ROS generation (C) in BMDMø from gp91phox
-
/-
 mice above control, however EtBr influx (D) is still observed (n = 5 ± s.e.m). E & F, Histograms 
demonstrating that ATP does not evoke ROS generation (E) in BMDMø from p47phox
-/-
 mice above control, 
however EtBr influx (F) is still observed (n = 3 ± s.e.m). Student’s two-tailed t-test *: p<0.05, **: p<0.01, 
***: p<0.001.  
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6.2.3 Spatial Localisation of ATP Induced Superoxide Generation 
Activation of NADPH oxidase will result in the transfer of electrons from NADPH across 
a membrane and coupling these to molecular oxygen to produce O2
-
. This can be produced 
outside or inside (within phagosomes etc) the cell. To investigate whether ATP stimulation 
of murine macrophages results in the generation of O2
-





SOD catalyses the dismutation of O2
-
 into oxygen and hydrogen peroxide. Although 
H2DCF does not sensitively detect O2
-
 it will detect ONOO
-





removed from the system by SOD levels of ONOO
-
 would be expected to decrease and 
levels of H2O2 and OH
-
 to increase.  
 
The addition of extracellular SOD (100 U ml
-1
) to J774.2 cells did not alter ATP evoked 
cellular oxidation (Figure 6-9A, n = 3). However pre-incubation with a membrane 
permeant SOD mimetic (Mn-cpx 3, 30 µM, 30 min) was observed to significantly increase 
ATP evoked ROS generation (Figure 6-9C, n = 3, p<0.05). By contrast, addition of 
extracellular SOD (100 U ml
-1
) to BMDMø inhibited ATP mediated ROS formation 
(Figure 6-9B, n = 3, p<0.05).  
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Figure 6-9. Spatial Localisation of ATP Induced ROS Generation in Murine Macrophages. A, 
Histogram demonstrating that extracellular SOD (100 U ml
-1
) does not effect ATP induced ROS generation 
in J774.2 cells (n = 3 ± s.e.m). B, Histogram demonstrating that extracellular SOD (100 U ml-1) significantly 
decreases BMDMø cellular oxidation induced by ATP (n = 3 ± s.e.m). C, Histogram demonstrating that a 
cell permeant SOD mimetic (Mn-cpx 3) significantly increases ATP evoked ROS generation in J774.2 cells 
(n = 3 ± s.e.m). Student’s two-tailed t-test *: p<0.05. 
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6.2.4 Role of Reactive Oxygen Species in ATP Evoked Cell Death 
As demonstrated in previous chapters prolonged activation of the P2X7R can cause the 
release of LDH indicative of a breakdown in the plasma membrane and therefore cell 
death. ROS have been well documented to be involved in the induction of apoptotic cell 
death (Simon et al., 2000). ROS are able to directly or indirectly via ceramide production 
induce the release of cytochrome-c from mitochondria. Cytochrome-c is able to go on to 
form part of the apoptosome which causes the activation of caspase-9 which can then go 
on to activate effector caspases such as caspase-3 and 7 which are responsible for 
destroying the cell from within.  
 
Therefore we investigated whether ATP evoked LDH release could be inhibited by ROS 
inhibitors. 1 mM ATP was observed to evoke significant release of LDH from J774.2 cells 
(Figure 6-10A) after a 30 and 60 min stimulation (n = 3, p<0.01). Using a range of ATP 
concentrations, determined that 1 mM ATP caused peak LDH release with a decline in 
release being observed with 3 and 5 mM (Figure 6-10B, n = 3). Pre-incubating J774.2 cells 
with DPI (100 µM, 1.5 hours) was observed to significantly reduce ATP (1 mM) evoked 
LDH release at a range of stimulation times (15, 30 and 60 min) (Figure 6-10C, n = 3). 
However pre-incubating J774.2 cells with apocynin (100 µM, 5 min) did not effect ATP 
induced cell death (Figure 6-10D, n = 3, p<0.05).  
 
ATP (5 mM, 60 min) was also observed to evoke cell death in BMDMø (Figure 6-11A), in 
contrast with the results observed with the J774.2 cells DPI (100 µM, 1.5 hours) failed to 
reduce release of LDH (Figure 6-11B). Furthermore ATP was able to evoke release of 
LDH from gp91phox
-/-
 BMDMø at similar levels to wild-type BMDMø (Figure 6-11C, n = 
3). Rotenone also failed to inhibit ATP induced cell death in BMDMø (Figure 6-11D, n = 
3).  
 
Caspases have been documented to play an important role in cell death; such as caspase-3 
and 7 in apoptosis and caspase-1 in pyroptosis. Due to the role of the P2X7R in the 
activation of caspase-1, I decided to investigate whether the caspase-1 inhibitor Z-YVAD-
FMK could modulate ATP induced cell death in murine macrophages. I observed that ATP 
evoked cell death in J774.2 cells (Figure 6-12A) and BMDMø (Figure 6-12B) was 
significantly reduced by pre-incubating cells with Z-YVAD-FMK (10 µM, 30 min) (n = 3).  
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Figure 6-10. Role of ROS in ATP Induced Cell Death in J774.2 Cells. A, Histogram demonstrating that 1 
mM ATP evokes LDH release from J774.2 cells after a 30 – 60 min stimulation (n = 3 ± s.e.m). B, 
Histogram demonstrating that only 1 mM ATP evoked a significant release of LDH from J774.2 cells (n = 3 
± s.e.m). C, Histogram demonstrating that DPI significantly inhibited LDH release from J774.2 cells 
stimulated with 1 mM ATP for 15, 30 and 60 min (n = 3 ± s.e.m). D, Histogram demonstrating that apocynin 
did not significantly effect LDH release from J774.2 cells stimulated with 1 mM ATP for 15, 30 and 60 min 
(n = 3 ± s.e.m). Student’s two-tailed t-test *: p<0.05, **:p<0.001, ***:p<0.001.  
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Figure 6-11. ROS appear to not be involved in ATP Induced Cell Death in BMDMø. A, Histogram 
demonstrating that 5 mM ATP evokes LDH release from BMDMø after a 60 min stimulation (n = 3 ± s.e.m). 
B, Histogram demonstrating that DPI failed to significantly inhibit LDH release from BMDMø stimulated 
with 5 mM ATP for 60 min (n = 3 ± s.e.m). C, Histogram demonstrating that ATP evoked LDH release from 
gp91phox
-/-
 BMDMø did not significantly differ from WT BMDMø (n = 3 ± s.e.m). D, Histogram 
demonstrating that rotenone did not significantly effect LDH release from BMDMø stimulated with 5 mM 
ATP for 60 min (n = 3 ± s.e.m). Student’s two-tailed t-test, ***: p<0.001.  
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Figure 6-12. Role of Caspase-1 in ATP Induced Cell Death in Murine Macrophages. A, Histogram 
demonstrating that Z-YVAD-FMK significantly inhibited LDH release from J774.2 cells stimulated with 1 
mM ATP for 60 min (n = 3 ± s.e.m). B, Histogram demonstrating that YVAD significantly inhibited LDH 
release from BMDMø stimulated with 5 mM ATP for 60 min (n = 3 ± s.e.m). Student’s two-tailed t-test, *: 
p<0.05 ***: p<0.001.  
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6.3 DISCUSSION 
In this study I determined that extracellular ATP is able to evoke ROS generation in 
murine macrophages via activation of NADPH oxidase. I also determined that the 
mechanism, location and effect of these ROS are dependent on the cell type used.  
 
6.3.1 P2 Receptor Activation of NADPH Oxidase 
An application of ATP to J774.2 cells, BMDMø and peritoneal cells (Figure A-5) was 
observed to evoke an increase in DCF fluorescence indicative of ROS generation. In order 
to determine that the signal produced was due to cellular oxidation I pre-incubated cells 
with either the antioxidant NAC or the flavoprotein oxidoreductase inhibitor DPI which 
was observed to decrease ATP evoked ROS in all three cell types. Many of the producers 
of ROS are flavoprotein oxidoreductases therefore in order to determine the generator of 
ATP evoked oxidative stress I firstly identified a likely candidate using a panel of 
pharmacological inhibitors and secondly used BMDMø from mice lacking the functional 
generator. Using this method I identified that the major source of ATP evoked ROS is 
NADPH oxidase (NOX2). This correlated with our labs previous finding that ATP could 
induce (i) an increase in the association of the p47phox and p67phox subunits and (ii) an 
increase in the translocation of the p67phox subunit to the cell membranes in a human 
monocytic cell line (Hewinson et al., 2008).  
 
The activity of NADPH oxidase activity can be regulated by Ca
2+
 fluxes, p38 MAPK, PKC 
and PI3 kinase. All of which have been observed to be activated by P2X7 receptors 
(Bradford et al., 2002; Jacques-Silva et al., 2004; Moore et al., 2007; Pfeiffer et al., 2004). 
I observed that although a pre-treatment of J774.2 cells with the human P2X7R antagonist 
KN-62 significantly inhibited ROS generation, KN-04 did not. KN-62 can act as 
calcium/calmodulin dependent kinase II inhibitor whereas KN-04 which is a structural 
analogue of KN-62 lacks this inhibitory activity whilst retaining its P2X7R antagonist 
activity (Tokumitsu et al., 1990). Therefore this suggested that the inhibitory effect 
observed with KN-62 was potentially due to its action as a calcium/calmodulin dependent 
kinase II inhibitor rather than as a P2X7R antagonist. Further work employing the use of 
other calcium/calmodulin dependent kinase II inhibitors would be required in order to 
address this issue. These results however do not completely rule out a role for the P2X7R 
in ATP evoked ROS generation as EtBr influx into J774.2 cells was poorly antagonised by 
both KN-04 and KN-62.  
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KN-62 has been observed to be able to block mP2X7R activation (Hibell et al., 2001; 
Moore et al., 2007) although not as potently as the human orthologues. Furthermore in the 
preceding chapters I have demonstrated that ATP evoked responses in RAW264.7 cell 
which are typical of P2X7R activation are robustly blocked by KN-62. Potentially 
calcium/calmodulin dependent kinase II activation could play a role in ‘P2X7R’ evoked 
responses.  
 
Much of the past work implicating extracellular ATP activation of cellular oxidation via 
the P2X7R primarily has relied on the use of non-specific inhibitors or BzATP which 
although sometimes used as a specific P2X7R agonist it is able to activate other P2X 
receptors. Recent work has improved the evidence for the P2X7R being involved in ROS 
generation, for example a study by Pfeiffer et al., 2007 determined that the 
pharmacological profile of ROS generation was comparable with P2X7R activation and use 
of a macrophage cell line deficient in a functional P2X7R failed to evoke cellular oxidation 
in response to BzATP. Furthermore work in our own lab demonstrated that use of specific 
human P2X7R antagonists could inhibit cellular oxidation in THP-1 cells and human 
monocytes (Hewinson et al., 2008). However these antagonists only partially inhibited the 
response and a study by Ferrari et al., 2000 also demonstrated only partial block with KN-
62 and furthermore observed that the P2Y2 receptor agonist UTP also triggered robust 
ROS formation. In a preliminary experiment I observed inhibition of ROS generation in 
J774.2 cells by the potent non-selective adenosine receptor antagonist CGS 15943 (n = 1, 
Figure A-7). This was surprising as adenosine has been observed to be a potent inhibitor of 
ROS production by NADPH oxidase in fMLF-stimulated neutrophils. The mechanism is 
suggested to involve activation of the A3R leading to endocytosis and/or redistribution of 
the p22phox/gp91phox heterodimer between subcellular compartments (Swain et al., 2003; 
van der Hoeven et al., 2008). Further investigation is required to elucidate which 
purinergic receptors are involved in activating NADPH oxidase. Therefore I suggest that 
cellular oxidation evoked by ATP is mediated by multiple purinergic receptors and that 
further work employing the use of specific purinergic receptor agonists and antagonists is 
required and potentially receptor knock-down/knock-out studies in order to ascertain 
specifically which receptors are involved in ATP evoked activation of NADPH oxidase.  
 
The signaling pathway from P2 receptor activation to NADPH oxidase has not been widely 
examined. In the case of P2X receptors mobilisation of extracellular calcium could initiate 
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the activation of NOX2; chelation of extracellular Ca
2+
 has been reported to block ROS 
generation by P2X agonists (Ferrari et al., 2000; Murphy et al., 1993). Our lab has 
evidence that PI3K and iPLA2 could have a potential role in mediating P2 receptor 
activation of NADPH oxidase. ATP induced ROS generation in ‘primed’ THP-1 
monocytes was observed to be partially inhibited by the PI3K inhibitors LY294002 and 
wortmannin and the calcium-independent phospholipase A2 inhibitor bromoenol lactone (J 
Hewinson 2006 8
th
 International Symposium on Adenine and Adenosine Nucleotides, 
Ferrara, Italy) (J Hewinson 2007 LifeSciences 2007, Glasgow, UK).  A review by Guerra 
et al., 2007 proposed a four step model of P2 activation of NADPH Oxidase (Figure 6-13).  
1. P2X induced increase in [Ca
2+
]i could activate certain PKC isoforms that are 
essential for the activation/phosphorylation of NADPH oxidase subunits. 
2. P2X7R activation of p38 MAPK could facilitate activation of NADPH oxidase. 
3. P2Y receptors could activate PLC leading to generation of IP3 and DAG which 
would lead to increases in [Ca
2+
]i and therefore lead to PKC activation. 
4. P2Y receptors such as P2Y2 could activate the small G-protein Rac which would be 




Figure 6-13. Schematic of how P2Rs could Couple to Activation of NADPH Oxidase. Adapted from 
(Guerra et al., 2007) 
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Murine macrophages have been proposed to express A2B and A3 receptors (Xaus et al., 
1999); potentially these adenosine receptors could couple in to the some of the signaling 
pathways suggested to induce NADPH oxidase activation such as activation of PLC, PKC 
and p38 MAPK (Feoktistov et al., 1997; Feoktistov et al., 1999; Jacobson et al., 2006; 
Schulte et al., 2003) 
 
6.3.2 Cell Background Differences in ATP Evoked ROS Generation 
The term macrophage encompasses many different cell types with a monocytic origin that 
acquire functional properties dependent on the environment they are in. The effects of 
oxidants on redox signaling are largely cell and stimulus specific (Forman et al., 2001). 
Therefore differences in the redox properties of different macrophages should be expected, 
for example alveolar macrophages are observed to have high basal NADPH oxidase 
activity (Tephly et al., 2007) in comparison to peritoneal macrophages.  
 
In this study I observed that inhibition of mitochondrial electron transport failed to inhibit 
ATP evoked ROS generation in the J774.2 cells; a macrophage cell line originally derived 
from the ascites (peritoneal cavity fluid) and solid tumour of a BALB/c mouse and native 
peritoneal cells from C57BL/6 mice (Figure A-5). Whereas the complex I inhibitor 
rotenone partially blocked ATP evoked ROS generation in macrophages generated from 
the bone marrow of C57BL/6 mice (BMDMø). Spatial localisation of ROS generation also 
seemed to differ between cell types, in the BMDMø extracellular SOD reduced ATP 
cellular oxidation suggesting generation of ROS by NADPH oxidase was occurring at least 
in part at the plasma membrane. Whereas extracellular SOD had no effect on ATP evoked 
ROS generation in J774.2 or peritoneal cells (Figure A-5). However use of a cell 
permeable SOD mimetic (Mn-cpx 3) potentiated ATP induced cellular oxidation in J774.2 
and peritoneal cells, suggesting O2
-
 could be being generated within membrane bound 
compartments in the cell.  The nature of ROS means they are diffusible, short-lived 
molecules and therefore localising ROS production to a specific subcellular compartment 
would be of importance for activating redox signaling events. Clearly, these results 
demonstrate that results from one macrophage type may not be simply extrapolated to 
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6.3.3 Modulation of Cell Death by Cellular Oxidation & Caspase-1 
I determined that pre-treatment of J774.2 cells but not BMDMø or native peritoneal cells 
with DPI could inhibit ATP evoked LDH release. This suggests that in some cell types 
ATP induced cellular oxidation can activate cell death signaling pathways. ATP induced 
oxidative stress could be potentially activating cell death pathway via c-Jun N-terminal 
kinase (JNK) and/or p38 mitogen-activated protein kinase. Both of these kinases have been 
observed to be activated downstream of P2X7R activation (Humphreys et al., 2000; 
Pfeiffer et al., 2007) and furthermore play important roles in induction of apoptosis 
(Shacka et al., 2006). A study by Noguchi et al., 2008 using the RAW264.7 cells 
determined that ATP induced apoptosis was lost in ASK1
-/-
 (apoptosis signal-regulating 
kinase 1) spleen-derived macrophages. ASK-1 is upstream of JNK and p38 kinases and is 
activated by various stresses including ROS (Takeda et al., 2008). Noguchi et al., put 
forward a model (Figure 6-14) suggesting that ATP induced ROS via NADPH oxidase 
would activate ASK1 and in turn p38 MAPK leading to the induction of apoptosis via a 
caspase-3 dependent pathway.   
 
 
Figure 6-14. Schematic of how P2X7R activation could cause ROS dependent apoptosis. Adapted from 
(Noguchi et al., 2008) 
 
P2X7R stimulation is a known activator of caspase-1 (Kahlenberg et al., 2004b). Caspase-1 
as already stated is a mediator of a form of cell death known as pyroptosis (Fink et al., 
2005). Furthermore P2X7R induced cell death in LPS primed macrophages has been 
observed to be reduced although not eliminated in macrophages derived from caspase-1 
KO mice (Le Feuvre et al., 2002). In agreement to this study I observed that ATP evoked 
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LDH release in LPS primed J774.2 cells or BMDMø (not peritoneal cells) was partially 
reduced by pre-treating cells with the caspase-1 inhibitor Z-YVAD-FMK. In J774.2 cells I 
see regulation of cell death by both ROS and caspase-1 therefore I could hypothesise three 
potential models: 
 
1. ROS activation of p38 MAPK could lead to the activation of caspase-1. An 
increase in caspase-1 activity induced by dextran sulphate sodium was found to be 
significantly inhibited by a p38 MAPK inhibitor and the antioxidant NAC (Kwon et 
al., 2007). 
2.  Caspase-1 activity could be regulated by the redox status of the cell directly.  
3. Caspase-1 activity and ROS generation are two separate events.  
 
6.3.4 Concluding Remarks 
Here I demonstrated that extracellular ATP can activate NADPH Oxidase leading to an 
increase in the generation of ROS. Considering the growing body of evidence that suggests 
O2
-
 and H2O2 could potentially act as ‘second messengers’ I hypothesise that ATP evoked 
ROS generation could potentially activate, propagate and/or amplify some of the functional 
responses associated with the activation of purinergic receptors. Here I briefly examined 
the role of ATP evoked ROS in mediating P2X7R induced cell death, in the following 
chapter I take these studies further and examine the role of ROS in other ‘P2X7R’ 
functional responses.  
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CHAPTER 7  
REDOX REGULATION OF CASPASE-1 
 
7.1 INTRODUCTION 
In the previous chapter it was demonstrated that extracellular ATP can evoke an increase in 
the generation of ROS. It was hypothesized at the end of the chapter that the activity of the 
IL-1β activating enzyme; caspase-1 could be regulated by the redox status of the cell. The 
P2X7R on LPS primed macrophages, microglia and dendritic cells has been previously 
demonstrated to activate caspase-1 and ultimately induce the processing and secretion of 
IL-1β (Ferrari et al., 1997b; Ferrari et al., 1997c; MacKenzie et al., 2001; Pizzirani et al., 
2007; Solle et al., 2001). The secretion of active/mature IL-1β is an important part of the 
innate immune response with low level release promoting the resolution of infections and 
induction of wound healing. However aberrant release can induce skin rashes, 
inflammatory arthritis and systemic fever. Determining the mechanism of regulation of IL-
1β maturation and secretion is therefore of great interest. However the mechanism of how 
P2X7R activation couples to caspase-1 activation has remained controversial. I therefore 
proposed to investigated whether ATP evoked ROS generation is the missing link between 
the P2X7R and the activation of caspase-1.  
 
7.1.1 P2X7R Mediated Processing and Secretion of IL-1β  
Activation of TLR4 by LPS will induce the synthesis of the inactive 31 kDa precursor of 
IL-1β (Pro- IL-1β) via the via the transcription factor NF-κB downstream of the MyD88 
adapter. A second signal is then required to initiate the processing and secretion of IL-1β, 
which is thought to be activation of the P2X7R by ATP. This is based on the observation 
that P2X7R
-/-
 macrophages fail to process and secrete IL-1β in response to ATP, and 
injection of ATP in to mice deficient in this receptor failed to evoke an increase in levels of 
IL-1β in peritoneal lavage (Solle et al., 2001).  This second signal is required for the 
activation caspase-1 which is able to cleave pro-IL-1β between D116 and A117 releasing 
the COOH-terminal mature IL-1β and an NH2-terminal IL-1β pro-peptide. The mature 
form of IL-1β is then rapidly released from the cell via a non-classical secretory 
mechanism. The precise mechanism of release is controversial with five different pathways 
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1. Microvesicle Shedding (Bianco et al., 2005; MacKenzie et al., 2001)  
2. Exocytosis of secretory lysosomes (Andrei et al., 1999; Carta et al., 2006)  
3. Direct membrane efflux (Brough et al., 2007) 
4. Exocytosis via multivesicular bodies (Qu et al., 2007)  
5. Cell lysis 
 
7.1.2 Activation of Caspase-1 by the NALP3 Inflammasome 
Caspase-1 is a cysteine protease that is able to cleave proteins after an aspartic acid 
residue. It plays an essential role in hose defence and the execution of the innate immune 
response, which is highlighted by the observation that caspase-1 deficient mice exhibit 
increase susceptibility to bacterial infection (Li et al., 1995). It is synthesized as an inactive 
45-kDa zymogen; pro-caspase-1 that undergoes autocatalytic processing (Figure 7-1). The 
active form of the enzyme comprises a p20 and p10 subunit which assembles with another 




Figure 7-1. Diagram of Caspase-1 showing Domain Organization & Cleavage Sites.  
 
Activation of caspase-1 occurs within a cytosolic multiple adaptor complex termed the 
inflammasome. An inflammasome consists of a NOD-like receptor protein (NLR) which 
will associate with an adaptor protein apoptosis-associated speck-like protein (ASC) which 
in turn will recruit pro-inflammatory-caspase precursors (Figure 7-2). Various microbial 
and endogenous stimuli activate different types of inflammasome, in the case of the LPS / 
ATP it is the NALP3 (NLR3, Cryopyrin, CIAS1) containing inflammasome.  
 
Mutations in NALP3 had previously been observed to cause three autoinflammatory 
disorders; Muckle-Wells syndrome (MWS), familial cold urticaria (FCU) and chronic 
infantile neurological cutaneous and articular syndrome (CINCA) (Neven et al., 2004). All 
involve recurrent inflammatory episodes generally associated with fever, arthralgia and 
urticaria. A clinical study in 2004 observed that both clinical and serological evidence of 
active MWS was resolved rapidly and completely during treatment with the IL-1R 
S.F.Moore 
CHAPTER 7: REDOX REGULATION OF CASPASE-1 
171 
antagonist anakinra (Hawkins et al., 2004). Later in 2006 three articles were published in 
Nature demonstrating that knocking out NALP3 inhibited caspase-1 activation and IL-1β 
secretion in response to uric acid crystals (Martinon et al., 2006), bacterial RNA 




Figure 7-2. Schematic of Caspase-1 Activation by the NALP3 Containing Inflammasome. A 
conformational change in NALP3 allows the binding of adaptor proteins such as ASC and CARDINAL 
which can recruit caspase-1. It is proposed that the proximity of the caspase-1 molecules allows autocatalytic 
processing resulting in the activation of caspase-1.  
 
How the components of the inflammasome sense the various activators is not known there 
are two basic models (i) a direct ligand receptor interaction or (ii) each ligand induces a 
common cellular signal. Evidence for a direct ligand receptor interaction can be found in a 
study by Kanneganti et al., 2007 who suggested that pathogens who can secrete pore 
forming proteins can gain entry to the cell where they are sensed by NALP3; whereas 
those bacteria that do not secrete pore-forming proteins could gain access to the cell via the 
ATP/P2X7R pore (pannexin-1). The suggested common cellular signal is proposed to be 
some form of change in the intracellular ionic milieu or generation of a metabolite (Pétrilli 




based on the 
following evidence: 
• IL-1β processing and secretion is inhibited in cells bathed in a high [K+] solution 
(Dostert et al., 2008; Kahlenberg et al., 2004b). 
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• The efflux of K+ would result in the activation of iPLA2, whose inhibition has 
been observed to prevent the processing of IL-1β (Andrei et al., 2004; Walev et 
al., 2000).  
• Other agents that lower intracellular [K+] such as the K+ ionophores nigericin and 
maitotoxin can induce robust IL-1β processing (Perregaux et al., 1992; Perregaux 
et al., 1994).  
• ASC oligomerization and recruitment of caspase-1 by NALP3 is inhibited by K+ 
(Pétrilli et al., 2007b). 
 
7.1.3 Reactive Oxygen Species and Caspase-1 Activation  
There is increasing evidence that ROS in addition to other potential activators (Yu et al., 
2008) could also play a role in the maturation of caspase-1, either directly or via activation 
of different components of the inflammasome (Cruz et al., 2007; Dostert et al., 2008; 
Hewinson et al., 2008; Pétrilli et al., 2007b). A study by Sekiyama et al., observed in 
stressed mice that SOD reduced caspase-1 activity and SOD and DPI reduced the 
accumulation of IL-18 in the plasma (Sekiyama et al., 2005). Work from our lab 
demonstrated that LPS/ATP induced processing of IL-1β in THP-1 monocytes and human 
blood-derived monocytes was significantly reduced when cells were pre-incubated with 
either DPI or the ONOO
-
 decomposition catalyst FeTPPS (Hewinson et al., 2008).   
 
As yet a mechanism of how ROS could activate caspase-1 and where activation takes place 
has yet to be fully characterized. As mentioned in the previous chapter ROS could activate 
the p38 MAPK which could ultimately activate caspase-1. However there is another 
mechanism that could potentially activate caspase-1 and this is by modification of the 
protein itself. It has been recently accepted that ROS can act as second messenger 
molecules; however it is unlikely that they are recognized specifically by a protein and 
therefore modulation would not be mediated by their reversible binding to proteins (Rhee 
et al., 2003).  
 
As already stated caspases are cysteine protease and therefore modification of the active 
site cysteine could regulate caspase activity. Similar to phosphorylation of serine, tyrosine, 
histidine, aspartate and threonine residues, the modification of cysteine residues is 
established as a mechanism for controlling protein activity. Cysteine residues are able to 
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sense redox signals because the thiol side-chain (-SH) can be oxidized to several different 
redox states, many of which are reversible (Green et al., 2004) (Figure 7-3).  
 
 
Figure 7-3. Schematic of the Different Redox States of Cysteine. R-S-S-R = disulphide, R-SOH = 
sulphenic acid, R-SNO = S-nitrosothiol, R-SO2H = sulphinic acid, R-SO3H = sulphonic acid, X-SH2 = 
cellular reductant. Adapted from (Green et al., 2004).  
 
The cysteine thiol group can react with RNS (NO, ONOO
-
) in the presence of an electron 
acceptor to form an S-NO bond (Figure 7-4). S-nitrosylated proteins can existed in 
physiological conditions with the concentration of S-NOs varying from nM - µM levels in 
mammalian tissues. Thiol S-nitrosylation and NO transfer reactions are thought to be 
involved in a range of cell signaling events including the regulation of ion channels and G-
protein coupled reactions to receptor stimulation and activation of nuclear regulatory 
proteins. S-nitrosylation of –SH groups can increase or decrease protein activity (Gaston et 
al., 2003). S-nitrosylated proteins can be readily reduced by glutathione (GSH) or 
thioredoxin (Trx); therefore proteins which are endogenously S-nitrosylated are protected 
by compartmentalization into lipophillic protein folds, vesicles and interstitial spaces with 
release into the cytosol initiating denitrosylation.  Both caspase-3 and 9 within the 
mitochondria but not the cytosol has been reported to S-nitrosylated (Mannick et al., 2001). 
The S-nitrosylation of the active site thiol (-SH) of caspase-3 has been observed to keep 
caspase-3 in an inactive state, with denitrosylation initiated by the Fas apoptotic pathway 
allowing the enzyme to function (Mannick et al., 1999). It has therefore been hypothesized 
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that S-nitrosylation could be a general mechanism by which caspase activity is controlled, 
preventing inappropriate caspase autoactivation.  
 
 
Figure 7-4. Schematic of S-Nitrosylation of a Cysteine containing Protein. The cysteine thiol group (-SH) 
can undergo S- Nitrosylation by a direct reaction with either nitric oxide (NO) or peroxynitrite (ONOO
-
). S-
Nitrosylated proteins can be enzymatically denitrosylated by cellular reductants such as GSH and Trx.  
 
Thiol groups (-SH) can also undergo oxidation. The intracellular environment of a cell is 
generally reducing and therefore the cysteine generally exists in its reduced form. Few 
proteins would be expected to possess a cysteine residue vulnerable to oxidation by H2O2 
(Kim et al., 2000) due to Cys-SH being less readily oxidized by H2O2 than the cysteine 
thiolate anion (Cys-S
-
) and the pKa of most cysteines being approximately 8.5.  However 
certain cysteine residues have low pKa values and exist as thiolate anions at neutral pH 
because nearby positively charged amino acid residues are available for interaction with 
the negatively charged thiolate. Proteins with low-pKa
 
cysteine residues could therefore be 
targets of specific oxidation by
 
H2O2, which could be reversed by thiol donors such
 
as 
GSH, glutaredoxin (GRX) and Trx (Rhee et al., 2003).  Meissner et al., reported that 
caspase-1 could be oxidized at S362 and S397 which allowed glutathionylation of these 
residues (Figure 7-5) (Meissner et al., 2008). In this study ROS via oxidation and S-
glutathionylation was observed to decrease caspase-1 activity. A recent study by Huang et 
al., 2008 demonstrated that caspase-3 activity was also inhibited by S-glutathionylation, 
which may suggest the balance of cellular oxidation could differentially regulate caspase 
activity (Huang et al., 2008). This idea is supported by the observation that low 
concentrations of H2O2 (50 µM) but not high concentrations (200 – 500 µM) was effective 
S.F.Moore 
CHAPTER 7: REDOX REGULATION OF CASPASE-1 
175 




Figure 7-5. Schematic of Glutathionylation of a Cysteine Containing Protein. The cysteine thiolate anion 
(-S
-
) can undergo S-glutathionylation by a direct reaction with oxidized glutathione (GSSG) or can be 
oxidized itself (-SOH) and then react with the reduced form of glutathione (GSH). Both reactions can be 
reversed by cellular reductants such as GRX and Trx.  
 
In this study I determined whether ATP evoked ROS generation in murine macrophages 
played a role in activating caspase-1, resulting in the processing of pro-IL-1β to the active 
mature form. I have investigated the potential cell signaling pathways coupling P2X7Rs to 
caspase-1 activation and the importance of ROS directly activating caspase-1 through 
protein modification or by activating signaling cascades upstream of 
inflammasome/caspase-1 activation.  
 
The key findings of this study were:  
1. The flavoprotein oxidoreductase inhibitor DPI inhibited LPS/ATP evoked 
activation of IL-1β. 
2. BMDMø deficient in gp91 and p47 phox processed IL-1β at similar levels to WT.  
3. The mitochondrial complex I inhibitor rotenone partially inhibited LPS/ATP 
evoked IL-1β activation but not cell death. 
4. Trx reductase (TrxR) inhibitors inhibited LPS/ATP evoked IL-1β activation and 
cell death.  
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7.2 RESULTS 
7.2.1 ATP Induces the Processing and Secretion of IL-1β from Murine Macrophages 
Using western blot analysis J774.2 cells primed for 6 hours with LPS (1 µg ml-1) were 
found to contain the pro forms of IL-1β (Figure 7-6A, Figure 7-6B) and caspase-1 (Figure 
7-6C) (n = 3). Stimulating J774.2 cells for 30 minutes with ATP at concentrations ≥ 800 
µM was observed to evoke processing of pro IL-1β into the mature 17kD active form 
(Figure 7-6A). In agreement with other reports mature IL-1β was mainly found to be 
present in the secreted protein fraction and rarely found within the cell, therefore 
suggesting that once IL-1β is fully matured it is rapidly released from the cell. Stimulating 
J774.2 cells for ≥ 15 minutes with 1 mM ATP was observed to induce processing and 
secretion of IL-1β (Figure 7-6B) and the appearance of the p10 subunit of caspase-1 
indicative of caspase-1 activation (Figure 7-6C).  
 
Similar findings where observed using LPS primed BMDMø. 5 mM ATP (30 minutes) was 
observed to evoke robust processing and secretion of IL-1β (Figure 7-7A). 5 mM ATP (30 
minutes) was also observed to increase levels of the p10 subunit of caspase-1 in the cell 









Figure 7-6. ATP Evokes the Activation of IL-1β and Caspase-1 in LPS Primed J774.2 Cells. A, 
Stimulating cells with ATP (30 minutes, 37 
o
C) induced concentration-dependent processing and secretion of 
IL-1β. B, A stimulation of ≥ 15 minutes with 1 mM ATP was required to evoke processing and secretion of 
IL-1β. C, A stimulation of ≥ 15 minutes with 1 mM ATP was required to induce the activation of caspase-1 









Figure 7-7. ATP Evokes the Activation of IL-1β & Caspase-1 in LPS Primed BMDMø. A, Stimulating 
cells with 5 mM ATP (30 minutes, 37 
o
C) induced the processing and secretion of IL-1β. B, Stimulating cells 
with 5 mM ATP (30 minutes, 37 
o
C) induced the activation and secretion of caspase-1 which was determined 
by the appearance of the p10 subunit. All blots are representative of at least 3 experiments.  
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7.2.2 A Flavoprotein Oxidoreductase Inhibitor Blocks IL-1β and Caspase Activation. 
Pre-treatment of J774.2 cells with the flavoprotein oxidoreductase inhibitor; DPI (100 µM, 
1.5 hours) was found to inhibit both secretion of the pro form of IL-1β and the processing 
of IL-1β (Figure 7-8A) (n = 3). In contrast pre-treating J774.2 cells with the caspase-1 
inhibitor; Z-YVAD-FMK (10 µM, 30 minutes) did not inhibit secretion of the pro form of 
IL-1β (Figure 7-8A) (n = 3). However a reduction in the mature form of IL-1β in the 
secreted protein fraction was observed when cells were pre-treated with Z-YAVD-FMK. 
Similar findings were observed using the BMDMø (Figure 7-8C) (n = 3). Western blot 
analysis also revealed that DPI (100 µM, 1.5 hours) reduced the level of the p10 subunit of 
caspase-1 in both J774.2 cell and BMDMø samples, indicative of an inhibition of caspase-
1 activation (Figure 7-8B & D).  
 
7.2.3 Inhibition of NADPH Oxidase Activity Failed to Inhibit Processing of IL-1β 
Based on findings from the previous chapter I hypothesised that the inhibition of IL-1β 
processing by DPI was due to its action on NADPH Oxidase. However pre-treatment of 
J774.2 cells with the NADPH oxidase inhibitor; apocynin (100 µM, 5 minutes) failed to 
inhibit both processing and secretion of IL-1β (Figure 7-9A) (n = 3). Furthermore BMDMø 
lacking in NADPH oxidase activity either due to loss of the gp91phox (Figure 7-9B) (n = 
5) or p47phox subunit (Figure 7-9C) (n = 4) were observed to secrete similar levels of pro 
and mature IL-1β compared to WT. Chronic pre-treatment of J774.2 cells with apocynin 
(100 µM, 6 hours) did result in a reduction in the processing of IL-1β; however the effect 
was variable and was sometimes accompanied by a reduction in pro-IL-1β levels in the cell 
lysates (data not shown). This therefore suggested that chronic apocynin was potentially 
interfering with the priming of the J774.2 cells with LPS. This could potentially be due to 
other effects of apocynin such as its ability to inhibit Rho kinase activity (Schlüter et al., 
2008) or other antioxidant effects not involving NADPH oxidase (Heumüller et al., 2008).  
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Figure 7-8. Modulation of IL-1β Processing & Secretion of DPI and Z-YVAD-FMK. A, ATP (1 mM, 30 
minutes) evoked processing IL-1β was blocked by pre-treating J774.2 cells with DPI (100 µM, 1.5 hours) or 
Z-YVAD-FMK (10 µM, 30 minutes). DPI was also observed to reduce both basal and ATP evoked secretion 
of pro IL-1β. B, ATP (1 mM, 15 minutes) evoked increases in the p10 form of caspase-1 in J774.2 cells were 
blocked by DPI. C, ATP (5 mM, 30 minutes) evoked processing IL-1β was blocked by pre-treating BMDMø 
with DPI (100 µM, 1.5 hours) or Z-YVAD-FMK (YVAD) (10 µM, 30 minutes). DPI was also observed to 
inhibit secretion of pro IL-1β. D, ATP (5 mM, 30 minutes) evoked increases in the p10 form of caspase-1 in 
BMDMø were blocked by DPI. All blots are representative of at least 3 experiments.  
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Figure 7-9. NADPH Oxidase Is Not Required for Processing & Secretion of IL-1β. A, ATP (1 mM, 30 
minutes) evoked processing IL-1β was not inhibited by pre-treating J774.2 cells with apocynin (100 µM, 30 
minutes). B, ATP (5 mM, 30 minutes) evoked processing and secretion of IL-1β in WT and gp91-/- BMDMø.  
C, ATP (5 mM, 30 minutes) evoked processing and secretion of IL-1β in WT and p47-/- BMDMø. All blots 
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7.2.4 Rotenone and Thioredoxin Reductase Inhibitors Block IL-1β Processing  
DPI is a general inhibitor of flavoprotein oxidoreductases and can therefore inhibited other 
enzymes including complex I of the mitochondrial electron transport chain. Pre-treating 
J774.2 cells or BMDMø with the complex I inhibitor rotenone (5 µM, 30 minutes) was 
observed to reduce the levels of mature IL-1β in the secreted protein fraction (Figure 7-
10A, Figure 7-10B) (n = 3). Therefore suggesting that complex I activity maybe required 
for the processing but not secretion of IL-1β.  
 
Several studies have reported cysteine S-nitrosylation as a post-translational mechanism to 
regulate caspase-3 and caspase-1 activity (Fiorucci et al., 2000a; Li et al., 1997a; Mannick 
et al., 1999; Mannick et al., 2001). Casase-1 activity is inhibited by addition of exogenous 
NO via a pathway hypothesised to involve S-nitrosylation of the active site cysteine 
(Fiorucci et al., 2000b; Kim et al., 1998). A recent study reports that the cellular reductant 
Trx acted as a denitrosylase for caspase-3 (Benhar et al., 2008). Trx is a protein that can 
act as an antioxidant by facilitating the reduction of other proteins by cysteine thiol-
disulfide exchange. Trx is itself kept in a reduced form by TrxR which is a flavoprotein 
oxidoreductase and can therefore be inhibited by DPI (Gray et al., 2007). Furthermore 
rotenone has been reported to preferentially oxidise the mitochondrial form of Trx known 
as Trx-2 (Trx-1 is localised to the cytosol) (Ramachandiran et al., 2007). Therefore pre-
treatment of murine macrophages with either DPI or rotenone could be hypothesised to 
result in oxidation of Trx-2.  
 
Use of either of the TrxR inhibitors auranofin (5 µM, 5 minutes) or 2,4-
dinitrochlorobenzene (DNCB) (30 µM, 30 minutes) resulted in a loss of the processing of 
IL-1β into its active form in both J774.2 cells (Figure 7-10A) and BMDMø (Figure 7-10C) 














Figure 7-10. Rotenone & TrxR Inhibition Results in a Reduction of IL-1β Activation. A, ATP (1 mM, 
30 minutes) evoked processing IL-1β was inhibited by pre-treating J774.2 cells with auranofin (5µM, 5 
minutes), DNCB (30 µM, 30 minutes) or rotenone (5 µM, 30 minutes). B, ATP (5 mM, 30 minutes) evoked 
processing IL-1β was inhibited by pre-treating BMDMø with rotenone (5 µM, 30 minutes). C, ATP (5 mM, 
30 minutes) evoked processing IL-1β was inhibited by pre-treating BMDMø with auranofin (5 µM, 5 
minutes) or DNCB (30 µM, 30 minutes). All blots are representative of at least 3 experiments.  
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7.2.5 Thioredoxin Reductase Inhibitors Block ATP Evoked Cell Death 
The reduced form of Trx is known to be able to prevent oxidative stress induced apoptosis 
via mechanisms such as the removal of H2O2 (Andoh et al., 2002) or inhibition of ASK1-
induced apoptosis (Liu et al., 2002).  Therefore inhibitors of TrxR have been observed to 
induce apoptosis in a range of cell types. In order to determine that the effects of the Trx 
inhibitors and rotenone on IL-1β processing were not due to an increase in cell death, 
cytotoxicity studies were performed.  
 
Pre-treatment of J774.2 cells with rotenone (5 µM, 30 minutes) did not significantly 
increase basal or ATP evoked release of LDH (n = 3, p>0.05) (Figure 7-11A). Pre-
treatment of J774.2 cells with auranofin (5 µM, 5 minutes) or DNCB (30 µM, 30 minutes) 
did not significantly increase basal LDH release (n = 3, p>0.05) (Figure 7-11B, Figure 7-
11D). Interestingly ATP evoked LDH release was significantly inhibited by pre-treating 
J774.2 cells with either auranofin (5 µM, 5 minutes) or DNCB (30 µM, 30 minutes) (n = 3, 
p<0.001). EtBr influx evoked by ATP was not significantly changed by auranofin or 
DNCB (n = 3, p>0.05) (Figure 7-11C, Figure 7-11E) therefore suggesting that pore 
formation is not regulated by Trx.  
 
Similar results were observed using BMDMø. Pre-treatment of BMDMø with rotenone 
failed to inhibit either ATP evoked cell death or EtBr influx (n =3, p>0.05) (Figure 7-12A, 
Figure 7-12B). Pre-treatment of BMDMø with auranofin or DNCB inhibited ATP evoked 
cell death (Figure 7-12C, Figure 7-12E) (n = 3, p<0.001). However ATP evoked EtBr 
influx in BMDMø was also inhibited by auranofin and DNCB suggesting that in this cell 
type that (i) EtBr influx/pore opening could be modulated by Trx or (ii) cell lysis could 
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Figure 7-11. TrxR Inhibitors but not Rotenone Inhibit ATP Evoked Cell Death in J774.2 Cells.  A, ATP 
(1 mM, 30 minutes) evoked cell death was not inhibited by pre-treating cells with rotenone (5 µM, 30 
minutes). ATP (1 mM, 30 minutes) evoked cell death was inhibited by pre-treating cells with (B) auranofin 
(5µM, 5 minutes) or (D) DNCB (30 µM, 30 minutes) without effect on EtBr influx (C & D). All bars are n = 
3 ± s.e.m. Two-way Student’s t-test where ***: p<0.001.  
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Figure 7-12. TrxR Inhibitors but not Rotenone Inhibit ATP Evoked Cell Death in BMDMø.  A & B, 
ATP (5 mM, 30 minutes) evoked cell death and EtBr influx was not inhibited by pre-treating cells with 
rotenone (5 µM, 30 minutes). C & D, ATP (5 mM, 30 minutes) evoked cell death and EtBr influx was 
inhibited by pre-treating cells with auranofin (5µM, 5 minutes). E & F, ATP (5 mM, 30 minutes) evoked cell 
death and EtBr influx was inhibited by pre-treating cells with DNCB (30 µM, 30 minutes). All bars are n = 3 
± s.e.m. Two-way Student’s t-test where ***: p<0.001.  
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7.3 DISCUSSION 
In this chapter I have observed that (i) ATP evoked processing of IL-1β and secretion is 
inhibited by a general flavoprotein oxidoreductase inhibitor (DPI), (ii) loss of NADPH 
oxidase activity does not result in a loss of IL-1β processing or secretion, (iii) agents that 
can modulate Trx activity (oxidation) result in the loss of IL-1β processing and (iv) the 
TrxR inhibitors are able to inhibit ATP evoked cell death.  
 
7.3.1 Do Two Distinct Pathways Regulate IL-1β Processing and Secretion? 
In agreement with other studies ATP was observed to induce activation of caspase-1 which 
was accompanied by the processing and rapid secretion of mature/active IL-1β. Pre-
treating cells with DPI or Z-YVAD-FMK was observed to inhibit the processing of pro IL-
1β to mature IL-1β. This observation agrees with previous work demonstrating that 
caspase-1 activation and ultimately IL-1β activation via the NALP3 inflammasome was 
inhibited by DPI (Cruz et al., 2007; Dostert et al., 2008; Hewinson et al., 2008). The 
inhibition of the formation of mature/active IL-1β by Z-YVAD-FMK was not 
accompanied by an inhibition of the release of the pro-peptide which correlated with other 
reports (Laliberte et al., 1999; Mehta et al., 2001). However DPI was observed to inhibit 
release of the pro-peptide, suggesting that the action of DPI was resulting in (i) inhibition 
of caspase-1 activation and therefore IL-1β and (ii) inhibition of a distinct pathway/protein 
involved in the secretory mechanism. Laliberte et al., demonstrated that the caspase-1 
inhibitor ZVAD-DCB inhibited both IL-1β maturation and propeptide secretion whereas 
YVAD-CHO and YVAD-CMK only blocked IL-1β maturation. In their study they also 
determined that the non-selective thiol reagents N-ethylmaleimide (NEM) and 
phenylarsine oxide (PAO) blocked IL-1β maturation and propeptide release (Laliberte et 
al., 1999). This led them to suggest that ZVAD-DCB, NEM and PAO in addition to 
caspase-1 inhibition, could either impair other caspase family members and/or other thiol 
dependent enzymes whose activity is required for the secretory mechanism. We could 
therefore hypothesise that the non-caspase-1 cellular polypeptide that is inhibited by 
ZVAD-DCB is also a target of DPI (Figure 7-13). 
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Figure 7-13. Schematic of the Inhibition of the Maturation of IL-1β & the Release of the Pro-Peptide 
could be Mediated by Two Distinct Thiol Proteases. Caspase-1 is protease mediating the former whereas 
the latter is unknown.  
 
7.3.2 Identification of DPI Target Involved in IL-1β Processing and/or Secretion 
Based on findings from the previous chapter that ATP evoked ROS generation was 
primarily induced by activation of NADPH oxidase and the finding by Dostert et al., that 
NALP3 activation by asbestos and silica was inhibited by pre-treating cells with apocynin 
or knock out of p22phox (a subunit of NADPH oxidase) (Dostert et al., 2008). I 
hypothesised that the effect/s of DPI on IL-1β was due to its action on NADPH Oxidase. 
However the use of apocynin on J774.2 cells, or knocking out either the gp91phox or 
p47phox subunits of NADPH oxidase did not result in significant loss of IL-1β maturation 
of release of the pro-peptide. Other ROS inhibitors such as the glutathione precursor NAC, 
ONOO
-
 decomposer FeTPPS, xanthine oxidase inhibitor allopurinol and SOD resulted in 
either no effect or variable effects on IL-1β processing and secretion (data not shown).  
 
Use of the mitochondrial ETC complex I inhibitor; rotenone did result in robust and 
consistent inhibition of IL-1β maturation without inhibition of release of the pro-peptide. 
Rotenone is able to both increase and decrease ROS production at complex I depending on 
forward (glutamate-malate) or reverse (succinate) electron flux (Batandier et al., 2006). If 
rotenone was increasing the formation of O2
-
 in macrophages, I could hypothesise that the 
resultant increase in H2O2 would be removed by a system involving Trx-2, ultimately 
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leading to formation of oxidised Trx-2 (Ramachandiran et al., 2007) and a potential 




Figure 7-14. Schematic of the Generation & Removal of ROS from the Mitochondria by MnSOD & 
Trx-2.  
 
The only known reducer of Trx is TrxR which is a pyridine nucleotide-disulfide 
oxidoreductase which is closely related to glutathione reductase but
 
has a Cys-SeCys 
(selenocysteine)
 
sequence as an additional redox centre. The antirheumatic 
gold(I)compound auranofin (brand name: Ridaura) is able to bind to the c-terminal 
selenocysteine (Gromer et al., 1998) of  both cytosolic and mitochondrial TrxR inhibiting 
its activity (Omata et al., 2006). Pre-treatment of murine macrophages with auranofin 
resulted in the loss of maturation of IL-1β without inhibition of the secretion of the pro-
peptide. Furthermore use of the contact sensitizer DNCB that is able to inhibit TrxR by the 
irreversible
 
modification of the selenocysteine residue also resulted in the loss of IL-1β 
maturation. These data suggested that reduced Trx is required for the activation of caspase-
1. This could occur by modification of caspase-1 itself or modification of a molecule 
upstream of caspase-1 activation. This modification by Trx could potentially include (i) 
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disulphide bond reduction (Figure 7-15), (ii) reduction of an S-OH group or (iii) 




Figure 7-15. Schematic of Trx Induced Reduction of Protein Disulfide Bonds.  Resultant thiol groups are 
able to undergo oxidation or nitrosylation by ROS and RNS respectively. New bond formation is shown in 
red.  
 
As already stated mitochondrial caspase-3 has been suggested to be maintained in an 
inactive state by nitrosylation of the active site cysteine. Caspase-3 is then activated when 
engagement of the Fas receptor promotes denitrosylation of the active site ultimately 
leading to apoptosis. The precise mechanism of how denitrosylation occurred was until 
recently not known however a study by Benhar et al., determined that it was mediated by 
the Trx-2/TrxR-2 system (Benhar et al., 2008). A similar mechanism of denitrosylation of 
caspase-1 could therefore be hypothesized to occur upon activation of the P2X7R.  
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Figure 7-16. Schematic of how Trx is able to Denitrosylate S-NO groups.  
 
7.3.3 Role of Thioredoxin in ATP Evoked Cell Death 
Inhibitors of TrxR have previously been reported to induce cell death in a range of cell 
types. Pre-treatment of murine macrophages with auranofin or DNCB could have been 
predicted to increase basal and/or ATP evoked LDH release. However both compounds 
failed to significantly increase basal LDH release and furthermore caused a significant 
decrease in ATP evoked LDH release. Although rotenone was observed to inhibit 
maturation of IL-1β it was found to not inhibit ATP evoked LDH release. This could 
reflect (i) its inhibitory action at complex I of the mitochondrial therefore likely to promote 
cell death, although no increase in basal LDH release was observed, (ii) its different mode 
of action on Trx-2 promoting is oxidation rather than inhibition of its reduction or (iii) its 
ability to only act on Trx-2 and not on cytosolic Trx-1.  
 
7.3.4 Concluding Remarks 
Here I demonstrated that extracellular ATP is able to induce maturation and secretion of 
IL-1β and cell death in murine macrophages. Although further work is required to fully 
elucidate the signaling mechanisms involved. However based on these findings I 
hypothesize that (Figure 7-17): 
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1. Secretion of IL-1β (mature and pro-peptide) occurs via a caspase-1 independent 
pathway that is activated by a flavoprotein oxidoreductase/s.  
2. Maturation of IL-1β occurs via a caspase-1 dependent pathway involving Trx-2 
3. Cell death is partially controlled by caspase-1 and involves Trx-1.  
 
Figure 7-17. Schematic of the Maturation of IL-1β & Cell Death Evoked by Extracellular ATP. Based 
on previous literature and the findings of this study I propose that (i) Trx-2 is required for denitrosylation of 
caspase-1 ultimately resulting in maturation of IL-1β and (ii) Trx-1 is required for modification of an 
unidentified protein/molecule and caspase-1 resulting in ATP evoked cell death.  
 
This work highlights how changes in the intracellular oxidative state of a macrophage by 
purinergic receptor activation can lead to a range of pro-inflammatory events subtly 
controlled by different redox signaling molecules and proteins. It is also important to 
remember that the redox status of the cell is controlled by a multitude of mechanisms all of 
which are interlinked.  TrxR inhibitors are already available as disease treatments. 
Auranofin is prescribed to patients with rheumatoid arthritis which is a disease were (i) 
increased levels of IL-1β and ROS are observed (ii) the P2X7R antagonist AZD9056 is in 
phase II clinical trials for and (iii) loss of the P2X7 receptor in animal models can attenuate 
symptoms. This work therefore supports the role of the P2X7R in rheumatoid arthritis. 
Furthermore auranofin could potentially be employed for treatment of other inflammatory 
diseases where the P2X7R/IL-1β is observed to play a role.  
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CHAPTER 8  
CONCLUSIONS AND FUTURE DIRECTIONS 
 
8.1 CONCLUSIONS 
In the preceding chapters I have demonstrated the role extracellular ATP and the 
purinergic receptors can play in immunomodulation and inflammatory responses. From 
this work I can conclude: 
 
1. The extracellular milieu can modulate activation of the P2X7R. With divalent 




 potentially suppressing P2X7R activation under 
physiological conditions. Furthermore the mechanism of divalent cation 
modulation is dependent on the species of receptor, agonist used to activate the 
receptor and other ions present in the extracellular milieu.  
 
2. Activation of the P2X7R can induce apoptotic/pyroptotic events such as reversible 
permeabilisation of the plasma membrane (pore formation), microvesicle shedding 
and translocation of PS from the inner to the outer leaflet of the plasma membrane. 
These events occur prior to the loss of plasma membrane integrity in which release 
of LDH occurs. This supports the notion that the P2X7R is involved in the 
clearance/death of infected or damaged host cells and that over activation of the 
receptor could lead to the full release of the inflammatory contents of a 
macrophage.  
 
3. P2X7R evoked changes in cellular morphology are able to support the 
generation/activation of pro-coagulant factors. These pro-coagulant factors 
themselves are known via PAR’s to mediate the production of pro-inflammatory 
cytokines. This suggests that in inflammatory situations the P2X7R could propagate 
and amplify pro-coagulant process’s which would ultimately lead to a positive 
feedback onto the inflammatory response. This may be of importance in situations 
such as sepsis and atherosclerosis where dysregulation of coagulation and 
inflammation occurs. It may also be of interest in diseases such as RA where PARs, 
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4. Purinergic receptors can couple to the activation of NADPH oxidase leading to the 
generation of ROS, with the localisation of ROS generation occurring potentially at 
the plasma membrane and intracellularly. This may suggest that the purinergic 
receptors could enhance the digestion of phagocytosed bacterium by increasing the 
levels of cytotoxic products required during oxidative burst. Furthermore ROS have 
been observed to play a vital role in the induction of some signaling processes; 
therefore they could potentially be a link between P2 receptor activation and the 
activation of downstream signaling pathways and function responses.  
 
5. The processing of the IL-1β pro-peptide to its activated mature form by LPS/ATP 
requires the activation of caspase-1 and the Trx-TrxR system. Furthermore 
LPS/ATP evoked cell death also requires the caspase-1 and the Trx-TrxR system 
suggesting a similar pathway is activated. However in the case of cell death this 
pathway is insensitive to inhibition of complex I of the ETC. Secretion of the IL-1β 
pro-peptide occurs independently of the Trx-TrxR system and caspase-1.  
 
8.2 FUTURE DIRECTIONS 
8.2.1 What is the Nature of P2X7R Mediated Cell Death in Macrophages? 
Several studies have demonstrated that activation of the P2X7R leads to changes in cellular 
morphology and ultimately loss of cell viability. Depending on the cell system, agonist, 
constituents of the extracellular solution and assays employed to explore these areas 
several different morphological and biochemical changes have been reported. A study by 
Kong et al., stated that the P2X7R induced apoptotic cell death in rat primary cortical 
neurons (Kong et al., 2005). They observed caspase-3 activation, nuclear condensation and 
DNA fragmentation and hypothesised through the use of specific caspase inhibitors that 
apoptosis was occurring through an intrinsic caspase-8/-9/-3 cell death pathway involving 
ERK1/2 and JNK. Whereas Mackenzie et al., using HEK293 transfected with the rP2X7R 
described the sequence of events they observed after brief activation of the P2X7R as 
“pseudoapoptotic” because they observed an almost complete repertoire of extracellular 
events classically associated with apoptosis (Mackenzie et al., 2005). These events such as 
mitochondrial depolarisation and swelling, increases in cytosolic and mitochondrial Ca
2+
, 
exposure of PS, F-actin disruption and zeiotic membrane blebbing; however occurred in 
the absence of the release of cytochrome-c and where reversible. Jun et al., described 
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P2X7R mediated cell death in SN4741 cells; a mouse dopaminergic neuron cell line as 
necrotic (Jun et al., 2007). They observed nuclear swelling and spill over of nuclear DNA 
into the extracellular space, loss of endoplasmic reticulum integrity and the formation of 
cytoplasmic vacuoles. Furthermore these events and subsequent cell death were not 
inhibited by caspase inhibitors.  
 
There are incredible similarities between the events I observed and those reported to occur 
in pyroptosis as activated by microbial pathogens such as Salmonella spp and Listeria spp 
this similarity was also highlighted by Brough et al., (Brough et al., 2007). However recent 
work by Pelegrin et al., determined that the RAW264.7 macrophage cell line that I used for 
my morphological study lacks ASC (Pelegrin et al., 2008). ASC not only forms an 
important part of the caspase-1 activating inflammasome but is hypothesised to form the 
cell death mediating pyroptosome. Therefore the events I observed using the RAW264.7 
cells are not likely to be mediated by caspase-1 activation and therefore could not be 
attributed to pyroptosis. In order to determine the “type” of cell death evoked by ATP in 
macrophages requires a study of the biochemical features such as the dependence of 
caspases, DNA laddering and HMGB1 retention in the nucleus. Furthermore the 
RAW264.7 cell line could be used as a novel tool; with the morphological and biochemical 
features evoked by ATP being compared to those in other macrophage types. Furthermore 
the expression of multiple types of P2 receptor may determine the route of cell death 
induced by ATP; therefore a pharmacological study using P2Y and P2X specific agonists 
and antagonists could be performed to observe their effects on biochemical and 
morphological cell death events.   
 
The signaling pathways involved in extracellular ATP evoked cell death also remain 
elusive. The JNK and p38 MAPK’s are already known to play an important role in the 
induction of apoptosis. Furthermore activation of the P2X7R has been established to 
activate ERK1/2, p38 and JNK (Humphreys et al., 2000; Pfeiffer et al., 2004). Inhibition of 
the p38 MAPK pathway has been observed to: 
• Inhibit BzATP evoked pore formation but not IL-1β processing in LPS/IFNγ 
primed THP-1 monocytes (Donnelly-Roberts et al., 2004). 
• Inhibit BzATP actin reorganisation and membrane blebbing in RAW264.7 cells 
(Pfeiffer et al., 2004). 
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• Inhibit ATP induced DNA fragmentation and PS exposure in RAW264.7 cells 
(Noguchi et al., 2008). 
 
The study by Noguchi et al., determined that ATP on RAW264.7 cells evoked ROS 
generation which in turn  induced apoptosis via an ASK-1/p38 MAPK pathway (Noguchi 
et al., 2008). This observation was of interest; as ASK-1 is found in an inactive form 
bound to reduced Trx. When Trx is oxidised by ROS it dissociates from ASK-1 allowing it 
to autophosphorylate and activate downstream MAPK’s such as p38 (Saitoh et al., 1998). 
This appears to conflict with the observations I made; use of TrxR inhibitors which would 
decrease levels of reduced Trx and therefore decrease the amount of bound/inactivate 
ASK-1 led to a decrease in LPS/ATP evoked cell death in J774.2 cells and BMDMφ. 
However if we were to hypothesise that Trx is involved in denitrosylation of S-nitrosylated 
thiol groups, we would expect that due to transnitrosation that Trx would in turn become 
nitrosylated. S-nitrosylation of reduced Trx by S-nitrosoglutathione (GSNO) has been 
reported to evoke an increase in the activity of ASK-1 in HEK293 cells (Sumbayev, 2003). 
In order to establish a role for p38 MAPK and ASK-1 in ATP or LPS/ATP evoked cell 
death the use of specific p38 MAPK inhibitors such as SB202190 and SB203580 could be 
employed and ASK-1
-/-
 macrophages (Noguchi et al., 2008). The role of reduced and S-
nitrosylated Trx could be determined by observing whether extracellular ATP evokes 
nitrosylation of Trx1 and Trx2 using the Jaffrey biotin-switch method based on western 
blot analysis (Jaffrey et al., 2001). The effect of ATP on levels of oxidised and reduced 
forms of Trx1 and Trx could also be established by employing redox western analysis of 
Trx (Hanson et al., 2004; Ramachandiran et al., 2007; Watson et al., 2003).  
 
Finally another factor to address is potentially that in fact the inducer of LPS/ATP evoked 
cell death is TrxR and not Trx. The observation that rotenone was unable to inhibit 
LPS/ATP evoked cell death initially suggested that perhaps Trx-1 but not Trx-2 was 
involved in mediating cell death. However another way of interpreting this data is that both 
auranofin and DNCB will directly inhibit TrxR while rotenone has effects only on Trx 
itself. TrxRs have broad substrate specificity and are able to reduce ubiquinone (Q10/co-
enzyme Q) (Xia et al., 2003), ascorbic acid (May et al., 1998; May et al., 1997), lipoic acid 
(Nordberg et al., 2001), lipid hydroperoxides and cytochrome-c (Nalvarte et al., 2004). 
The role of TrxR vs. Trx in cell death could perhaps be investigated by employing the use 
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of specific TRX inhibitors such as 1-methylpropyl 2-imidazolyl disulfide (IV-2) 
(Kirkpatrick et al., 1998; Lee et al., 2002) or by knocking out Trx1 or Trx2.  
 
8.2.2 How does Secretion of the Pro and Mature Forms of IL-1β Occur? 
From my study it was determined that LPS/ATP evoked secretion of IL-1β occurred via a 
pathway inhibited by DPI but not dependent on NADPH oxidase, Trx-TrxR or caspase-1. 
We also observed that extracellular ATP in the presence of calcium can evoke the shedding 
of microvesicles; which some groups propose act as a potential vehicle for the release of 
both pro and mature IL-1β (Bianco et al., 2005; MacKenzie et al., 2001). Furthermore 
Bianco et al., determined that microvesicles shed from LPS/ATP stimulated microglia 
contained pro-IL-1β and caspase-1 and where therefore the site of processing of IL-1β.   
 
However the mechanism and signaling pathways involved in the secretion of the IL-1 
cytokines is controversial. As previously stated there have been at least four potential 
release pathways put forward; these being exocytosis of secretory lysosomes (Andrei et al., 
1999), microvesicle shedding, exocytosis of multivesicular bodies (Qu et al., 2007) and 
direct efflux (Brough et al., 2007). Furthermore the signaling mechanisms involved in the 
secretory pathway have been attributed to involve K
+
 efflux, iPLA2, caspase-1, ASC, 
extracellular Ca
2+
 and pannexin-1 (Pelegrin et al., 2008; Qu et al., 2007).  
 
The observations made can differ widely between different research groups, within the 
same group and between different monocyte/macrophage types (Kahlenberg et al., 2004a). 
Some examples include: 
• In my study YVAD-FMK failed to inhibit release of the IL-1β pro-peptide and 
a p20 form of IL-1β but Qu et al., 2007 determined that caspase-1 was required 
for secretion. 
• Qu et al., 2007 determined that extracellular Ca2+ was not required for secretion 
whereas Brough et al., 2003 determined that it was.  
• Pelegrin et al., 2008 observed release of pro-IL-1β from RAW264.7 cells which 
do not express ASC whereas Qu et al., 2007 reported a loss of secretion in 
ASC
-/-
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Pelegrin et al., 2008 hypothesised that there were potentially the existence of multiple 
release pathways for IL-1 cytokines. They put forward three potential secretion pathways: 
1. A cytolytic pathway. 
2. A non cytolytic glycine inhibitable pathway whereby pro-IL-1β is processed 
outside the cell to mature IL-1β by extracellular proteases. 
3. A non cytolytic pannexin-1, inflammasome and caspase-1 dependent pathway. 
 
Studying the secretion of IL-1β separately from the processing of IL-1β appears to be of 
difficulty as many inhibitors of IL-1β secretion prevent IL-1β processing. Some groups 
suggest this is due to processing of IL-1β occurring only outside of the cell which fits with 
several groups finding that only the pro form and never the active/mature form is found in 
the cell lysates (Laliberte et al., 1999; MacKenzie et al., 2001; Perregaux et al., 1994). 
However both Brough et al., 2007 and Qu et al., 2007 observed mature IL-1β in cell 
extracts at early ATP stimulation time points therefore supporting a case for intracellular 
processing. Furthermore examination of western blots in previous reports suggests that 
pro-IL-1β is not always found to be present in the secreted protein fraction even when the 
mature form is present. One way in which to overcome these issues would be to study the 
secretion of IL-1α whose secretion but not activation can be initiated by ATP.  
 
In order for myself to examine the secretory mechanism for murine macrophages, similar 
techniques as to those employed by Qu et al., whereby they determined whether 
endosomal or lysosomal markers were release at similar time points as mature IL-1β (in 
this study pro-IL-1β was not present in the extracellular medium) could be employed. The 
effect of inhibitors which block IL-1β secretion (in the case of my study this was DPI), 
could then be examined on the release of these markers. It may also be of interest to 
examine the effect of other flavoprotein oxidoreductase inhibitors to determine what DPI is 
targeting to have such a profound effect on the secretion of pro-IL-1β. However DPI is 
reported to have other effects such as the inhibition of potassium and calcium channel 
currents (Weir et al., 1994; Wyatt et al., 1994). This observation along with the important 
role K
+
 efflux plays in IL-1β processing and secretion suggests that the effect of potassium 
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8.2.3 How is Trx-TrxR involved in the Processing of IL-1β?  
In this study I established that inhibition of TrxR and the use of the mitochondrial complex 
I inhibitor rotenone could abolish LPS/ATP evoked processing of IL-1β. I hypothesised 
that rotenone lead to the oxidation of Trx2 and therefore a reduction in levels of reduced 
Trx2; implicating that reduced Trx2 was involved in the activation of caspase-1 and 
maturation of IL-1β. However this hypothesis requires further investigation; use of 
techniques described for investigating the role of Trx or TrxR in ATP mediated cell death 
could be employed. This would include knock-down of Trx1 or Trx2 using siRNA or 
specific Trx rather than TrxR inhibitors. Also the examination of how LPS and LPS/ATP 
treatment effects the oxidation state of Trx using an electrophoretic shift assay which can 
determine whether Trx is fully reduced, where one cysteine is reduced or where both 
cysteines are oxidised (Bersani et al., 2002; Hurd et al., 2007).  
 
An important question to answer is how is Trx regulating caspase-1 activation? Is Trx 
inducing denitrosylation of S-nitrosylated caspase-1, similar to that reported for caspase-3 
by Benhar et al., 2008? Use of the Jaffrey biotin-switch method could be employed to 
answer this question. The Trx, Grx and GSH system can cross-talk (Figure 8-1), therefore 
could the Trx system be involved in oxidation and glutathionylation of caspase-1, similar 
to that reported for caspase-1 (Meissner et al., 2008). In the study by Meissner et al., they 
determined that caspase-1 was glutathionylated in SOD1
-/-
 deficient macrophages by 
loading the cells with BioGEE (Invitrogen™, UK) which is a cell-permeant, biotinylated 
glutathione analogue. ATP evoked whole cell glutathionylation could be assessed using a 
fluorescent streptavidin conjugate and FACS or fluorescent microscopy or specific proteins 
could be identified by precipitation from cell lysates with streptavidin-agarose beads and 
detection by western blotting.  
 
The above methods could also be employed to determine whether caspase-1 is the target of 
thiol modification. The lysosomal protease cathepsin B has been observed to evoke the 
activation of mouse caspase-11 (Schotte et al., 1998), which is hypothesised to lie 
upstream of both caspase-1 and caspase-3 activation (Kang et al., 2000).  Furthermore a 
study by Hentze et al determined that the K
+
 ionophore nigericin in the absence of LPS 
priming promoted caspase activation and IL-18 maturation via a cathepsin B dependent 
pathway in the human monocytic cell line; THP-1 (Hentze et al., 2003). Both cathepsin B 
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and caspase-11 are thiol proteases and therefore could be targets of thiol modification by 
the Trx-TrxR system.  
 
Potentially LPS/ATP treatment of macrophages could result in modification of several 
protein thiol groups which in the case of S-NO groups could be identified using the biotin 
switch method or oxidised thiols by using the redox-DIGE as described in Hurd et al., 
2007 followed by peptide mass fingerprinting and tandem mass spectrometry.  
 
 
Figure 8-1. Schematic of the Cross Talk between the Trx, Grx and GSH Systems. Grx is able to convert 
between a dithiol (-SH), glutathionylated (S-SG) and disulphide form (S-S). In doing this it can catalyse the 
glutathionylation and deglutathionylation of protein thiol groups (PrSH) and the reversible formation of 
protein disulphides. Thioredoxin reductase is able to reduce Grx. Adapted from (Hurd et al., 2005) 
 
8.2.4 Does P2X7R Activation Induce Inflammasome Assembly? 
What potentially evokes the formation of the inflammasome? Work by Kanneganti et al.,  
determined that caspase-1 activation could occur independently of TLR activation 
(Kanneganti et al., 2007). Stimulating TLR2 or TLR4 deficient macrophages with TLR 
ligands (3hrs) followed by a 30 min ATP pulse resulted caspase-1 activation equivalent to 
WT. They suggested that ATP evoked opening of the pannexin-1 pore allows the 
intracellular uptake of bacterial component through an endosomal pathway and their 
delivery into the host cytosol where they are sensed by NALP3. Furthermore they 
determined that delivering heat-killed bacteria into the cytosol using the pore-forming 
protein Streptolysin-O evoked caspase-1 activation in the absence of ATP. Therefore is the 
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P2X7R merely providing an entry route for bacterial products and is in fact not involved in 
inflammasome formation or caspase-1 activation directly? This concept would not appear 
to fit with observations made by myself whereby inhibition of TrxR in J774.2 cells resulted 
in loss of IL-1β processing in the absence of any effect on pore-formation and those of 
Hentze et al., 2003 whereby nigericin in the absence of LPS priming evoked caspase-1 
activation.  
 
Therefore a simple experiment would be to determine the effects of LPS vs. ATP vs. 
LPS+ATP on the activation of caspase-1. Further experiments looking at the expression 
and interactions of caspase-1, and other inflammasome components such as NALP3, ASC 
and caspase-11 could be investigated. Potentially LPS may be involved in the upregulation 
of one of more of the inflammasome proteins and that the P2X7R is involved in evoking 
formation of the complex. If associations between inflammasome proteins were observed 
to be evoked by ATP then blockade of K
+
 efflux, Trx-TrxR or iPLA2 could determine 
which signaling pathways are involved in inflammasome assembly.   
 
8.3 FINAL WORD 
Purinergic signaling has come a long way since its foundations in the 1970’s. It has been 
established to be involved in many physiological and pathophysiological responses. Here I 
have demonstrated that extracellular ATP plays an important role in immunomodulation 
and inflammation and is therefore an exciting target for new drug therapies. Currently there 
is an ever growing field developing in determining the role of redox molecules in 
intracellular signaling and the mechanism of how activation of the inflammasome. 
Furthermore the link between these two fields is also being rapidly established with several 
papers published in the past year investigating this link (Cruz et al., 2007; Dostert et al., 
2008; Hewinson et al., 2008; Meissner et al., 2008; Pétrilli et al., 2007b). Activation of the 
NALP3 inflammasome is not only important in conditions involving bacterial infection but 
has also been determined to be activated by asbestos and silica (Dostert et al., 2008), 
amyloid-β  (Halle et al., 2008) and uric acid crystals (Martinon et al., 2006) suggesting that 
unravelling its pathways could help our understanding of diseases such as sepsis, 







Supplementary Data - “GENERAL PHARMACOLOGY & THE EFFECT OF DIVALENT CATIONS 
AT THE MURINE P2X7 RECEPTOR” 
 
 
Figure A-1 P2X7R is Expressed in RAW264.7 Cells. A, Western-blot for the P2X7R in RAW264.7 cells 
and THP-1 monocytes. B, Immunohistochemistry for the P2X7R in RAW264.7 cells. Both performed using 
the anti-P2X7R antibody following the manufacturer’s instructions (Alamone Labs, Bucks, UK). 
 
 
Figure A-2. Pannexin-1 Blockers Failed to Inhibit P2X7R Mediated Dye Uptake in RAW264.7 cells. A, 
Cells pre-treated (45 min) with probenecid (2.5 mM) had similar levels of dye-influx compared to control 
cells. B, Cells pre-treated (30 min) with carbenoxolone (CBX) had increased levels of dye-influx in response 
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Figure A-4. A, SIN-1 Induced ROS Generation in WT (Mouse No. 9) & gp91
-/-
 BMDMø. B, SIN-1 










Figure A-5. Effect of ROS Inhibitors on ATP Evoked Cellular Oxidation in Peritoneal Cells. A, NAC 
(20 mM, 2 hrs) inhibited ATP evoked ROS generation. B, DPI (100 µM, 1.5 hrs) inhibited ATP evoked ROS 
generation. C, Allopurinol (100 µM, 30 min) potentiated ATP evoked ROS generation. D, Rotenone (5 µM, 
30 min) did not effect ATP evoked ROS generation. E, Extracellular SOD (100 U ml
-1
) did not effect ATP 
evoked ROS generation. F, The SOD mimetic Mn-cpx 3 potentiated ATP evoked ROS generation. Student’s 
two-tailed t-test *:p<0.05, **:p<0.01, ***:p<0.001, n = 3 ± s.e.m. Isolation and Culture of Murine Peritoneal 
Cells. Male C57BL/6 mice 8-12 wks of age were sacrificed by cervical dislocation. Native peritoneal cells 
were harvested by peritoneal lavage with 8 ml of DMEM:F12 (1:1). Cells were centrifuged at 240 xg for 4 
minutes at RT (S4180 rotor, Beckman GS-15R). Cells were resuspended in warmed complete culture 
medium, counted and re-seeded as required for experimental assays. After 6 hours incubation complete 
culture medium and suspension cells were aspirated off and the remaining adherent cell population washed 
with complete culture medium. Adherent cells were then primed with 25 ng ml
-1
 LPS overnight (16 – 18 





Figure A-6. Effect of DPI & YVAD on LDH Release from ATP Stimulated Peritoneal Cells.  One-way 





Figure A-7. Effect of CGS 15943 on ROS Generation in J774.2 Cells. n = 1 ± SD.
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